<SEC-DOCUMENT>0000947871-20-000487.txt : 20200518
<SEC-HEADER>0000947871-20-000487.hdr.sgml : 20200518
<ACCEPTANCE-DATETIME>20200518170750
ACCESSION NUMBER:		0000947871-20-000487
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		20
CONFORMED PERIOD OF REPORT:	20200514
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200518
DATE AS OF CHANGE:		20200518

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BOSTON SCIENTIFIC CORP
		CENTRAL INDEX KEY:			0000885725
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				042695240
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11083
		FILM NUMBER:		20890563

	BUSINESS ADDRESS:	
		STREET 1:		300 BOSTON SCIENTIFIC WAY
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752-1234
		BUSINESS PHONE:		508-683-4000

	MAIL ADDRESS:	
		STREET 1:		300 BOSTON SCIENTIFIC WAY
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752-1234
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ss173781_8k.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:BSX="http://BSX/20200514">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" /></head>
<!-- Field: Set; Name: xdx; ID: xdx_029_US%2DGAAP%2D2020 -->
<!-- Field: Set; Name: xdx; ID: xdx_03F_BSX_BSX_20200514 -->
<!-- Field: Set; Name: xdx; ID: xdx_04F_20200514_20200514 -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DEntityCentralIndexKey_0000885725 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
  <ix:hidden>
    <ix:nonNumeric contextRef="From2020-05-14to2020-05-14" name="dei:EntityCentralIndexKey">0000885725</ix:nonNumeric>
    <ix:nonNumeric contextRef="From2020-05-14to2020-05-14" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
    </ix:hidden>
  <ix:references>
    <link:schemaRef xlink:href="bsx-20200514.xsd" xlink:type="simple" />
    </ix:references>
  <ix:resources>
    <xbrli:context id="From2020-05-14to2020-05-14">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-05-14</xbrli:startDate>
        <xbrli:endDate>2020-05-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-05-142020-05-14_custom_CommonStock0.01ParValuePerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BSX:CommonStock0.01ParValuePerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-05-14</xbrli:startDate>
        <xbrli:endDate>2020-05-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-05-142020-05-14_custom_Sec0.625SeniorNotesDue2027Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BSX:Sec0.625SeniorNotesDue2027Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-05-14</xbrli:startDate>
        <xbrli:endDate>2020-05-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    </ix:resources>
  </ix:header>
</div>


<p style="margin: 0"></p>

<p style="font: 14pt/120% Times New Roman, Times, Serif; margin: 0; text-align: center"><b></b></p>

<!-- Field: Rule-Page --><div style="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; font-size: 1pt; border-bottom: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 14pt/120% Times New Roman, Times, Serif; margin: 0; text-align: center"><b>UNITED STATES </b></p>

<p style="font: 14pt/120% Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 12pt/120% Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Washington, DC 20549</b></p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="text-decoration: underline">_____________________________________________________________________</span></p>

<p style="font: 14pt/120% Times New Roman, Times, Serif; margin: 0; text-align: center"><b>FORM <span id="xdx_901_edei--DocumentType_c20200514__20200514_zDlExGEKQoX2"><ix:nonNumeric contextRef="From2020-05-14to2020-05-14" name="dei:DocumentType">8-K</ix:nonNumeric></span> </b></p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: center"><b>PURSUANT TO SECTION 13 OR 15(d) OF THE</b></p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SECURITIES EXCHANGE ACT OF 1934</b></p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="text-decoration: underline">_____________________________________________________________________</span></p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Date of Report (Date of earliest event
reported): <span id="xdx_90E_edei--DocumentPeriodEndDate_c20200514__20200514_zDqNIdgfLKX8"><ix:nonNumeric contextRef="From2020-05-14to2020-05-14" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">May 14, 2020</ix:nonNumeric></span> </b></p>

<p style="font: 16pt/120% Times New Roman, Times, Serif; margin: 0; text-align: center"><b><span style="text-decoration: underline"><span id="xdx_902_edei--EntityRegistrantName_c20200514__20200514_zambrbCs7z14"><ix:nonNumeric contextRef="From2020-05-14to2020-05-14" name="dei:EntityRegistrantName">BOSTON SCIENTIFIC CORPORATION</ix:nonNumeric></span></span></b></p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: center">(Exact name of registrant as specified
in its charter)</p>

<p style="font: 2pt Calibri Light,sans-serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="padding: 1.5pt; vertical-align: top; text-align: center"><span style="font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_904_edei--EntityIncorporationStateCountryCode_c20200514__20200514_zjNhwX28Oy3h"><ix:nonNumeric contextRef="From2020-05-14to2020-05-14" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></span></b></span></td>
    <td style="padding: 1.5pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 1.5pt; vertical-align: top; text-align: center"><span style="font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_909_edei--EntityFileNumber_c20200514__20200514_zgQ9N3Qymd58"><ix:nonNumeric contextRef="From2020-05-14to2020-05-14" name="dei:EntityFileNumber">1-11083</ix:nonNumeric></span></span></b></span></td>
    <td style="padding: 1.5pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 1.5pt; vertical-align: top; text-align: center"><span style="font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_906_edei--EntityTaxIdentificationNumber_c20200514__20200514_z8VfdJnui5C3"><ix:nonNumeric contextRef="From2020-05-14to2020-05-14" name="dei:EntityTaxIdentificationNumber">04-2695240</ix:nonNumeric></span></span></b></span></td></tr>
<tr>
    <td style="padding: 1.5pt; vertical-align: top; text-align: center"><span style="font-size: 10pt">(State or other jurisdiction of incorporation or organization)</span></td>
    <td style="padding: 1.5pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 1.5pt; vertical-align: top; text-align: center"><span style="font-size: 10pt">(Commission File Number)</span></td>
    <td style="padding: 1.5pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 1.5pt; vertical-align: top; text-align: center"><span style="font-size: 10pt">(I.R.S. Employer Identification No.)</span></td></tr>
</table>
<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 31.5pt"><b>&#160;</b></p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 31.5pt"><b><span style="text-decoration: underline"><span id="xdx_90C_edei--EntityAddressAddressLine1_c20200514__20200514_zOKgBsO03i5l"><ix:nonNumeric contextRef="From2020-05-14to2020-05-14" name="dei:EntityAddressAddressLine1">300 Boston Scientific
Way</ix:nonNumeric></span>, <span id="xdx_907_edei--EntityAddressCityOrTown_c20200514__20200514_zgRG9f0fvN22"><ix:nonNumeric contextRef="From2020-05-14to2020-05-14" name="dei:EntityAddressCityOrTown">Marlborough</ix:nonNumeric></span>, <span id="xdx_909_edei--EntityAddressStateOrProvince_c20200514__20200514_zRq3AEdpXG8a"><ix:nonNumeric contextRef="From2020-05-14to2020-05-14" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">Massachusetts</ix:nonNumeric></span></span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
<span style="text-decoration: underline"><span id="xdx_90F_edei--EntityAddressPostalZipCode_c20200514__20200514_z0RLrYAfuuZe"><ix:nonNumeric contextRef="From2020-05-14to2020-05-14" name="dei:EntityAddressPostalZipCode">01752-1234</ix:nonNumeric></span></span></b></p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 1in">(Address of Principal
Executive Offices)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
(Zip Code)</p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><b><span id="xdx_903_edei--CityAreaCode_c20200514__20200514_zJcxNBiUheIh"><ix:nonNumeric contextRef="From2020-05-14to2020-05-14" name="dei:CityAreaCode">508</ix:nonNumeric></span> <span id="xdx_902_edei--LocalPhoneNumber_c20200514__20200514_zWmKsMcWhiEa"><ix:nonNumeric contextRef="From2020-05-14to2020-05-14" name="dei:LocalPhoneNumber">683-4000</ix:nonNumeric></span> </b></p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: center">(Registrant&#8217;s telephone number, including
area code)</p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0 0 12pt">Check the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="padding: 1.5pt"><span style="font: 10pt Arial Unicode MS,serif"><span id="xdx_90A_edei--WrittenCommunications_c20200514__20200514_z5bacPQHQrjl"><ix:nonNumeric contextRef="From2020-05-14to2020-05-14" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="padding: 1.5pt"><span style="font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 1.5pt">&#160;</td>
    <td style="padding: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 1.5pt"><span style="font: 10pt Arial Unicode MS,serif"><span id="xdx_906_edei--SolicitingMaterial_c20200514__20200514_zEJ2rlBecwPb"><ix:nonNumeric contextRef="From2020-05-14to2020-05-14" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="padding: 1.5pt"><span style="font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 1.5pt">&#160;</td>
    <td style="padding: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 1.5pt"><span style="font: 10pt Arial Unicode MS,serif"><span id="xdx_901_edei--PreCommencementTenderOffer_c20200514__20200514_zrPkUzkgGc3d"><ix:nonNumeric contextRef="From2020-05-14to2020-05-14" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="padding: 1.5pt"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 1.5pt">&#160;</td>
    <td style="padding: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 1.5pt"><span style="font: 10pt Arial Unicode MS,serif"><span id="xdx_90F_edei--PreCommencementIssuerTenderOffer_c20200514__20200514_zD28HMqimTYa"><ix:nonNumeric contextRef="From2020-05-14to2020-05-14" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="padding: 1.5pt"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
</table>
<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 12pt 0; border-top-width: 0in; border-top-color: Black">Securities
registered pursuant to Section 12(b) of the Act:</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; padding: 1.5pt; text-align: center"><span style="font-size: 8pt"><b>Title of each class</b></span></td>
    <td style="padding: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding: 1.5pt; text-align: center"><span style="font-size: 8pt"><b>Trading Symbol</b></span></td>
    <td style="padding: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding: 1.5pt; text-align: center"><span style="font-size: 8pt"><b>Name of each exchange on which registered</b></span></td></tr>
<tr>
    <td style="padding: 1.5pt; vertical-align: top; text-align: center"><span style="font-size: 10pt"><span id="xdx_90B_edei--Security12bTitle_c20200514__20200514__us-gaap--StatementClassOfStockAxis__custom--CommonStock0.01ParValuePerShareMember_zWF1jq0BcX9l"><ix:nonNumeric contextRef="From2020-05-142020-05-14_custom_CommonStock0.01ParValuePerShareMember" name="dei:Security12bTitle">Common Stock, $0.01 par value per share</ix:nonNumeric></span></span></td>
    <td style="padding: 1.5pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 1.5pt; vertical-align: top; text-align: center"><span style="font-size: 10pt"><span id="xdx_90A_edei--TradingSymbol_c20200514__20200514__us-gaap--StatementClassOfStockAxis__custom--CommonStock0.01ParValuePerShareMember_zlcyegrIbaC3"><ix:nonNumeric contextRef="From2020-05-142020-05-14_custom_CommonStock0.01ParValuePerShareMember" name="dei:TradingSymbol">BSX</ix:nonNumeric></span></span></td>
    <td style="padding: 1.5pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 1.5pt; vertical-align: top; text-align: center"><span style="font-size: 10pt"><span id="xdx_909_edei--SecurityExchangeName_c20200514__20200514__us-gaap--StatementClassOfStockAxis__custom--CommonStock0.01ParValuePerShareMember_z3tmkRGDLy3l"><ix:nonNumeric contextRef="From2020-05-142020-05-14_custom_CommonStock0.01ParValuePerShareMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonNumeric></span></span></td></tr>
<tr>
    <td style="padding: 1.5pt; vertical-align: top; text-align: center"><span style="font-size: 10pt"><span id="xdx_904_edei--Security12bTitle_c20200514__20200514__us-gaap--StatementClassOfStockAxis__custom--Sec0.625SeniorNotesDue2027Member_zoJyZD56haIc"><ix:nonNumeric contextRef="From2020-05-142020-05-14_custom_Sec0.625SeniorNotesDue2027Member" name="dei:Security12bTitle">0.625% Senior Notes due 2027</ix:nonNumeric></span></span></td>
    <td style="padding: 1.5pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 1.5pt; vertical-align: top; text-align: center"><span style="font-size: 10pt"><span id="xdx_90C_edei--TradingSymbol_c20200514__20200514__us-gaap--StatementClassOfStockAxis__custom--Sec0.625SeniorNotesDue2027Member_zuNs2m2kUl2f"><ix:nonNumeric contextRef="From2020-05-142020-05-14_custom_Sec0.625SeniorNotesDue2027Member" name="dei:TradingSymbol">BSX27</ix:nonNumeric></span></span></td>
    <td style="padding: 1.5pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 1.5pt; vertical-align: top; text-align: center"><span style="font-size: 10pt"><span id="xdx_906_edei--SecurityExchangeName_c20200514__20200514__us-gaap--StatementClassOfStockAxis__custom--Sec0.625SeniorNotesDue2027Member_zBh9eQGubFp9"><ix:nonNumeric contextRef="From2020-05-142020-05-14_custom_Sec0.625SeniorNotesDue2027Member" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonNumeric></span></span></td></tr>
</table>
<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 12pt 0; border-top-width: 0in; border-top-color: Black">Indicate by
check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0 0 12pt; border-top-width: 0in; border-top-color: Black">Emerging growth
company&#160;&#160;&#160;<span style="font-family: Arial Unicode MS,serif"><span id="xdx_902_edei--EntityEmergingGrowthCompany_c20200514__20200514_ztVQWePn22g8"><ix:nonNumeric contextRef="From2020-05-14to2020-05-14" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; border-top-width: 0in; border-top-color: Black">If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with
any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;&#160;<span style="font-family: Arial Unicode MS,serif">&#9744;</span></p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt; border-bottom: Black 2pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0"><b></b></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">&#160;</td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0"><b>ITEM 1.01</b>&#160;&#160;&#160;&#160;<b>ENTRY INTO A MATERIAL
DEFINITIVE AGREEMENT</b></p>

<p style="font: 12pt/120% Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 14, 2020, Boston Scientific Corporation
(the &#8220;Company&#8221;) entered into an Underwriting Agreement, (as supplemented by the Terms Agreement, also dated May 14,
2020, the &#8220;Underwriting Agreement&#8221;), among the Company and Barclays Capital Inc., Citigroup Global Markets Inc., J.P.
Morgan Securities LLC and Wells Fargo Securities, LLC, as representatives of the underwriters named in the Underwriting Agreement
(the &#8220;Underwriters&#8221;), in connection with the Company&#8217;s previously announced pricing of $1.7 billion aggregate
principal amount of senior notes. Pursuant to the Underwriting Agreement, the Underwriters agreed to purchase $500.0 million in
aggregate principal amount of the Company&#8217;s 1.900% Senior Notes due 2025 (the &#8220;2025 Notes&#8221;) and $1.2 billion
in aggregate principal amount of the Company&#8217;s 2.650% Senior Notes due 2030 (the &#8220;2030 Notes&#8221; and, together with
the 2025 Notes, the &#8220;Notes&#8221;) under the Company&#8217;s shelf registration statement on Form S-3 (File No. 333-223095).
The Underwriting Agreement contains customary representations, warranties and agreements of the Company and customary conditions
to closing, indemnification rights and obligations of the parties and termination provisions. The Underwriters and their affiliates
have performed commercial banking, investment banking and advisory services for the Company from time to time for which they have
received customary fees and expenses. The Underwriters and their affiliates may, from time to time, engage in transactions with
and perform services for the Company in the ordinary course of their business.</p>

<p style="font: 12pt/120% Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: justify">The Notes were issued pursuant to an indenture
dated as of May 29, 2013 between the Company and U.S. Bank National Association, as trustee (the &#8220;Indenture&#8221;). The
Indenture contains covenants that restrict the Company&#8217;s ability, with certain exceptions, to (i) merge or consolidate with
another entity or transfer all or substantially all of its property and assets, and (ii) incur liens. These covenants are subject
to important exceptions and qualifications, as described in the Indenture. The Indenture also provides for customary events of
default. Additional terms of each series of Notes are set forth in the form of notes corresponding to such series.</p>

<p style="font: 12pt/120% Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: justify">The foregoing descriptions of the Underwriting
Agreement, the Indenture and the Notes are summaries and are qualified in their entirety by reference to such documents, which
are attached as Exhibits 1.1, 4.1, 4.2 and 4.3 to this Current Report on Form 8-K, respectively, and all of which are incorporated
herein by reference.</p>

<p style="font: 12pt/120% Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0"><b>ITEM 8.01 &#160;&#160;&#160;&#160;OTHER EVENTS</b></p>

<p style="font: 12pt/120% Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0"><i>Closing of Notes Offering</i></p>

<p style="font: 12pt/120% Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 18, 2020, the Company completed
the offering of the Notes. The net proceeds from the offering of the Notes, after deducting underwriting discounts and estimated
offering expenses, were approximately $1,682.2 million. As previously announced, the Company intends to use the net proceeds from
the offering of the Notes towards (i) refinancing $450.0 million of borrowings under its revolving credit facility and a portion
of its pre-payable bank debt, including $750.0 million under its $1.0 billion term loan credit facility maturing in February 2021
and $500.0 million under its $1.25 billion term loan credit facility maturing in April 2021 and (ii) paying related fees, expenses
and premiums.</p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: justify">A copy of the press release pertaining
to the completion of the offering of the Notes is filed with this report as Exhibit&#160;99.1 and incorporated herein by reference.</p>

<p style="font: 12pt/120% Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">&#160;</td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: justify">Additionally, in connection with the offering
of the Notes, the Company is filing a legal opinion regarding the validity of the Notes, attached as Exhibit 5.1 to this Current
Report on Form 8-K.</p>

<p style="font: 12pt/120% Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0"><b>ITEM 9.01. &#160;&#160;&#160;&#160;FINANCIAL STATEMENTS
AND EXHIBITS.</b></p>

<p style="font: 12pt/120% Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0">(d)&#160;&#160;Exhibits</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td colspan="3">&#160;</td></tr>
<tr>
    <td style="width: 15%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 84%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; padding: 1.5pt"><span style="font-size: 9pt"><b>Exhibit No.</b></span></td>
    <td style="padding: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding: 1.5pt"><span style="font-size: 9pt"><b>Description </b></span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 1.5pt">&#160;</td>
    <td style="padding: 1.5pt">&#160;</td>
    <td style="padding: 1.5pt">&#160;</td></tr>
<tr>
    <td style="padding: 1.5pt; vertical-align: top"><span style="font-size: 10pt"><a href="ss173781_ex0101.htm">1.1</a>*</span></td>
    <td style="padding: 1.5pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 1.5pt; vertical-align: bottom"><a href="ss173781_ex0101.htm"><span style="font-size: 10pt">Underwriting Agreement, dated as of May 14, 2020, as supplemented by the Terms Agreement, dated May 14, 2020, among Boston Scientific Corporation and Barclays Capital Inc., Citigroup Global Markets Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, as representatives of the underwriters.</span></a></td></tr>
<tr>
    <td style="padding: 1.5pt; vertical-align: top"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/885725/000104746913006559/a2215392zex-4_1.htm">4.1</a></span></td>
    <td style="padding: 1.5pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 1.5pt; vertical-align: bottom"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/885725/000104746913006559/a2215392zex-4_1.htm">Indenture dated as of May&#160;29, 2013, between Boston Scientific Corporation and&#160;U.S. Bank National Association, as trustee (filed as Exhibit&#160;4.1 to the Company&#8217;s Registration Statement on Form&#160;S-3 filed on May&#160;29, 2013 and incorporated herein by reference).</a></span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 1.5pt"><span style="font-size: 10pt"><a href="ss173781_ex0402.htm">4.2</a>*</span></td>
    <td style="padding: 1.5pt">&#160;</td>
    <td style="padding: 1.5pt"><a href="ss173781_ex0402.htm"><span style="font-size: 10pt">Form of 1.900% Senior Note due 2025.</span></a></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 1.5pt"><span style="font-size: 10pt"><a href="ss173781_ex0403.htm">4.3</a>*</span></td>
    <td style="padding: 1.5pt">&#160;</td>
    <td style="padding: 1.5pt"><span style="font-size: 10pt"><a href="ss173781_ex0403.htm">Form of 2.650% Senior Note due 2030.</a></span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 1.5pt"><span style="font-size: 10pt"><a href="ss173781_ex0501.htm">5.1</a>*</span></td>
    <td style="padding: 1.5pt">&#160;</td>
    <td style="padding: 1.5pt"><span style="font-size: 10pt"><a href="ss173781_ex0501.htm">Opinion dated May 18, 2020&#160;of Shearman&#160;&#38; Sterling LLP.</a></span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 1.5pt"><span style="font-size: 10pt"><a href="ss173781_ex0501.htm">23.1</a>*</span></td>
    <td style="padding: 1.5pt">&#160;</td>
    <td style="padding: 1.5pt"><span style="font-size: 10pt"><a href="ss173781_ex0501.htm">Consent of Shearman&#160;&#38; Sterling LLP (included in Exhibit&#160;5.1).</a></span></td></tr>
<tr>
    <td style="padding: 1.5pt; vertical-align: bottom"><span style="font-size: 10pt"><a href="ss173781_ex9901.htm">99.1</a>*</span></td>
    <td style="padding: 1.5pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 1.5pt; vertical-align: top"><span style="font-size: 10pt"><a href="ss173781_ex9901.htm">Press Release issued by Boston Scientific Corporation dated May 18, 2020.</a></span></td></tr>
<tr>
    <td style="padding: 1.5pt; vertical-align: bottom"><span style="font-size: 10pt">104</span></td>
    <td style="padding: 1.5pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 1.5pt; vertical-align: top"><span style="font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document).</span></td></tr>
<tr>
    <td style="padding: 1.5pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 1.5pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 1.5pt; vertical-align: top">&#160;</td></tr>
</table>
<p style="font: 12pt/120% Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">* Documents filed or furnished with this report.</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 6pt 0.75pt"></p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">&#160;</td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SIGNATURE</b></p>

<p style="font: 12pt/120% Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0">Pursuant to the requirements of the Securities Exchange Act
of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p>

<p style="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-indent: 4in">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td colspan="4">&#160;</td></tr>
<tr>
    <td style="width: 6%">&#160;</td>
    <td style="width: 38%">&#160;</td>
    <td style="width: 5%">&#160;</td>
    <td style="width: 51%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 1.5pt; text-align: right"><span style="font-size: 10pt">Date:</span></td>
    <td style="padding: 1.5pt"><span style="font-size: 10pt">May 18, 2020</span></td>
    <td colspan="2" style="padding: 1.5pt"><span style="font-size: 10pt">BOSTON SCIENTIFIC CORPORATION</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 1.5pt">&#160;</td>
    <td style="padding: 1.5pt">&#160;</td>
    <td style="padding: 1.5pt">&#160;</td>
    <td style="padding: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 1.5pt">&#160;</td>
    <td style="padding: 1.5pt">&#160;</td>
    <td style="padding: 1.5pt"><span style="font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; padding: 1.5pt"><span style="font-size: 10pt">/s/ Vance R. Brown</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 1.5pt">&#160;</td>
    <td style="padding: 1.5pt">&#160;</td>
    <td style="padding: 1.5pt">&#160;</td>
    <td style="padding: 1.5pt"><span style="font-size: 10pt">Vance R. Brown</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 1.5pt">&#160;</td>
    <td style="padding: 1.5pt">&#160;</td>
    <td style="padding: 1.5pt">&#160;</td>
    <td style="padding: 1.5pt"><span style="font-size: 10pt">Vice President and Chief Corporate Counsel</span></td></tr>
</table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 6pt 0.75pt"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 100%"><div style="border-top: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 6pt 0.75pt">&#160;</p>


</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJx1kNFKwzAUhp9g73Aoeje6NLM6emmdQ9xGWWV4G9szDWtzykk63SP5lqYpwxsNgZCc/ztfOFE0jVb0qBtkeL3freEF265RDmGHB2Q0FfpE/vScgT93+K6tY2VcuF7AnDyDnknjufLvIXnSFusMRDpLFjMpQMyzmwUUm2gy1HMyB12jcVo1oEwNBVPHGp3i89jhRX2RofYcTHtkq8lkkMRiLH+DFImELZ3UJ/HRwnqdR5NpWJNoxdR3g6a3jlpYNth6lx3R3x2+UoVMVmIl4luZlmg08ZYc2ocepZB3G2zfkH0yEdJL0+VIh/Q1jHkIANQ9woD80d8PqSVTOqqOIhZJoXivmh4L5PJDMf4jGSkI2BSuBhI6xXAaWOj88O1AX3w/FlqFkA== -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ss173781_ex0101.htm
<DESCRIPTION>UNDERWRITING AGREEMENT, DATED AS OF MAY 14, 2020
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>


<P STYLE="text-align: right; margin: 0"><B>Exhibit 1.1</B></P>

<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="margin: 0; text-align: right"><B>EXECUTION VERSION</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">BOSTON SCIENTIFIC CORPORATION<BR>
Debt Securities</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">UNDERWRITING AGREEMENT-BASIC PROVISIONS</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: right">May 14, 2020</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt">To:&#9;The Underwriters named in the within-mentioned Terms
Agreement</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt">Ladies and Gentlemen:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Boston Scientific Corporation (the &ldquo;Company&rdquo;)
proposes to issue and sell its Debt Securities having an aggregate principal amount of U.S. $1,700,000,000 or the equivalent thereof
in foreign currencies or currency units (the &ldquo;Securities&rdquo;). The Securities will be issued under an indenture dated
as of May 29, 2013 between the Company and U.S. Bank National Association, as trustee (the &ldquo;Trustee&rdquo;), as supplemented
from time to time by supplemental indentures and/or modified from time to time by resolutions of the Board of Directors of the
Company, Pricing Certificate of Authorized Officers thereof or Officer&rsquo;s Certificate as provided in Section 301 of such indenture
(such indenture as so supplemented and/or modified being hereinafter referred to as the &ldquo;Indenture&rdquo;).</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Whenever the Company determines to make
an offering of Securities, it will enter into an agreement substantially in the form of Exhibit A hereto (a &ldquo;Terms Agreement&rdquo;)
providing for the sale of such Securities to, and the purchase and offering thereof by, the underwriter or underwriters named therein
(each an &ldquo;Underwriter&rdquo; and, collectively, the &ldquo;Underwriters&rdquo; or &ldquo;you,&rdquo; which terms shall include
the underwriter or underwriters named therein whether acting alone in the resale of the Securities or as members of an underwriting
syndicate). The Terms Agreement relating to each offering of Securities shall specify the principal amount of Securities to be
issued and their terms not otherwise specified in the Indenture, the name or names of the Underwriters participating in such offering
(subject to substitution as provided in Section 10 hereof) and the principal amount of Securities which each severally agrees to
purchase, the name or names of each Underwriter acting as a &ldquo;Representative,&rdquo; manager or co-manager in connection with
such offering, if any, the price at which the Securities are to be purchased by the Underwriters from the Company, the initial
public offering price, any delayed delivery arrangements and the time and place of delivery and payment. Each offering of Securities
will be governed by this underwriting agreement (the &ldquo;Agreement&rdquo;), as supplemented by the applicable Terms Agreement,
and this Agreement and such Terms Agreement shall inure to the benefit of and be binding upon each Underwriter participating in
the offering of such Securities.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations
and Warranties</U>. The Company represents and warrants to you that as of the date hereof, as of the Applicable Time and as of
the Closing Time (each as hereinafter defined) under such Terms Agreement (in each case, the &ldquo;Representation Date&rdquo;)
as set forth below. Certain terms used in this Section 1 are defined in paragraphs (C) and (D) hereof.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
the offering of the Securities is a Delayed Offering (as specified in the relevant Terms Agreement), paragraph (i) below is applicable
and, if the offering of the Securities is a Non-Delayed Offering (as so specified), paragraph (ii) below is applicable.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company meets the requirements for the use of Form S-3 under the Securities Act of 1933, as amended (the &ldquo;1933 Act&rdquo;),
and the rules and regulations promulgated thereunder (the &ldquo;Regulations&rdquo;), and has filed with the Securities and Exchange
Commission (the &ldquo;Commission&rdquo;) a registration statement (File No. 333-223095) on such Form, including a Basic Prospectus,
for registration under the 1933 Act of the offering and sale of the Securities. </P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in">The Company may have filed one or more amendments
thereto, and may have used a Preliminary Prospectus, each of which has previously been furnished to you. Such registration statement,
as amended, including the financial statements, exhibits and schedules thereto, at each time of effectiveness under the 1933 Act,
including any required information deemed to be a part thereof at the time of effectiveness pursuant to Rule 430B under the 1933
Act or the Securities Exchange Act of 1934, as amended (the &ldquo;1934 Act&rdquo;), is called the &ldquo;Registration Statement.&rdquo;
Such Registration Statement, as so amended, has become effective. The offering of the Securities is a Delayed Offering and, although
the Basic Prospectus may not include all the information with respect to the Securities and the offering thereof required by the
1933 Act and the rules thereunder to be included in the Final Prospectus, the Basic Prospectus included all such information required
by the 1933 Act and the rules thereunder to be included therein as of the Effective Date. The Company will next file with the Commission
pursuant to Rules 415 and 424(b) a Final Prospectus relating to the Securities and the offering thereof. The Final Prospectus shall
only contain information in the Disclosure Package (as hereinafter defined) and the Final Term Sheet (as hereinafter defined),
except to the extent the Representatives shall agree to any additional information.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company meets the requirements for the use of Form S-3 under the 1933 Act and has filed with the Commission a registration statement
(File No. 333-223095) on such Form, including a Basic Prospectus, for registration under the 1933 Act of the offering and sale
of the Securities. The Company may have filed one or more amendments thereto, and including a Preliminary Prospectus, each of which
has previously been furnished to you. Such registration statement, as amended, including the financial statements, exhibits and
schedules thereto, at each time of effectiveness under the 1933 Act, including any required information deemed to be a part thereof
at the time of effectiveness pursuant to Rule 430B under the 1933 Act or the 1934 Act, is called the &ldquo;Registration Statement.&rdquo;
The Company will next file with the Commission either (x) a Final Prospectus relating to the Securities in accordance with Rules
430B and 424(b), or (y) prior to the effectiveness of such Registration Statement, an amendment to such Registration Statement,
including the form of Final Prospectus. In the case of clause (x), the Company has included in such Registration Statement, as
amended at the Effective Date, all information (other than Rule 430B Information) required by the 1933 Act and the rules thereunder
to be included in the Final Prospectus with respect to the Securities and the offering thereof. The Final Prospectus shall only
contain information in the Disclosure Package (as hereinafter defined) and the Final Term Sheet (as hereinafter defined), except
to the extent the Representatives shall agree to any additional information.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
the Effective Date, the Registration Statement did, at the Applicable Time the Preliminary Prospectus did, and when the Final Prospectus
is first filed (if required) in accordance with Rule 424(b) and at the Closing Time, the Final Prospectus (and any supplement thereto)
will, comply in all material respects with the applicable requirements of the 1933 Act, the 1934 Act and the Trust Indenture Act
of 1939, as amended (the &ldquo;Trust Indenture Act&rdquo;), and the respective rules thereunder; on the Effective Date, the Registration
Statement did not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein
or necessary in order to make the statements therein not misleading; the Indenture complies in all material respects with the requirements
of the Trust Indenture Act and the rules thereunder; and the Final Prospectus will not, on the date such Final Prospectus is first
issued and at the Closing Time, include any untrue statement of a material fact or omit to state a material fact necessary in order
to make the statements therein, in the light of the circumstances under which they were made, not misleading; <U>provided</U>,
<U>however</U>, that the Company makes no representations or warranties as to (i) that part of the Registration Statement which
shall constitute the Statement of Eligibility and Qualification (Form T-1) under the Trust Indenture Act of the Trustee or (ii)
the information contained in or omitted from the Registration Statement or the Final Prospectus (or any supplement thereto) in
reliance upon and in conformity with information furnished in writing to the Company by or on behalf of any Underwriter through
the Representatives specifically for inclusion in the Registration Statement or the Final Prospectus (or any supplement thereto);
it being understood and agreed that the only such information furnished by or on behalf of any Underwriter consists of the information
in Exhibit 1 to the Terms Agreement.</P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
term &ldquo;Disclosure Package&rdquo; shall mean (i) the Basic Prospectus, including any preliminary prospectus supplement, as
amended or supplemented prior to the Applicable Time, (ii) the Issuer Free Writing Prospectuses (as defined below), if any, identified
in Annex A to the Terms Agreement, (iii) any other free writing prospectus that the parties hereto shall hereafter expressly agree
in writing to treat as part of the Disclosure Package and (iv) the Final Term Sheet, which shall be identified in Annex B to the
Terms Agreement. As of the Applicable Time, the Disclosure Package did not, and at the Closing Time will not, contain any untrue
statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light
of the circumstances under which they were made, not misleading; <U>provided</U>, <U>however</U>, that the Company makes no representations
or warranties as to the information contained in or omitted from the Disclosure Package in reliance upon and in conformity with
information furnished in writing to the Company by or on behalf of any Underwriter through the Representatives specifically for
inclusion in the Disclosure Package; it being understood and agreed that the only such information furnished by or on behalf of
any Underwriter consists of the information in Exhibit 1 to the Terms Agreement.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">D.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
terms which follow, when used in this Agreement, shall have the meanings indicated. The term &ldquo;the Effective Date&rdquo; shall
mean each date that the Registration Statement and any post-effective amendment or amendments thereto became or become effective.
&ldquo;Applicable Time&rdquo; shall mean the date and time on the date of execution of the Terms Agreement (as set forth in the
Terms Agreement), which the Company has informed the Underwriters as the time when sales of the Securities may be first made by
the Underwriters in the offering. &ldquo;Basic Prospectus&rdquo; shall mean the prospectus referred to in paragraph (A)(i) above
contained in the Registration Statement at the Effective Date including, in the case of a Non-Delayed Offering, any Preliminary
Prospectus. &ldquo;Preliminary Prospectus&rdquo; shall mean any preliminary prospectus supplement to the Basic Prospectus which
describes the Securities and the offering thereof including the Basic Prospectus and is used prior to filing of the Final Prospectus.
&ldquo;Final Prospectus&rdquo; shall mean the final prospectus supplement relating to the Securities that is filed pursuant to
Rule 424(b) after the Applicable Time, together with the Basic Prospectus or, if, in the case of a Non-Delayed Offering, no filing
pursuant to Rule 424(b) is required, shall mean the form of final prospectus relating to the Securities, including the Basic Prospectus,
included in the Registration Statement at the Effective Date. Any reference herein to the Registration Statement, the Basic Prospectus,
any Preliminary Prospectus, the Disclosure Package or the Final Prospectus shall be deemed to refer to and include the documents
incorporated by reference therein pursuant to Item 12 of Form S-3 which were filed under the 1934 Act on or before the Effective
Date of the Registration Statement or the issue date of the Basic Prospectus, any Preliminary Prospectus, the Disclosure Package
or the Final Prospectus, as the case may be; and any reference herein to the terms &ldquo;amend,&rdquo; &ldquo;amendment&rdquo;
or &ldquo;supplement&rdquo; with respect to the Registration Statement, the Basic Prospectus, any Preliminary Prospectus, the Disclosure
Package or the Final Prospectus shall be deemed to refer to and include the filing of any document under the 1934 Act after the
Effective Date or the issue date of the Basic Prospectus, any Preliminary Prospectus, the Disclosure Package or the Final Prospectus,
as the case may be, deemed to be incorporated therein by reference; <U>provided</U> that no such document filed after the Applicable
Time shall be deemed incorporated into the Disclosure Package. A &ldquo;Non-Delayed Offering&rdquo; shall mean an offering of securities
which is intended to commence promptly after the effective date of the Registration Statement, with the result that, pursuant to
Rules 415 and 430B, all information (other than Rule 430B Information) with respect to the securities so offered must be included
in such Registration Statement at the effective date thereof. A &ldquo;Delayed Offering&rdquo; shall mean an offering of securities
pursuant to Rule 415 which does not commence promptly after the effective date of the Registration Statement, with the result that
only information required pursuant to Rule 415 need be included in such Registration Statement at the effective date thereof with
respect to the securities so offered. Whether an offering of the Securities is a Non-Delayed Offering or a Delayed Offering shall
be set forth in the relevant Terms Agreement.</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">E.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)
At the time of filing the Registration Statement, (ii)&nbsp;at the time of the most recent amendment thereto for the purposes of
complying with Section&nbsp;10(a)(3) of the 1933 Act (whether such amendment was by post-effective amendment, incorporated report
filed pursuant to Section&nbsp;13 or&nbsp;15(d) of the 1934 Act or form of prospectus), (iii) at the time the Company or any person
acting on its behalf (within the meaning, for this clause only, of Rule&nbsp;163(c) of the 1933 Act) made any offer relating to
the Securities in reliance on the exemption of Rule&nbsp;163 of the 1933 Act, and&nbsp;(iv)&nbsp;at the Applicable Time (with such
date being used as the determination date for purposes of this clause (iv)), the Company was, is and will be a &ldquo;well-known
seasoned issuer&rdquo; as defined in Rule&nbsp;405 of the 1933 Act. The Registration Statement is an &ldquo;automatic shelf registration
statement,&rdquo; as defined in Rule&nbsp;405 of the 1933 Act, that initially became effective within three years of the date hereof,
and the Company has not received from the Commission any notice pursuant to Rule 401(g)(2) of the 1933 Act objecting to use of
the automatic shelf registration statement form and the Company has not otherwise ceased to be eligible to use the automatic shelf
registration statement form. No order suspending the effectiveness of the Registration Statement has been issued by the Commission
and no proceeding for that purpose or pursuant to Section 8A of the 1933 Act against the Company or related to the offering of
the Securities has been initiated or, to the Company&rsquo;s knowledge, threatened by the Commission.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">F.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;At
the earliest time after the filing of the Registration Statement relating to the Securities that the Company or another offering
participant made a <I>bona fide</I> offer (within the meaning of Rule 164(h)(2)) of the 1933 Act and (ii) as of the Applicable
Time, the Company was not and is not an Ineligible Issuer (as defined in Rule 405 of the 1933 Act), without taking account of any
determination by the Commission pursuant to Rule 405 of the 1933 Act that it is not necessary that the Company be considered an
Ineligible Issuer.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">G.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither
any issuer free writing prospectus as defined in Rule 433 of the 1933 Act (each, an &ldquo;Issuer Free Writing Prospectus&rdquo;)
(which shall include any electronic road show) nor the Final Term Sheet, as of its issue date and at all subsequent times through
the completion of the offering of the Securities or until any earlier date that the Company notified or notifies the Representatives
as described in the next sentence, did not, does not and will not include any information that conflicted, conflicts or will conflict
with the information contained in the Registration Statement, including any document incorporated by reference therein that has
not been superseded or modified. If at any time following issuance of an Issuer Free Writing Prospectus there occurred or occurs
an event or development as a result of which such Issuer Free Writing Prospectus conflicted or would conflict with the information
contained in the Registration Statement, the Company has promptly notified or will promptly notify the Representatives and has
promptly amended or supplemented or will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus
to eliminate or correct such conflict. The foregoing two sentences do not apply to statements in or omissions from any Issuer Free
Writing Prospectus based upon and in conformity with written information furnished to the Company by any Underwriter through the
Representatives specifically for use therein, <FONT STYLE="letter-spacing: -0.15pt">it being understood and agreed that the only
such information furnished by any Underwriter consists of the information described as such Exhibit 1 to the Terms Agreement</FONT>.</P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">H.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company has not distributed and will not distribute, prior to the later of the Closing Time and the completion of the Underwriters&rsquo;
distribution of the Securities, any offering material in connection with the offering and sale of the Securities other than the
Preliminary Prospectus, the Final Prospectus, any Issuer Free Writing Prospectus reviewed and consented to by the Representatives
and included in Annex A to the Terms Agreement or the Registration Statement.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">I.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
consolidated financial statements included or incorporated by reference in the Registration Statement, the Disclosure Package and
the Final Prospectus present fairly in all material respects the consolidated financial position of the Company and its consolidated
subsidiaries as at the dates indicated and the results of their operations for the periods specified; said financial statements
have been prepared in conformity with generally accepted accounting principles applied on a consistent basis during the periods
involved, except as indicated therein; the supporting schedules included or incorporated by reference in the Registration Statement,
if any, present fairly the information required to be stated therein; if pro forma financial statements are included or incorporated
by reference in the Registration Statement, the Disclosure Package and the Final Prospectus, the assumptions used in preparing
the pro forma financial statements included therein provide a reasonable basis for presenting the significant effects directly
attributable to the transactions or events described therein, the related pro forma adjustments give appropriate effect to those
assumptions, and the pro forma columns therein reflect the proper application of those adjustments to the corresponding historical
financial statement amounts. No pro forma financial information is required to be filed with the Commission pursuant to any acquisitions
or dispositions by the Company pursuant to Regulation S-X with respect to any acquisitions or dispositions by the Company since
January 1, 2017.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">J.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
documents incorporated by reference in the Final Prospectus and the Disclosure Package, at the time they were or hereafter are
filed with the Commission, complied and will comply in all material respects with the requirements of the 1934 Act and the rules
and regulations thereunder, and, when read together and with the other information in the Final Prospectus, the Disclosure Package
and the Registration Statement, at each Representation Date, did not and will not contain an untrue statement of a material fact
or omit to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the
circumstances under which they were made, not misleading.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">K.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Since
the respective dates as of which information is given in the Registration Statement, the Disclosure Package and the Final Prospectus,
except as may otherwise be stated therein or contemplated thereby, (i) there has been no material adverse change in the condition
(financial or other), earnings, results of operations, business or properties of the Company and its subsidiaries, considered as
one enterprise, whether or not arising from transactions in the ordinary course of business and (ii) there have been no material
transactions entered into by the Company or any of its subsidiaries, other than those in the ordinary course of business.</P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">L.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company has been duly incorporated and is validly existing as a corporation in good standing under the laws of the State of Delaware
with corporate power and authority to own, lease and operate its properties and conduct its business as now being conducted and
as described in the Registration Statement, the Disclosure Package and the Final Prospectus; and the Company is duly qualified
as a foreign corporation to transact business and is in good standing in each jurisdiction in which such qualification is required,
whether by reason of the ownership or leasing of property or the conduct of business, except where the failure to so qualify would
not have a material adverse effect on the condition (financial or other), earnings, results of operations, business or properties
of the Company and its subsidiaries, considered as one enterprise (a &ldquo;Material Adverse Effect&rdquo;).</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">M.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Schedule
I hereto sets forth each domestic and foreign subsidiary of the Company which the Company deems to be a &ldquo;significant subsidiary&rdquo;
(each, a &ldquo;Material Subsidiary&rdquo; and collectively, the &ldquo;Material Subsidiaries&rdquo;). Each Material Subsidiary
of the Company has been duly incorporated and is validly existing as a corporation in good standing under the laws of the jurisdiction
of its incorporation, has corporate power and authority to own, lease and operate its properties and conduct its business as described
in the Registration Statement, the Disclosure Package and the Final Prospectus and is duly qualified as a foreign corporation to
transact business and is in good standing in each jurisdiction in which such qualification is required, whether by reason of the
ownership or leasing of property or the conduct of business, except where the failure to be in good standing or to so qualify would
not have a Material Adverse Effect, and, except as otherwise disclosed in the Registration Statement, the Disclosure Package or
the Final Prospectus, all of the issued and outstanding capital stock of each such Material Subsidiary has been duly authorized
and validly issued, is fully paid and non-assessable and is owned by the Company (except for directors&rsquo; qualifying shares
and shares held by individuals for the purpose of satisfying the legal requirements of the jurisdiction of incorporation), directly
or through subsidiaries, free and clear of any security interest, mortgage, pledge, lien, encumbrance, claim or equity.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">N.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither
the Company nor any of its subsidiaries is in violation of its or any of their charters or bylaws, or in default in the performance
or observance of any obligation, agreement, covenant or condition contained in any contract, indenture, mortgage, loan agreement,
note, lease or other instrument to which it or any of them is a party or by which it or any of them or their properties may be
bound where any such violation or default would have a Material Adverse Effect; and the execution of this Agreement, the execution
and delivery of the Indenture and the applicable Terms Agreement (including this Agreement as incorporated by reference therein),
the filing of the Registration Statement and the consummation of the transactions contemplated herein and therein (including the
issuance, authentication, sale and delivery of the Securities) have been duly authorized by all necessary corporate action and
will not conflict with or constitute a breach of, or default under, or result in the creation or imposition of any lien, charge
or encumbrance upon any property or assets of the Company or any of its subsidiaries pursuant to, any contract, indenture, mortgage,
loan agreement, note, lease or other instrument to which the Company or any of its subsidiaries is a party or by which it or any
of them may be bound or to which any of the property or assets of the Company or any of its subsidiaries is subject where any such
conflict, breach, default, creation or imposition would have a Material Adverse Effect, nor will such action result in any violation
of the provisions of the charter or bylaws of the Company or, to the best of its knowledge, any law, administrative regulation
or administrative or court decree (except for such violations of any law, administrative regulation or administrative or court
decree that would not have a Material Adverse Effect and would not have a material adverse effect on the Company&rsquo;s ability
to consummate the transactions contemplated by this Agreement), and no consent, approval, authorization or order of any court or
governmental authority or agency is required for the consummation by the Company of the transactions contemplated by this Agreement,
(including the issuance, authentication, sale and delivery of the Securities in accordance with the terms and conditions of the
Indenture) except such as may be required under the 1933 Act or the Regulations, the Trust Indenture Act or state securities or
&ldquo;blue sky&rdquo; laws.</P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">O.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company and its Material Subsidiaries possess adequate certificates, authorities or permits issued by the appropriate state, federal
or foreign regulatory agencies or bodies necessary to conduct the business now operated by them, except such certificates, authorities
or permits which are not material to such conduct of their business, and neither the Company nor any of its Material Subsidiaries
has, to the knowledge of the Company, received any notice of proceedings relating to the revocation or modification of any such
certificate, authority or permit which, singly or in the aggregate, if the subject of any unfavorable decision, ruling or finding,
would have a Material Adverse Effect.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">P.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as set forth in the Registration Statement or the Disclosure Package and the Final Prospectus, there is no action, suit or proceeding
before or by any court or governmental agency or body, domestic or foreign, now pending or, to the knowledge of the Company, threatened
against or affecting the Company or any of its subsidiaries that might reasonably be expected to result in a Material Adverse Effect,
or that might reasonably be expected to materially and adversely affect the offering of the Securities.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">Q.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There
are no contracts or documents of the Company or any of its subsidiaries which are required to be filed as exhibits to the Registration
Statement (including the documents incorporated by reference therein) by the 1933 Act or the Regulations which have not been so
filed.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">R.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company has full right, power and authority to execute and deliver this Agreement, the Securities and the Indenture (collectively,
the &ldquo;Transaction Documents&rdquo;) and to perform its obligations hereunder and thereunder.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">S.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Indenture has been duly and validly authorized, when executed and delivered by the Company and, assuming due execution and delivery
by the Trustee, constitutes a valid and binding agreement of the Company, enforceable in accordance with its terms, except as enforcement
thereof may be limited by bankruptcy, insolvency or other similar laws affecting creditors&rsquo; rights generally and subject
to the applicability of general principles of equity, and has been duly qualified under the Trust Indenture Act.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">T.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Securities have been duly authorized for issuance and sale pursuant to this Agreement and the applicable Terms Agreement (or will
have been so authorized prior to each issuance of Securities) and, when executed and authenticated in accordance with the provisions
of the Indenture and the Resolutions of the Board of Directors of the Company or a Pricing Committee thereof or Pricing Certificate
of Authorized Officers of the Board of Directors, and delivered to and paid for by the purchasers thereof, will constitute legal,
valid and binding obligations of the Company enforceable in accordance with their terms (subject, as to enforcement of remedies,
to applicable bankruptcy, fraudulent transfer, reorganization, insolvency, moratorium or other laws affecting creditors&rsquo;
rights generally from time to time in effect and to principles relating to the availability of equitable remedies to the extent
that adequate remedies at law may exist) and will be entitled to the benefits of the Indenture, which will be substantially in
the form heretofore delivered to you; and the Securities and the Indenture will conform when executed and delivered in all material
respects to all statements relating thereto contained in the Disclosure Package and the Final Prospectus.</P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">U.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as disclosed in the Registration Statement or the Disclosure Package and the Final Prospectus, and except as where such failure
would not have a Material Adverse Effect, the Company and its subsidiaries own, possess, license or have the right to use the patents,
patent rights, licenses, inventions, copyrights, know-how (including trade secrets and other unpatented and/or unpatentable proprietary
or confidential information, systems or procedures), trademarks, service marks, trade names and other rights or interests in items
of intellectual property as are necessary for the operation and conduct of the businesses now operated by them (the &ldquo;patent
and proprietary rights&rdquo;); and except as disclosed in the Registration Statement or the Disclosure Package and the Final Prospectus,
the Company has no knowledge of any infringement of or conflict with asserted rights of others with respect to any patent and proprietary
rights which, singly or in the aggregate, if the subject of an unfavorable decision, ruling or finding, would have a Material Adverse
Effect, and, except as disclosed in the Registration Statement or the Disclosure Package and the Final Prospectus, the Company
has no knowledge that any person or entity is infringing or otherwise violating any of the Company&rsquo;s patents, trademarks,
servicemarks or copyrights in a manner that could materially affect the use thereof by the Company or any of its subsidiaries and
which infringement would have a Material Adverse Effect.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">V.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
labor disturbance by the employees of the Company or any subsidiary exists or, to the knowledge of the Company, is imminent which
might reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">W.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company is not, and, after giving effect to the offering and sale of the Securities and the application of the proceeds thereof
as described in the Disclosure Package and the Final Prospectus, will not be an &ldquo;investment company&rdquo; or an entity &ldquo;controlled&rdquo;
by an &ldquo;investment company&rdquo; as such terms are defined in the Investment Company Act of 1940, as amended.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">X.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as described in the Registration Statement or the Disclosure Package and the Final Prospectus and except as could not reasonably
be expected to have a Material Adverse Effect, to the knowledge of the Company, the properties, assets and operations of each of
the Company and its subsidiaries are in compliance with all applicable federal, state, local and foreign laws (including, without
limitation, common law), rules and regulations, orders, decrees, judgments, permits and licenses relating to worker health and
safety, and to the protection and clean-up of the natural environment and to the protection or preservation of natural resources,
including, without limitation, those relating to the processing, manufacturing, generation, handling, disposal, transportation
or release of hazardous materials (collectively, &ldquo;Environmental Laws&rdquo;). With respect to such properties, assets and
operations, there are no events, conditions, circumstances, activities, practices, incidents, actions or plans of the Company or
any of its subsidiaries of which the Company is aware that may interfere with or prevent compliance or continued compliance with
applicable Environmental Laws or otherwise result in liability to the Company or any of its subsidiaries pursuant to applicable
Environmental Law in a manner that could reasonably be expected to have a Material Adverse Effect. Except as described in the Registration
Statement or the Disclosure Package and the Final Prospectus and except as could not reasonably be expected to have a Material
Adverse Effect, (A) to the Company&rsquo;s knowledge, none of the Company or any of its subsidiaries is the subject of any federal,
state, local or foreign investigation pursuant to Environmental Laws, (B) none of the Company or any of its subsidiaries has received
any written notice or claim pursuant to Environmental Laws and (C) there are no pending, or, to the knowledge of the Company, threatened
actions, suits or proceedings against the Company, any of its subsidiaries or its properties, assets or operations, in connection
with any Environmental Laws. The term &ldquo;hazardous materials&rdquo; shall mean those substances that are regulated by or pursuant
to any applicable Environmental Laws.</P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">Y.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
Agreement has been duly authorized, executed and delivered by the Company.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">Z.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
holders of securities of the Company have rights to the registration of such securities under the Registration Statement.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">AA.&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company maintains &ldquo;internal
control over financial reporting&rdquo; (as defined in Rule 13a-15(f) of the 1934 Act) that have been designed by, or under the
supervision of, the Company&rsquo;s principal executive and principal financial officers, or persons performing similar functions,
to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for
external purposes in accordance with generally accepted accounting principles.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">BB.&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has implemented
and maintains in effect policies and procedures reasonably designed to promote compliance by the Company, its subsidiaries and
their respective directors, officers and employees with Anti-Corruption Laws and Sanctions applicable to the Company, its subsidiaries
and their respective directors, officers and employees, and the Company, its subsidiaries and, to the knowledge of the Company,
their respective officers and employees and directors are in compliance with Anti-Corruption Laws and applicable Sanctions in all
material respects. As of the Applicable Time and at the Closing Time, none of (a)&nbsp;the Company, any subsidiary or, to the knowledge
of the Company, any of their respective directors or officers or (b)&nbsp;to the knowledge of the Company, any of the Company or
such subsidiary&rsquo;s respective employees is or will be a Sanctioned Person or organized or resident in a Sanctioned Country.
No use of proceeds of the offering of the Securities hereunder will be used by the Company or any of its subsidiaries directly
or to its knowledge indirectly to violate applicable Anti-Corruption Laws or applicable Sanctions. The term &ldquo;Anti-Corruption
Laws&rdquo; shall mean the United States Foreign Corrupt Practices Act of 1977, as amended, and all similar laws, rules, and regulations
of any jurisdiction applicable to the Company or its subsidiaries prohibiting bribery or corruption. &ldquo;Sanctioned Country&rdquo;
shall mean a country or territory, which is itself a subject or target of any Sanctions (as of the Applicable Time and at the Closing
Time, the Crimea region of Ukraine, Cuba, Iran, North Korea, and Syria). &ldquo;Sanctioned Person&rdquo; shall mean (a)&nbsp;any
person listed in any Sanctions-related list of designated persons maintained by the Office of Foreign Assets Control of the U.S.
Department of the Treasury, the U.S. Department of State, the United Nations Security Council, the European Union or the United
Kingdom, (b)&nbsp;any person operating, organized or resident in a Sanctioned Country or (c)&nbsp;any person 50 percent or more
owned or controlled by any such person. &ldquo;Sanctions&rdquo; shall mean economic or financial sanctions or trade embargoes imposed,
administered or enforced from time to time by (a) the U.S. government, including those administered by the Office of Foreign Assets
Control of the U.S. Department of the Treasury or the U.S. Department of State or (b) the United Nations Security Council, the
European Union or the United Kingdom.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in">Any certificate signed by any officer of the Company
and delivered to the Representatives or counsel for the Underwriters in connection with an offering of Securities shall be deemed
a representation and warranty by the Company, as to the matters covered thereby, to each Underwriter.</P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Purchase
and Sale</U>.&nbsp;&nbsp;The several commitments of the Underwriters to purchase securities pursuant to any Terms Agreement shall
be deemed to have been made on the basis of the representations and warranties herein contained and shall be subject to the terms
and conditions herein set forth.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payment
of the purchase price for, and delivery of, any Securities to be purchased by the Underwriters shall be made at the place set forth
in the applicable Terms Agreement, or at such other place as shall be agreed upon by the Representatives and the Company, on the
second business day (unless postponed in accordance with the provisions of Section 10 hereof) following the date of the applicable
Terms Agreement or such other time as shall be agreed upon by the Representatives and the Company (each such time and date being
referred to as a &ldquo;Closing Time&rdquo;). Except as indicated in the applicable Terms Agreement, payment shall be made to the
Company by wire transfer in same-day funds against delivery of the Securities to be purchased by the Representatives for the respective
accounts of the Underwriters. Such Securities shall be in such denominations and registered in such names as the Representatives
may request in writing at least two business days prior to the applicable Closing Time or shall be in global or bearer form as
permitted by the Indenture. Such Securities, which may be in temporary form, will be made available for examination and packaging
by the Representatives on or before the first business day prior to the Closing Time.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
authorized by the applicable Terms Agreement, the Underwriters named therein may solicit offers to purchase Securities from the
Company pursuant to delayed delivery contracts (&ldquo;Delayed Delivery Contracts&rdquo;) substantially in the form of Exhibit
B hereto, with such changes therein as the Company may approve.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
compensation for arranging Delayed Delivery Contracts, the Company will pay to the Representatives at Closing Time, for the accounts
of the Underwriters, a fee equal to that percentage of the principal amount of Securities for which Delayed Delivery Contracts
are made at Closing Time as is specified in the applicable Terms Agreement. Any Delayed Delivery Contracts are to be with institutional
investors of the types which will be set forth in the applicable prospectus supplement included in the Final Prospectus. If applicable,
at Closing Time the Company will enter into Delayed Delivery Contracts (for not less than the minimum principal amount of Securities
per Delayed Delivery Contract specified in the applicable Terms Agreement) with all purchasers proposed by the Underwriters and
previously approved by the Company as provided below, but not for an aggregate principal amount of Securities in excess of that
specified in the applicable Terms Agreement. The Underwriters will not have any responsibility for the validity or performance
of Delayed Delivery Contracts.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">D.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Representatives are to submit to the Company, at least two business days prior to Closing Time, the names of any institutional
investors with which it is proposed that the Company will enter into Delayed Delivery Contracts and the principal amount of Securities
to be purchased by each of them, and the Company will advise the Representatives, at least one business day prior to Closing Time,
of the names of the institutions with which the making of Delayed Delivery Contracts is approved by the Company and the principal
amount of Securities to be covered by each such Delayed Delivery Contract.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">E.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
principal amount of Securities agreed to be purchased by the respective Underwriters pursuant to the applicable Terms Agreement
shall be reduced by the principal amount of Securities covered by Delayed Delivery Contracts, as to each Underwriter as set forth
in a written notice delivered by the Representatives to the Company; <U>provided</U>, <U>however</U>, that the total principal
amount of Securities to be purchased by all Underwriters shall be the total amount of Securities covered by the applicable Terms
Agreement, less the principal amount of Securities covered by Delayed Delivery Contracts.</P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">F.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company acknowledges and agrees that the purchase and sale of the Securities pursuant to this Agreement and the Terms Agreement
hereunder, including the determination of the public offering price of the Securities and any related discounts and commissions,
is an arm&rsquo;s-length commercial transaction between the Company, on the one hand, and the several Underwriters, on the other
hand.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Covenants
of the Company</U>.&nbsp;&nbsp;The Company covenants with each Underwriter as follows:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company will use commercially reasonable efforts to cause the Registration Statement, if not effective at the Applicable Time,
and any amendment thereto, to become effective. Immediately following the execution of each Terms Agreement, the Company will prepare
a final prospectus supplement to be included in the Final Prospectus setting forth the principal amount of Securities covered thereby
and their terms not otherwise specified in the Indenture, the names of the Underwriters and the principal amount of Securities
which each severally has agreed to purchase, the names of the Representatives, the price at which the Securities are to be purchased
by the Underwriters from the Company, the initial public offering price, the selling concession and reallowance, if any, any delayed
delivery arrangements, and such other information as the Representatives and the Company reasonably deem necessary in connection
with the offering of the Securities. Following the completion of the offering, the Company will promptly transmit copies of the
Final Prospectus to the Commission for filing pursuant to Rule 424(b) of the Regulations.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
at any time when a prospectus is required by the 1933 Act to be delivered in connection with sales of the Securities any event
shall occur or condition exist as a result of which it is necessary, in the opinion of counsel for the Underwriters or counsel
for the Company, to further amend or supplement the Disclosure Package or the Final Prospectus in order that the Disclosure Package
or the Final Prospectus will not include an untrue statement of a material fact or omit to state any material fact necessary to
make the statements therein not misleading in the light of circumstances existing at the time it is delivered to a purchaser or
if it shall be necessary, in the opinion of either such counsel, at any such time to amend or supplement the Registration Statement,
the Disclosure Package or the Final Prospectus in order to comply with the requirements of the 1933 Act or the Regulations, the
Company will promptly prepare and file with the Commission such amendment or supplement, whether by filing documents pursuant to
the 1934 Act or otherwise, as may be necessary to correct such untrue statement or omission or to make the Registration Statement
and the Disclosure Package comply with such requirements.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;With
respect to each sale of Securities, the Company will make generally available to its security holders and to the Representatives
as soon as practicable earnings statements of the Company that will satisfy the provisions of Section 11(a) of the 1933 Act and
Rule 158 of the Regulations.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">D.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;From
the date of a Terms Agreement, and for so long as a prospectus is required by the 1933 Act to be delivered in connection with the
sale of Securities covered by such Terms Agreement, the Company will give the Representatives notice of its intention to file any
documents amending or supplementing the Registration Statement, the Disclosure Package or the Final Prospectus, whether pursuant
to the 1934 Act, the 1933 Act or otherwise, and will furnish them with copies of any such proposed amendment or supplement or other
documents proposed to be filed a reasonable time in advance of filing and will provide the Representatives the opportunity to review
and comment on such documents.</P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->-&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">E.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;From
the date of a Terms Agreement, and for so long as a prospectus is required by the 1933 Act to be delivered in connection with the
sale of Securities covered by such Terms Agreement, the Company will notify the Representatives immediately, and confirm the notice
in writing, (i) of the effectiveness of any amendment to the Registration Statement, (ii) of the mailing or the delivery to the
Commission for filing of any supplement to the Final Prospectus or any document to be filed pursuant to the 1934 Act which will
be incorporated by reference into the Final Prospectus, (iii) of the receipt of any comments from the Commission with respect to
the Registration Statement, the Disclosure Package, the Final Prospectus or any prospectus supplement related thereto, (iv) of
any request by the Commission for any amendment to the Registration Statement or any amendment or supplement to the Disclosure
Package or the Final Prospectus or for additional information relating to the offering of the Securities, (v) of the issuance by
the Commission of any stop order suspending the effectiveness of the Registration Statement or the initiation of any proceedings
for that purpose and (vi) the commencement or threat of any Section 8A proceeding against the Company in connection with the Securities.
The Company will make every reasonable effort to prevent the issuance of any stop order and, if any stop order is issued, to obtain
the lifting thereof as soon as practicable.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">F.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company will deliver to the Representatives a conformed copy of the Registration Statement, any documents incorporated by reference
therein (unless such documents are available on the &ldquo;EDGAR&rdquo; website), and each amendment thereto for each of the Underwriters.
So long as delivery of a prospectus by an Underwriter or dealer may be required by the 1933 Act, the Company will deliver to the
Representatives as many copies of any Preliminary Prospectus and the Final Prospectus and any supplement thereto as the Representatives
may reasonably request.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">G.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company will arrange for the qualification of the Securities for offering and sale under the laws of such jurisdictions as the
Representatives, after consultation with the Company, may collectively designate and will maintain such qualifications in effect
so long as required for the distribution of the Securities, <U>provided</U>, <U>however</U>, that the Company shall not be obligated
to file any general consent to service of process or to qualify as a foreign corporation or as a dealer in securities in any jurisdiction
in which it is not so qualified or to subject itself to taxation in respect of doing business in any jurisdiction in which it is
not otherwise so subject.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">H.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company, during the period when the Final Prospectus is required to be delivered under the 1933 Act, will file promptly all documents
required to be filed with the Commission pursuant to Section 13 or 14 of the 1934 Act.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">I.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Between
the date of any Terms Agreement and the Closing Time the Company will not, without the prior consent of the Representatives, offer
or sell, or enter into any agreement to sell, any debt securities of the Company with a maturity of more than one year, including
additional Securities.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">J.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company and the Representatives will prepare a final term sheet containing only a description of the Securities, in a form agreed
between the Company and the Representatives, and the Company will file such term sheet pursuant to Rule 433(d) under the 1933 Act
within the time required by such rule (such term sheet, the &ldquo;Final Term Sheet&rdquo;).</P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->-&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">K.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company represents that it has not made, and agrees that, unless it obtains the prior written consent of the Representatives, and
each Representative represents that it has not made, and agrees that, unless it obtains the prior written consent of the Company,
it will not make, any offer relating to the Securities that would constitute an Issuer Free Writing Prospectus or that would otherwise
constitute a &ldquo;free writing prospectus&rdquo; (as defined in Rule 405 of the 1933 Act) required to be filed with the Commission
or retained by the Company under Rule 433 of the 1933 Act; <U>provided</U> that the prior written consent of the Company and the
Representatives hereto shall be deemed to have been given in respect of the Free Writing Prospectuses included in Annex A to the
Terms Agreement. Any such free writing prospectus consented to by the Company and the Representatives is hereinafter referred to
as a &ldquo;Permitted Free Writing Prospectus.&rdquo; The Company agrees that (i) it has treated and will treat, as the case may
be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied and will comply, as the
case may be, with the requirements of Rules 164 and 433 of the 1933 Act applicable to any Permitted Free Writing Prospectus, including
in respect of timely filing with the Commission, legending and record keeping. The Company consents to the use by any Underwriter
of a free writing prospectus that (a)&nbsp;is not an &ldquo;issuer free writing prospectus&rdquo; as defined in Rule&nbsp;433,
and (b)&nbsp;contains only (i)&nbsp;information describing the preliminary terms of the Securities or their offering, (ii) information
permitted by Rule 134 under the 1933 Act or (iii)&nbsp;information that describes the final terms of the Securities or their offering
and that is included in the Final Term Sheet of the Company contemplated in Section&nbsp;3(J) hereof.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">L.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company agrees to pay the required Commission filing fees relating to the Securities within the time required by Rule&nbsp;456(b)(1)
of the 1933 Act without regard to the proviso therein and otherwise in accordance with Rules&nbsp;456(b) and 457(r) of the 1933
Act.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Conditions
of Underwriters&rsquo; Obligations</U>.&nbsp;&nbsp;The obligations of the Underwriters to purchase Securities pursuant to any Terms
Agreement are subject to the accuracy of the representations and warranties on the part of the Company herein contained as of the
Applicable Time and Closing Time, to the accuracy of the statements of the Company&rsquo;s officers made in any certificate furnished
pursuant to the provisions hereof, to the performance by the Company of all of its covenants and other obligations hereunder and
to the following further conditions:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
the Registration Statement has not become effective prior to the Applicable Time, unless the Representatives agree in writing to
a later time, the Registration Statement will become effective not later than (i)&nbsp;6:00 p.m. New York City time, on the date
of determination of the public offering price, if such determination occurred at or prior to 3:00 p.m., New York City time, on
such date or (ii)&nbsp;12:00 Noon on the business day following the day on which the public offering price was determined, if such
determination occurred after 3:00 p.m., New York City time, on such date; if filing of the Final Prospectus, or any supplement
thereto, is required pursuant to Rule 424(b), the Final Prospectus, and any such supplement, shall have been filed in the manner
and within the time period required by Rule 424(b).</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At
the applicable Closing Time (i)&nbsp;no stop order suspending the effectiveness of the Registration Statement shall have been issued
under the 1933 Act or proceedings thereof or initiated or threatened by the Commission, (ii)&nbsp;there shall not have been since
the execution of such Terms Agreement any decrease in the ratings of any of the Company&rsquo;s debt securities by any of Moody&rsquo;s
Investors Service, Inc., S&amp;P Global Ratings, a division of S&amp;P Global, Inc., or Fitch Ratings, Inc. or any notice given
of any intended or potential decrease in any such rating or of a possible change in any such rating that does not indicate the
direction of the possible change and (iii)&nbsp;there shall not have come to the attention of the Representatives any facts that
would cause them reasonably to believe that the Disclosure Package or the Final Prospectus, at the time it was required to be delivered
to a purchaser of the Securities, contained an untrue statement of a material fact or omitted to state a material fact necessary
in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.</P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->-&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At
the applicable Closing Time you shall have received:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
favorable opinion, dated as of the Closing Time, of Shearman &amp; Sterling LLP, counsel of the Company, substantially in the form
set forth in Exhibit C.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
favorable opinion, dated as of the Closing Time, of Vance Brown, Vice President, Chief Corporate Counsel &amp; Assistant Secretary
of the Company, substantially in the form set forth in Exhibit D.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
favorable opinion or opinions, dated as of the applicable Closing Time, of Simpson Thacher &amp; Bartlett LLP, counsel for the
Underwriters, with respect to the issuance and sale of the Securities, the Indenture, the Registration Statement, the Final Prospectus
and other related matters as the Representatives may reasonably require, and the Company shall have furnished to such counsel such
documents as they may reasonably request for the purpose of enabling them to pass upon such matters.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">D.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At
the applicable Closing Time there shall not have been, since the Applicable Time or since the date and time of which information
is given in the Disclosure Package, any material adverse change in the condition (financial or otherwise), earnings, results of
operations, business or properties of the Company and its subsidiaries considered as one enterprise, whether or not arising from
transactions in the ordinary course of business, except as set forth or contemplated in the Disclosure Package and the Final Prospectus
(exclusive of any supplement thereto), and the Company shall have furnished to the Representatives a certificate of the Company,
signed by the Chairman of the Board, the Chief Executive Officer, the President, the principal financial officer or the principal
accounting officer of the Company, dated as of such Closing Time, to the effect that:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
representations and warranties of the Company in this Agreement are true and correct in all material respects on and as of the
Closing Time with the same effect as if made at the Closing Time and the Company has complied with all the agreements and satisfied
all the conditions on its part to be performed or satisfied at or prior to the Closing Time;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;no
stop order suspending the effectiveness of the Registration Statement has been issued and no proceedings for that purpose have
been instituted or, to the Company&rsquo;s knowledge, threatened; and</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;since
the date of the most recent financial statements or financial data included or incorporated by reference in the Disclosure Package
or the Final Prospectus (exclusive of any supplement thereto), there has been no material adverse change in the condition (financial
or other), earnings, results of operations, business or properties of the Company and its subsidiaries, considered as one enterprise,
whether or not arising from transactions in the ordinary course of business, except as set forth in or contemplated in the Disclosure
Package and the Final Prospectus (exclusive of any supplement thereto).</P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->-&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">E.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You
shall have received from Ernst &amp; Young LLP or other independent registered public accountants acceptable to the Representatives
a letter or letters, dated the date of the applicable Terms Agreement and as of the applicable Closing Time, in form and substance
satisfactory to the Representatives, containing statements and information of the type customarily included in accountants&rsquo;
&ldquo;comfort letters&rdquo; to underwriters with respect to the financial statements and certified financial information contained
or incorporated by reference in the Disclosure Package and the Final Prospectus; provided that such letters shall use a &ldquo;cut-off&rdquo;
date no more than five business days prior to the respective dates of such letters.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">F.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At
the applicable Closing Time, counsel for the Underwriters shall have been furnished with such documents and opinions as they may
reasonably require for the purpose of enabling them to pass upon the issuance and sale of the Securities as herein contemplated
and related proceedings or in order to evidence the accuracy and completeness of any of the representations and warranties, or
the fulfillment of any of the conditions, herein contained; and all proceedings taken by the Company in connection with the issuance
and sale of the Securities as herein contemplated shall be in all material respects satisfactory in form and substance to the Representatives
and counsel for the Underwriters.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">If any condition specified in this Section
shall not have been fulfilled when and as required to be fulfilled, the applicable Terms Agreement may be terminated by the Representatives
by notice to the Company at any time at or prior to the applicable Closing Time, and such termination shall be without liability
of any party to any other party except as provided in Section 5 hereof.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Payment
of Expenses</U>.&nbsp;&nbsp;The Company will pay all reasonable and necessary expenses incident to the performance of its obligations
under this Agreement and each Terms Agreement, including (a)&nbsp;the preparing, printing or other production and filing of the
Registration Statement (as originally filed) and all amendments thereto, (b)&nbsp;the preparation, issuance and delivery of the
Securities to the Underwriters, (c)&nbsp;the reasonable fees and disbursements of the Company&rsquo;s counsel and accountants and
of the Trustee and its counsel, (d)&nbsp;the qualification of the Securities under securities laws in accordance with the provisions
of Section 3(G) hereof, including filing fees and the reasonable fees and disbursements of counsel for the Underwriters in connection
therewith and in connection with the preparation of any Blue Sky Survey, (e)&nbsp;the printing or other production and delivery
to the Underwriters in quantities as hereinabove stated of copies of the Preliminary Prospectus, any Issuer Free Writing Prospectus
and the Final Prospectus and any amendments or supplements thereto, (f)&nbsp;the production and delivery to the Underwriters of
copies of the Indenture and any Blue Sky Survey reasonably requested by the Representatives, (g)&nbsp;the fees of rating agencies,
(h)&nbsp;the fees and expenses, if any, incurred in connection with the listing of the Securities on any securities exchange, and
(i)&nbsp;(x)&nbsp;the fees and expenses, if any, incurred in connection with any filing with, and clearance of the offering by,
the Financial Industry Regulatory Authority, Inc. and (y) the reasonable fees and expenses of counsel for the Underwriters in connection
therewith.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">If a Terms Agreement is terminated by
the Representatives in accordance with the provisions of Section 4 or Sections 9(i) and 9(iv) hereof, or if the sale of any Securities
provided for herein or in any Terms Agreement is not consummated because any condition to the obligations of the Underwriters set
forth herein is not satisfied by the Company or because of any refusal, inability or failure on the part of the Company to perform
any agreement herein or comply with any provision hereof, the Company shall reimburse the Underwriters named in such Terms Agreement
for all of their reasonable out-of-pocket expenses, including the reasonable fees and disbursements of counsel for the Underwriters,
that shall have been incurred by them in connection with the proposed purchase and sale of the Securities.</P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->-&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Indemnification</U>.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company agrees to indemnify and hold harmless each Underwriter and each person, if any, who controls any Underwriter within the
meaning of Section 15 of the 1933 Act or Section 20(a) of the 1934 Act, against any and all losses, liabilities, claims, damages
and expenses whatsoever as incurred (including but not limited to reasonable attorneys&rsquo; fees and any and all expenses reasonably
and necessarily incurred in investigating, preparing or defending against any litigation, commenced or threatened, or any claim
whatsoever, and any and all amounts paid in settlement of any claim or litigation), joint or several, to which they or any of them
may become subject under the 1933 Act, the 1934 Act or otherwise, insofar as such losses, liabilities, claims, damages or expenses
(or actions in respect thereof) arise out of or are based upon (i)&nbsp;any untrue statement or alleged untrue statement of a material
fact contained in the Registration Statement for the registration of the Securities, as originally filed or any amendment thereof,
or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein
or necessary to make the statements therein not misleading; or (ii)&nbsp;any untrue statement or alleged untrue statement of a
material fact contained in any related Preliminary Prospectus, any Issuer Free Writing Prospectus, the Disclosure Package or the
Final Prospectus, or in any supplement thereto or amendment thereof, or arise out of or are based upon the omission or alleged
omission to state therein a material fact required to be stated therein or necessary in order to make the statements therein, in
the light of the circumstances under which they were made, not misleading; <U>provided</U>, <U>however</U>, that the Company will
not be liable in any such case to the extent, but only to the extent, that any such loss, liability, claim, damage or expense arises
out of or is based upon any such untrue statement or alleged untrue statement or omission or alleged omission made therein in reliance
upon and in conformity with written information furnished to the Company by or on behalf of any Underwriter through the Representatives
expressly for use therein; it being understood and agreed that the only such information furnished by any Underwriter consists
of the information described in Exhibit 1 to the Terms Agreement. This indemnity will be in addition to any liability which the
Company may otherwise have, including under this Agreement.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Underwriter severally, and not jointly, agrees to indemnify and hold harmless the Company, each of the directors of the Company,
each of the officers of the Company who shall have signed the Registration Statement, and each other person, if any, who controls
the Company within the meaning of Section 15 of the 1933 Act or Section 20(a) of the 1934 Act, against any losses, liabilities,
claims, damages and expenses whatsoever as incurred (including but not limited to reasonable attorneys&rsquo; fees and any and
all expenses reasonably and necessarily incurred in investigating, preparing or defending against any litigation, commenced or
threatened, or any claim whatsoever, and any and all amounts paid in settlement of any claim or litigation) to which they or any
of them may become subject under the 1933 Act, the 1934 Act or otherwise, insofar as such losses, liabilities, claims, damages
or expenses (or actions in respect thereof) arise out of or are based upon (i)&nbsp;any untrue statement or alleged untrue statement
of a material fact contained in the Registration Statement for the registration of the Securities, as originally filed or any amendment
thereof, or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated
therein or necessary to make the statements therein not misleading; or (ii)&nbsp;upon any untrue statement or alleged untrue statement
of a material fact contained in any related Preliminary Prospectus, any Issuer Free Writing Prospectus, the Disclosure Package
or the Final Prospectus, or in any supplement thereto or amendment thereof, or arise out of or are based upon the omission or alleged
omission to state therein a material fact required to be stated therein or necessary in order to make the statements therein, in
the light of the circumstances under which they were made, not misleading, in each case to the extent, but only to the extent,
that any such loss, liability, claim, damage or expense arises out of or is based upon any such untrue statement or alleged untrue
statement or omission or alleged omission made therein in reliance upon and in conformity with written information furnished to
the Company by or on behalf of such Underwriter as set forth in Exhibit 1 to the Terms Agreement. It being understood and agreed
that the only such information furnished by any Underwriter consists of the information described as such in the Terms Agreement.
This indemnity will be in addition to any liability which any Underwriter may otherwise have, including under this Agreement.</P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->-&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Promptly
after receipt by an indemnified party under subsection (A) or (B) above of notice of the commencement of any action, such indemnified
party shall, if a claim in respect thereof is to be made against the indemnifying party under such subsection, notify each party
against whom indemnification is to be sought in writing of the commencement thereof (but the failure so to notify an indemnifying
party shall not relieve it from any liability which it may have under this Section 6). In case any such action is brought against
any indemnified party, and it notifies an indemnifying party of the commencement thereof, the indemnifying party will be entitled
to participate therein, and to the extent it may elect by written notice delivered to the indemnified party promptly after receiving
the aforesaid notice from such indemnified party, to assume the defense thereof with counsel reasonably satisfactory to such indemnified
party. Notwithstanding the foregoing, the indemnified party or parties shall have the right to employ its or their own counsel
in any such case, but the fees and expenses of such counsel shall be at the expense of such indemnified party or parties unless
(i)&nbsp;the employment of such counsel shall have been authorized in writing by one of the indemnifying parties in connection
with the defense of such action, (ii)&nbsp;the indemnifying parties shall not have employed counsel reasonably satisfactory to
the indemnified parties to have charge of the defense of such action within a reasonable time after notice of commencement of the
action, or (iii)&nbsp;such indemnified party or parties shall have reasonably concluded that there may be defenses available to
it or them which are different from or additional to those available to one or all of the indemnifying parties (in which case the
indemnifying parties shall not have the right to direct the defense of such action on behalf of the indemnified party or parties),
in any of which events such fees and expenses shall be borne by the indemnifying parties. Anything in this subsection to the contrary
notwithstanding, an indemnifying party shall not be liable for any settlement of any claim or action effected without its written
consent; <U>provided</U>, <U>however</U>, that such consent was not unreasonably withheld. No indemnifying party shall, without
the written consent of the indemnified party, effect any settlement of any pending or threatened proceeding in respect of which
any indemnified party is or could have been a party and indemnification could have been sought hereunder by such indemnified party,
unless such settlement (x)&nbsp;includes an unconditional release of such indemnified party, in form and substance reasonably satisfactory
to such indemnified party, from all liability on claims that are the subject matter of such proceeding and (y)&nbsp;does not include
any statement as to or any admission of fault, culpability or a failure to act by or on behalf of any indemnified party.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">D.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
at any time an indemnified party shall have requested an indemnifying party to reimburse the indemnified party for fees and expenses
of counsel, such indemnifying party agrees that it shall be liable for any settlement of the nature contemplated by Section 6(C)
hereof effected without its written consent if (i)&nbsp;such settlement is entered into more than 45 days after receipt by such
indemnifying party of the aforesaid request, (ii)&nbsp;such indemnifying party shall have received notice of the terms of such
settlement at least 30 days prior to such settlement being entered into and (iii)&nbsp;such indemnifying party shall not have reimbursed
such indemnified party in accordance with such request prior to the date of such settlement.</P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->-&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Contribution</U>.&nbsp;&nbsp;In
order to provide for contribution in circumstances in which the indemnification provided for in Section 6 hereof is for any reason
held to be unavailable from any indemnifying party or is insufficient to hold harmless a party indemnified thereunder, then the
indemnifying parties shall contribute to the aggregate losses, claims, damages, liabilities and expenses of the nature contemplated
by such indemnification provision (including any investigation, legal and other expenses incurred in connection with, and any amount
paid in settlement of, any action, suit or proceeding or any claims asserted, but after deducting in the case of losses, claims,
damages, liabilities and expenses suffered by the Company any contribution received by the Company from persons, other than the
Underwriters, who may also be liable for contributions, including persons who control the Company within the meaning of Section
15 of the 1933 Act or Section 20(a) of the 1934 Act, officers of the Company who signed the Registration Statement and directors
of the Company) as incurred to which the Company and one or more of the Underwriters may be subject, in such proportions as is
appropriate to reflect the relative benefits received by the Company and the Underwriters from the offering of the Securities or,
if such allocation is not permitted by applicable law or indemnification is not available as a result of the indemnifying party
not having received notice as provided in Section 6 hereof, in such proportion as is appropriate to reflect not only the relative
benefits referred to above but also the relative fault of the Company and the Underwriters in connection with the statements or
omissions which resulted in such losses, claims, damages, liabilities or expenses, as well as any other relevant equitable considerations.
The relative benefits received by the Company and the Underwriters shall be deemed to be in the same proportion as (x)&nbsp;the
total proceeds from the offering (net of underwriting discounts and commissions but before deducting expenses) received by the
Company and (y)&nbsp;the underwriting discounts and commissions received by the Underwriters, respectively, in each case as set
forth in the table on the cover page of the Final Prospectus. The relative fault of the Company and of the Underwriters shall be
determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission
or alleged omission to state a material fact relates to information supplied by the Company or the Underwriters and the parties&rsquo;
relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. The Company
and the Underwriters agree that it would not be just and equitable if contribution pursuant to this Section 7 were determined by
pro rata allocation (even if the Underwriters were treated as one entity for such purpose) or by any other method of allocation
which does not take account of the equitable considerations referred to above. Notwithstanding the provisions of this Section 7,
in no case shall any Underwriter be liable or responsible for any amount in excess of the underwriting discount applicable to the
securities purchased by such Underwriter hereunder. Notwithstanding the provisions of this Section 7 and the preceding sentence,
no person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the 1933 Act) shall be entitled to contribution
from any person who was not guilty of such fraudulent misrepresentation. For purposes of this Section 7, each person, if any, who
controls an Underwriter within the meaning of Section 15 of the 1933 Act or Section 20(a) of the 1934 Act shall have the same rights
to contribution as such Underwriter, and each person, if any, who controls the Company within the meaning of Section 15 of the
1933 Act or Section 20(a) of the 1934 Act, each officer of the Company who shall have signed the Registration Statement and each
director of the Company shall have the same rights to contribution as the Company, subject in each case to clauses (i) and (ii)
of this Section 7. Any party entitled to contribution will, promptly after receipt of notice of commencement of any action, suit
or proceeding against such party in respect of which a claim for contribution may be made against another party or parties, notify
each party or parties from whom contribution may be sought, but the omission to so notify such party or parties shall not relieve
the party or parties from whom contribution may be sought from any obligation it or they may have under this Section 7 or otherwise.
The obligation of the Underwriters to contribute pursuant to this Section 7 shall be several in proportion to their respective
underwriting obligations and not joint.</P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->-&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations,
Warranties and Agreements to Survive Delivery</U>.&nbsp;&nbsp;All representations, warranties, indemnities and agreements contained
in this Agreement or any Term Agreement, or contained in certificates of officers of the Company submitted pursuant hereto, shall
remain operative and in full force and effect regardless of any termination of the applicable Terms Agreement (including this Agreement
as incorporated by reference therein), or any investigation made by or on behalf of any Underwriter, controlling person or the
Company, and shall survive delivery of, and payment for, any Securities to the Underwriters.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination</U>.&nbsp;&nbsp;The
Representatives may terminate the applicable Terms Agreement (including this Agreement, as incorporated by reference therein),
immediately upon notice to the Company, at any time at or prior to the applicable Closing Time (i)&nbsp;if there has been, since
the date of such Terms Agreement or since the respective dates as of which information is given in the Disclosure Package or the
Final Prospectus, any material adverse change in the condition (financial or otherwise), earnings, results of operations, business
or properties of the Company and its subsidiaries considered as one enterprise, whether or not from transactions arising in the
ordinary course of business, or (ii)&nbsp;if there has occurred any outbreak or escalation of hostilities or other calamity or
crisis or change in general domestic or international economic, political or financial conditions either within or outside of the
United States the effect of which is such as to make it, in the judgment of the Representatives, impracticable or inadvisable to
proceed with the offering, sale or delivery of the Securities, or (iii)&nbsp;if trading in any Securities of the Company has been
suspended by the Commission or any securities exchange or in the over-the-counter market, or if trading generally on the American
Stock Exchange, the New York Stock Exchange or in the over-the-counter market has been suspended, or minimum or maximum prices
for trading have been fixed, or maximum ranges for prices for securities have been required, by either of said exchanges or by
order of the Commission or any other governmental authority, or if a banking moratorium has been declared by either Federal or
New York authorities, or (iv)&nbsp;there shall have been since the execution of such Terms Agreement any decrease in the ratings
of any of the Company&rsquo;s debt securities by any of Moody&rsquo;s Investors Service, Inc., S&amp;P Global Ratings, a division
of S&amp;P Global, Inc., or Fitch Ratings, Inc. or any notice given of any intended or potential decrease in any such rating or
of a possible change in any such rating that does not indicate the direction of the possible change.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Default</U>.&nbsp;&nbsp;If
one or more of the Underwriters shall fail at the applicable Closing Time to purchase the Securities which it or they are obligated
to purchase under the applicable Terms Agreement (the &ldquo;Defaulted Securities&rdquo;), then the Representatives shall have
the right, within 24 hours thereafter, to make arrangements for one or more of the non-defaulting Underwriters, or any other underwriters,
to purchase all, but not less than all, of the Defaulted Securities in such amounts as may be agreed upon and upon the terms herein
set forth. If, however, during such 24 hours you shall not have completed such arrangements for the purchase of all of the Defaulted
Securities, then:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if
the aggregate principal amount of Defaulted Securities does not exceed 10% of the aggregate principal amount of the Securities
to be purchased pursuant to such Terms Agreement, the non-defaulting Underwriters shall be obligated to purchase the full amount
thereof in the proportions that their respective underwriting obligations under the applicable Terms Agreement (including this
Agreement as incorporated by reference therein) bear to the underwriting obligations of all such non-defaulting Underwriters, unless
otherwise agreed, or</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if
the aggregate principal amount of Defaulted Securities exceeds 10% of the aggregate principal amount of the Securities to be purchased
pursuant to such Terms Agreement, such Terms Agreement (including this Agreement as incorporated by reference therein) shall terminate,
without any liability on the part of any non-defaulting Underwriter or the Company.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">No action taken pursuant to this Section&nbsp;10
shall relieve any defaulting Underwriter from liability in respect of any default of such Underwriter under the applicable Terms
Agreement or this Agreement.</P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->-&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">In the event of a default by any Underwriter
or Underwriters as set forth in this Section&nbsp;10 which does not result in termination of the applicable Terms Agreement, either
the Representatives or the Company shall have the right to postpone the applicable Closing Time for a period not exceeding seven
days in order that any required changes in the Registration Statement or the Final Prospectus or in any other documents or arrangements
may be effected.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Notices</U>.
All notices and other communications hereunder shall be in writing and shall be deemed to have been duly given if mailed or transmitted
by any standard form of telecommunication. Notices to the Underwriters shall be directed to you as provided in the applicable Terms
Agreement. Notices to the Company shall be directed to it at Boston Scientific Corporation, 300 Boston Scientific Way, Marlborough,
Massachusetts 01752-1234 (fax: 508-683-4350); Attention of the General Counsel and Corporate Secretary with a copy to the Assistant
General Counsel.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Parties</U>.&nbsp;&nbsp;The
applicable Terms Agreement and this Agreement shall inure to the benefit of and be binding upon the Underwriters and the Company,
and their respective successors and the officers and directors and any controlling persons referred to in Section 6 hereof. Nothing
expressed or mentioned in the applicable Terms Agreement or this Agreement is intended or shall be construed to give any person,
firm or corporation, other than the parties hereto or thereto and their respective successors and the controlling persons and officers
and directors referred to in Sections 6 and 7 hereof and their heirs and legal representatives, any legal or equitable right, remedy
or claim under or in respect of the applicable Terms Agreement or this Agreement or any provision therein or herein contained.
The applicable Terms Agreement and this Agreement and all conditions and provisions thereof and hereof are intended to be for the
sole and exclusive benefit of the parties and their respective successors and said controlling persons and officers and directors
and their heirs and legal representatives, and for the benefit of no other person, firm or corporation. No purchaser of Securities
from any Underwriter shall be deemed to be a successor by reason merely of such purchase.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Authority
of the Representatives</U>.&nbsp;&nbsp;Any action by the Underwriters hereunder may be taken by the Representatives on behalf of
the Underwriters, and any such action taken by the Representatives shall be binding upon the Underwriters.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Trial
by Jury</U>.&nbsp;&nbsp;The Company (on its behalf and, to the extent permitted by applicable law, on behalf of its stockholders
and affiliates) and each of the Underwriters hereby irrevocably waives, to the fullest extent permitted by applicable law, any
and all right to trial by jury in any legal proceeding arising out of or relating to this Agreement or the transactions contemplated
hereby.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Governing
Law</U>.&nbsp;&nbsp;THIS AGREEMENT AND EACH TERMS AGREEMENT SHALL BE GOVERNED BY THE LAWS OF THE STATE OF NEW YORK.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">16.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Recognition
of the U.S. Special Resolution Regimes</U>.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in">A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the
event that any Underwriter that is a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution Regime, the
transfer from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective
to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and any such
interest and obligation, were governed by the laws of the United States or a state of the United States.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in">B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the
event that any Underwriter that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a proceeding
under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are
permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime
if this Agreement were governed by the laws of the United States or a state of the United States.</P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-20-&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in">C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For the
purposes of this Section 16:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in">&ldquo;BHC Act Affiliate&rdquo; has the meaning assigned
to the term &ldquo;affiliate&rdquo; in, and shall be interpreted in accordance with, 12 U.S.C. &sect; 1841(k).</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in">&ldquo;Covered Entity&rdquo; means any of the following:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.25in">1.</TD><TD>a &ldquo;covered entity&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect; 252.82(b);</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.25in">2.</TD><TD>a &ldquo;covered bank&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect; 47.3(b); or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.25in">3.</TD><TD>a &ldquo;covered FSI&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect; 382.2(b).</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in">&ldquo;Default Right&rdquo; has the meaning assigned
to that term in, and shall be interpreted in accordance with, 12 C.F.R. &sect;&sect; 252.81, 47.2 or 382.1, as applicable.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in">&ldquo;U.S. Special Resolution Regime&rdquo; means each
of (1) the Federal Deposit Insurance Act and the regulations promulgated thereunder and (2) Title II of the Dodd-Frank Wall Street
Reform and Consumer Protection Act and the regulations promulgated thereunder.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">17.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Bail-in
Clause</U>.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in">A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding
and to the exclusion of any other term of this Agreement or any other agreements, arrangements, or understanding between the Company
and any BRRD Party, the Company acknowledges and accepts that a BRRD Liability arising under this Agreement may be subject to the
exercise of Bail-in Powers by the Relevant Resolution Authority, and acknowledges, accepts, and agrees to be bound by:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
effect of the exercise of Bail-in Powers by the Relevant Resolution Authority in relation to any BRRD Liability of any BRRD Party
to the Company under this Agreement, that (without limitation) may include and result in any of the following, or some combination
thereof:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(A)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
reduction of all, or a portion, of the BRRD Liability or outstanding amounts due thereon;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(B)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
conversion of all, or a portion, of the BRRD Liability into shares, other securities or other obligations of the relevant BRRD
Party or another person, and the issue to or conferral on the Company of such shares, securities or obligations;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(C)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
cancellation of the BRRD Liability;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(D)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
amendment or alteration of any interest, if applicable, thereon, the maturity or the dates on which any payments are due, including
by suspending payment for a temporary period; and</P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->-&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
variation of the terms of this Agreement, as deemed necessary by the Relevant Resolution Authority, to give effect to the exercise
of Bail-in Powers by the Relevant Resolution Authority.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in">(B)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For the
purposes of this Section 17, the following definitions shall apply;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">&ldquo;Bail-in Legislation&rdquo;
means in relation to the United Kingdom or a member state of the European Economic Area which has implemented, or which at any
time implements, the BRRD, the relevant implementing law, regulation, rule or requirement as described in the EU Bail-in Legislation
Schedule from time to time;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">&ldquo;Bail-in Powers&rdquo; means
any Write-down and Conversion Powers as defined in the EU Bail-in Legislation Schedule, in relation to the relevant Bail-in Legislation;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">&ldquo;BRRD&rdquo; means Directive
2014/59/EU establishing a framework for the recovery and resolution of credit institutions and investment firms, as amended;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">&ldquo;BRRD Liability&rdquo; means
a liability in respect of which the relevant Write Down and Conversion Powers in the applicable Bail-in Legislation may be exercised;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">&ldquo;BRRD Party&rdquo; means any
Underwriter which qualifies as an institution or entity referred to in paragraphs (a), (b), (c) or (d) of Article 1 of the BRRD,
as implemented in the applicable Bail-in Legislation;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">&ldquo;EU Bail-in Legislation Schedule&rdquo;
means the document described as such, then in effect, and published by the Loan Market Association (or any successor person) from
time to time at http://www.lma.eu.com/pages.aspx?p=499 (or any such successor webpage); and</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">&ldquo;Relevant Resolution Authority&rdquo;
means the resolution authority with the ability to exercise any Bail-in Powers in relation to the relevant BRRD Party.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">18.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendments
or Waivers</U>.<I>&nbsp;&nbsp;</I>No amendment or waiver of any provision of this Agreement, nor any consent or approval to any
departure therefrom, shall in any event be effective unless the same shall be in writing and signed by the parties hereto.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">19.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Counterparts</U><I>.</I>&nbsp;&nbsp;This
Agreement may be signed in counterparts (which may include counterparts delivered by any standard form of telecommunication), each
of which shall be an original and all of which together shall constitute one and the same instrument. The words &ldquo;execution,&rdquo;
&ldquo;signed,&rdquo; &ldquo;signature,&rdquo; &ldquo;delivery,&rdquo; and words of like import in or relating to this Agreement
or any document to be signed in connection with this Agreement shall be deemed to include electronic signatures, deliveries or
the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually
executed signature, physical delivery thereof or the use of a paper-based recordkeeping system, as the case may be, and the parties
hereto consent to conduct the transactions contemplated hereunder by electronic means.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">20.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Headings</U>.&nbsp;&nbsp;The
headings herein are included for convenience of reference only and are not intended to be part of, or to affect the meaning or
interpretation of, this Agreement.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><I>[Remainder of this page intentionally
left blank]</I></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><I></I></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->-&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 198pt; text-indent: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="2" CELLSPACING="0" STYLE="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">Very
truly yours,</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">BOSTON SCIENTIFIC CORPORATION</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 45%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">/s/ Robert J. Castagna</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>Robert J. Castagna</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Vice President and Treasurer</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 23; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: right">SCHEDULE I</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">MATERIAL SUBSIDIARIES</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.</TD><TD>Boston Scientific Scimed, Inc.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.</TD><TD>Target Therapeutics, Inc.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.</TD><TD>Boston Scientific Group plc</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.</TD><TD>Boston Scientific Limited</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.</TD><TD>Guidant Delaware Holding Corporation</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.</TD><TD>Cardiac Pacemakers, Inc.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7.</TD><TD>Boston Scientific de Costa Rica S.R.L.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8.</TD><TD>Bravo Bidco Limited</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">9.</TD><TD>Boston Scientific Medical Device Limited</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.</TD><TD>BTG Limited</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11.</TD><TD>BTG International (Holdings) Limited</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: right">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: right">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: right">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: right"></P>

<!-- Field: Page; Sequence: 24; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Schedule I-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: right"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: right">EXHIBIT A</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">BOSTON SCIENTIFIC CORPORATION<BR>
Debt Securities</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">TERMS AGREEMENT</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: right">Dated: May 14, 2020</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.75pt"></TD><TD STYLE="width: 29.75pt">To:</TD><TD>Boston Scientific Corporation<BR>
300 Boston Scientific Way<BR>
Marlborough, Massachusetts 01752-1234</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt">Ladies and Gentlemen:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">We understand that Boston Scientific
Corporation, a Delaware corporation (the &ldquo;Company&rdquo;), proposes to issue and sell its Debt Securities having an aggregate
principal amount of $1,700,000,000 (as described in more detail below, the &ldquo;Securities&rdquo;). Subject to the terms and
conditions set forth herein or incorporated by reference herein, the underwriters named below (the &ldquo;Underwriters&rdquo;)
hereby offer to purchase such Securities.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0.25in; text-indent: 0.5in">The Securities to be purchased by the
Underwriters, which are to be issued under an Indenture, dated as of May 29, 2013, between the Company and U.S. Bank National Association,
as Trustee, as supplemented from time to time by supplemental indentures and/or modified from time to time by resolutions of the
Board of Directors of the Company or a Pricing Committee or Authorized Officers thereof or Officer&rsquo;s Certificate as provided
in Section 301 of such Indenture, shall have the following terms:</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%; padding-right: 1.75pt; padding-left: 1.75pt">Principal amounts:</TD>
    <TD STYLE="width: 68%; padding-right: 1.75pt; padding-left: 1.75pt">$500,000,000 of 1.900% Senior Notes due 2025 (the &ldquo;2025 Notes&rdquo;)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">$1,200,000,000 of 2.650% Senior Notes due 2030 (the &ldquo;2030 Notes&rdquo;)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">Dates of maturity:</TD>
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">June 1, 2025 for the 2025 Notes</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">June 1, 2030 for the 2030 Notes</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">Interest rates:</TD>
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">
        <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">1.900% for the 2025 Notes</P>
        <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt">2.650% for the 2030 Notes</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">Interest payment dates:</TD>
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">June 1 and December 1 of each year, beginning December 1, 2020</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">Public offering prices:</TD>
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">99.952% of principal amount for the 2025 Notes</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">99.851% of principal amount for the 2030 Notes</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">Purchase prices:</TD>
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">99.352% of principal amount for the 2025 Notes</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">99.201% of principal amount for the 2030 Notes</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">Redemption provisions:</TD>
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">As described in the Prospectus Supplement, dated May 14, 2020</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">Form of securities:</TD>
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">Book-Entry</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 25; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt; width: 32%">&nbsp;</TD>
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt; width: 68%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">Underwriting discounts:</TD>
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">0.600% for the 2025 Notes</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">0.650% for the 2030 Notes</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 1.75pt; padding-left: 1.75pt">Aggregate purchase prices to be paid by Underwriters:</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 1.75pt; padding-left: 1.75pt">$496,760,000 for the 2025 Notes</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">$1,190,412,000 for the 2030 Notes</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">Closing date and location:</TD>
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">May 18, 2020 (T+2)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">Simpson Thacher &amp; Bartlett LLP<BR>
425 Lexington Avenue<BR>
New York, New York 10017</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">Representatives:</TD>
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">Barclays Capital Inc., Citigroup Global Markets Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">Applicable Time:</TD>
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">4:30&nbsp;p.m., New York City time, on the date hereof</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">Delayed Delivery Contracts:</TD>
    <TD STYLE="padding-right: 1.75pt; padding-left: 1.75pt">None</TD></TR>
</TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">All of the provisions contained in the
document entitled &ldquo;Boston Scientific Corporation Debt Securities, Underwriting Agreement-Basic Provisions,&rdquo; dated as
of May 14, 2020, are herein incorporated by reference in their entirety and shall be deemed to be a part of this Agreement to the
same extent as if such provisions had been set forth in full herein. Terms defined in such document are used herein as therein
defined. For the avoidance of doubt, the offering referred to in the Terms Agreement is Non-Delayed Offering, as such term is defined
therein.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Each Underwriter named below severally
agrees, subject to the terms and provisions of this Terms Agreement, including the terms and provisions incorporated by reference
herein, to purchase the principal amount of Securities set forth opposite its name:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 9pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Name</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Principal Amount of 1.900% Senior Notes due 2025</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Principal Amount of 2.650% Senior Notes due 2030</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 56%; text-align: left; padding-left: 0.05in">Barclays Capital Inc.&#9;</TD><TD STYLE="width: 8%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">30,000,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">72,000,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.05in">Citigroup Global Markets Inc.&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">60,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">144,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.05in">J.P. Morgan Securities LLC&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">60,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">144,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.05in">Wells Fargo Securities, LLC&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">60,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">144,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.05in">BofA Securities Inc.&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">72,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.05in">DNB Markets, Inc.&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">72,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.05in">RBC Capital Markets, LLC&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">72,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.05in">Scotia Capital (USA) Inc.&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">35,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">84,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.05in">SG Americas Securities, LLC&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">72,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.05in">Allied Irish Banks p.l.c.&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">48,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.05in">BNP Paribas Securities Corp.&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">48,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.05in">Goldman Sachs &amp; Co. LLC&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">36,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.05in">MUFG Securities Americas Inc.&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">48,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.05in">Standard Chartered Bank&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">48,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.05in">TD Securities (USA) LLC&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">48,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 0.05in">U.S. Bancorp Investments, Inc.&#9;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">20,000,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">48,000,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 11pt; padding-bottom: 2.5pt; padding-left: 0.05in">Total&#9;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">500,000,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,200,000,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify">&nbsp;</P>


<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0.5in">Any notice by the Company to the Underwriters
pursuant to this Terms Agreement shall be in writing and shall be deemed to have been duly given if mailed or transmitted by any
standard form of telecommunication addressed to:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>Barclays Capital Inc., 745 Seventh Avenue, New York, New York 10019, Attention: Syndicate Registration, Fax: (646) 834-8133.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>Citigroup Global Markets Inc., 383 Greenwich Street, New York, New York 10013, Fax: (646) 291-1469, Attention: General Counsel.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>J.P. Morgan Securities LLC, 383 Madison Avenue, New York, New York 10179, Attention: Investment Grade Syndication Desk, Fax:
(212) 834-6081.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>Wells Fargo Securities, LLC, 550 South Tryon Street, 5th Floor, Charlotte, North Carolina 28202, Attention: Transaction Management,
Fax: (704) 410-0326.</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Please accept this offer by signing a
copy of this Terms Agreement in the space set forth below and returning the signed copy to us.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 198pt; text-indent: 0pt; text-align: justify"></P>

<TABLE CELLPADDING="2" CELLSPACING="0" STYLE="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">                                                                                                                                                                                                                                                                                                                                                                                                <TR STYLE="vertical-align: top; text-align: left">
<TD>&nbsp;</TD>
    <TD COLSPAN="4">Acting on behalf of themselves and as the Representatives of the several Underwriters</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
<TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left"><TD>&nbsp;</TD>
    <TD COLSPAN="3">BARCLAYS CAPITAL INC.</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 45%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">/s/ Barbara Mariniello</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>Barbara Mariniello</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Managing Director</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="2" CELLSPACING="0" STYLE="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD>&nbsp;</TD>
    <TD COLSPAN="3">CITIGROUP GLOBAL
MARKETS INC.</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 45%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">/s/ Brian D. Bednarski</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>Brian D. Bednarski</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Managing Director</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"><TABLE CELLPADDING="2" CELLSPACING="0" STYLE="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="text-transform: uppercase">J.P.
MORGAN SECURITIES lLC</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 45%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">/s/ Som Bhattacharyya</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>Som Bhattacharyya</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Executive Director</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-right: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-right: 0"><TABLE CELLPADDING="2" CELLSPACING="0" STYLE="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="text-transform: uppercase">Wells
Fargo Securities, LLC</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 45%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">/s/ Carolyn Hurley</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>Carolyn Hurley</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Director</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-right: 0"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt">Accepted:</P>

<TABLE CELLPADDING="2" CELLSPACING="0" STYLE="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="3">BOSTON SCIENTIFIC CORPORATION</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 30%">&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">/s/ Robert J. Castagna&#9;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>Robert J. Castagna&#9;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Vice President and Treasurer </TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>&nbsp;</I></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 1in 6pt; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 44pt; text-indent: 0pt; text-align: right"><B>ANNEX
A</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 1in 6pt; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 1in 6pt; text-align: center">ISSUER FREE WRITING PROSPECTUSES</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>The Final Term Sheet, in substantially the form of Annex B hereto.</TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 1in 6pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 1in 6pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 1in 6pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 1in 6pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 1in 6pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 1in 6pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 1in 6pt"></P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 1in 6pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 44pt; text-indent: 0pt; text-align: right"><B>ANNEX
B</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 1in 6pt; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 1in 6pt; text-align: center">FORM OF FINAL TERM SHEET</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 1in 6pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 1in 6pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 1in 6pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 1in 6pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 1in 6pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 1in 6pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 1in 6pt"></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 1in 6pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>ANNEX B</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: right">Filed Pursuant to Rule 433 under the Securities
Act of 1933</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: right">Registration Statement No. 333-223095</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: right">Issuer Free Writing Prospectus, dated
May 14, 2020</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>Boston Scientific Corporation</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">$1,700,000,000</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">Senior Notes Offering</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><I>Terms and Conditions &ndash; 5- and
10-Year Fixed Rate Notes</I></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="2" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 25%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="width: 38%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 9pt">5-Year</FONT></TD>
    <TD STYLE="width: 37%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 9pt">10-Year</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">Issuer</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">Boston Scientific Corporation</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">Boston Scientific Corporation</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">Note Type</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">Senior Notes</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">Senior Notes</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">Form of Offering</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">SEC Registered</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">SEC Registered</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">Ratings<SUP>1</SUP></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt"></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">Principal Amount</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">$500,000,000</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">$1,200,000,000</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">Trade Date</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">May 14, 2020</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">May 14, 2020</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">Settlement Date (T+2)</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">May 18, 2020</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">May 18, 2020</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">Maturity Date</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">June 1, 2025</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">June 1, 2030</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">Coupon</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">1.900% per annum</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">2.650% per annum</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">Yield to Maturity</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">1.910% per annum</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">2.667% per annum</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">Price to Public</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">99.952%</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">99.851%</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">Spread to Benchmark Treasury</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">Plus 160 basis points</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">Plus 205 basis points</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">Benchmark Treasury</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">0.375% UST due April 30, 2025</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">1.500% UST due February 15, 2030</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">Benchmark Treasury Yield</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">0.310%</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">0.617%</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">Benchmark Treasury Price</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">100-10 &frac14;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">108-11</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">Interest Payment Dates</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">Semi-annually on June 1 and December 1</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">Semi-annually on June 1 and December 1</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">First Interest Payment Date</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">December 1, 2020</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">December 1, 2020</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">Make-whole Call</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">Prior to May 1, 2025, make-whole call at T+25 basis points</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">Prior to March 1, 2030, make-whole call at T+35 basis points</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">Par Call</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">On or after May 1, 2025</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">On or after March 1, 2030</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">Change of Control Repurchase Event</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">Putable at 101% of aggregate principal amount plus accrued and unpaid interest, if any, to, but not including, the date of repurchase</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">Putable at 101% of aggregate principal amount plus accrued and unpaid interest, if any, to, but not including, the date of repurchase</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">Day Count Basis</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">30/360</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">30/360</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">Minimum Denominations</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">$2,000 and integral multiples of $1,000 in excess of such amount</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">$2,000 and integral multiples of $1,000 in excess of such amount</FONT></TD></TR>
</TABLE>


<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"><I>&nbsp;</I></P>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="2" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; width: 25%; border-bottom: Black 1pt solid; font: 11pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 38%; border-bottom: Black 1pt solid; font: 11pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 9pt">5-Year</FONT></TD>
    <TD STYLE="white-space: nowrap; width: 37%; border-bottom: Black 1pt solid; font: 11pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 9pt">10-Year</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; font: 11pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">CUSIP / ISIN</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; font: 11pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">101137 AZ0 / US101137AZ01</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; font: 11pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">101137 BA4 / US101137BA41</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; font: 11pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">Joint Bookrunners</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0">Barclays Capital Inc.</P>
        <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0">Citigroup Global Markets Inc.</P>
        <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0">J.P. Morgan Securities LLC</P>
        <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0">Wells Fargo Securities, LLC</P>
        <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0">BofA Securities Inc.</P>
        <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0">DNB Markets, Inc.</P>
        <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0">RBC Capital Markets, LLC</P>
        <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0">Scotia Capital (USA) Inc.</P>
        <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0">SG Americas Securities, LLC</P></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0">Barclays Capital Inc.</P>
        <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0">Citigroup Global Markets Inc.</P>
        <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0">J.P. Morgan Securities LLC</P>
        <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0">Wells Fargo Securities, LLC</P>
        <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0">BofA Securities Inc.</P>
        <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0">DNB Markets, Inc.</P>
        <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0">RBC Capital Markets, LLC</P>
        <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0">Scotia Capital (USA) Inc.</P>
        <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0">SG Americas Securities, LLC</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; font: 11pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 9pt">Co-Managers</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0">Allied Irish Banks p.l.c.</P>
        <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0">BNP Paribas Securities Corp.</P>
        <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0">Goldman Sachs &amp; Co. LLC</P>
        <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0">MUFG Securities Americas Inc.</P>
        <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0">Standard Chartered Bank</P>
        <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0">TD Securities (USA) LLC</P>
        <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0">U.S. Bancorp Investments, Inc.</P></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0">Allied Irish Banks p.l.c.</P>
        <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0">BNP Paribas Securities Corp.</P>
        <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0">Goldman Sachs &amp; Co. LLC</P>
        <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0">MUFG Securities Americas Inc.</P>
        <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0">Standard Chartered Bank</P>
        <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0">TD Securities (USA) LLC</P>
        <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0">U.S. Bancorp Investments, Inc.</P></TD></TR>
</TABLE>


<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 12pt 0"><U>Note:</U></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 27pt"><SUP>1</SUP></TD><TD>A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at
any time.</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B>The Issuer has filed a registration statement (including
a preliminary prospectus supplement and accompanying prospectus) with the U.S. Securities and Exchange Commission (the &ldquo;SEC&rdquo;)
for the offering to which this communication relates. Before you invest, you should read the preliminary prospectus supplement
and accompanying prospectus and other documents the Issuer has filed with the SEC for more complete information about the Issuer
and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at <I>www.sec.gov</I>. Alternatively,
the Issuer, any underwriter or any dealer participating in the offering will arrange to send you the preliminary prospectus supplement
and accompanying prospectus if you request it by calling Barclays Capital Inc. toll-free at (888) 603-5847, Citigroup Global Markets
Inc. toll-free at (800) 831-9146, J.P. Morgan Securities LLC collect at (212) 834-4533 or Wells Fargo Securities, LLC toll-free
at (800) 645-3751.</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B>Any disclaimers or other notices that may appear below
are not applicable to this communication and should be disregarded. Such disclaimers or other notices were automatically generated
as a result of this communication being sent via Bloomberg or another email system.</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>

<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: right"><B>EXHIBIT
1</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 1in 24pt; text-align: center">INFORMATION FURNISHED BY THE UNDERWRITERS</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>the names of the Underwriters on the cover page of the Preliminary Prospectus and the Final Prospectus.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>the following information under the caption &#8220;Underwriting&#8221; in the Preliminary Prospectus and the Final Prospectus:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Courier New, Courier, Monospace">o</FONT></TD><TD>the names of the Underwriters and their respective allocations</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Courier New, Courier, Monospace">o</FONT></TD><TD>the second sentence of the fourth paragraph</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Courier New, Courier, Monospace">o</FONT></TD><TD>the first paragraph under the sub-heading &ldquo;Commissions and Discounts&rdquo;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Courier New, Courier, Monospace">o</FONT></TD><TD>the third and fourth sentences under the sub-heading &ldquo;New Issues of Notes&rdquo;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Courier New, Courier, Monospace">o</FONT></TD><TD>the two paragraphs under the sub-heading &ldquo;Price Stabilization and Short Positions&rdquo;</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: right">EXHIBIT B</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">BOSTON SCIENTIFIC CORPORATION<BR>
Debt Securities</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">DELAYED DELIVERY CONTRACT</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: right">___________ __, ______</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt">Boston Scientific Corporation<BR>
c/o [Name and address of Representatives]</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt">Attention:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt">Ladies and Gentlemen:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The undersigned hereby agree to purchase
from Boston Scientific Corporation (the &ldquo;Company&rdquo;), and the Company agrees to sell to the undersigned on __________
__, ____ (the &ldquo;Delivery Date&rdquo;), principal amount of the Company&rsquo;s Debt Securities due ___________ __, ____ (the
&ldquo;Securities&rdquo;), offered by the Company&rsquo;s Basic Prospectus dated ____, as supplemented by its Final Prospectus
dated ___________ __, ____, receipt of which is hereby acknowledged, at a purchase price of ____% of the ________ principal amount
thereof, plus accrued interest from ____, to the Delivery Date, and on the further terms and conditions set forth in the contract.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Payment for the Securities which the
undersigned has agreed to purchase on the Delivery Date shall be made to the Company or by wire transfer in same day funds, on
the Delivery Date, upon delivery to the undersigned at the office of [name and address of Representatives], of the Securities to
be purchased by the undersigned in definitive form and in such denominations and registered in such names as the undersigned may
designate by written or telegraphic communication addressed to the Company not less than five full business days prior to the Delivery
Date.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The obligation of the undersigned to
take delivery of and make payment for Securities on the Delivery Date shall be subject only to the conditions that (1) the purchase
of Securities to be made by the undersigned shall not on the Delivery Date be prohibited under the laws of the jurisdiction to
which the undersigned is subject and (2) the Company, on or before ___________ __, ____, shall have sold to the Underwriters of
the Securities (the &ldquo;Underwriters&rdquo;) such principal amount of the Securities as is to be sold to them pursuant to the
Terms Agreement dated ___________ __, ____ between the Company and the Underwriters. The obligation of the undersigned to take
delivery of and make payment for Securities shall not be affected by the failure of any purchaser to take delivery of and make
payment for Securities pursuant to other contracts similar to this contract. The undersigned represents and warrants to you that
its investment in the Securities is not, as of the date hereof, prohibited under the laws of any jurisdiction to which the undersigned
is subject and which govern such investment.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Promptly after completion of the sale
to the Underwriters, the Company will mail or deliver to the undersigned at its address set forth below notice to such effect,
accompanied by a copy of the opinion of counsel for the Company delivered to the Underwriters in connection therewith.</P>

<!-- Field: Page; Sequence: 34; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">By the execution hereof, the undersigned
represents and warrants to the Company that all necessary corporate action for the due execution and delivery of this contract
and the payment for and purchase of the Securities has been taken by it and no further authorization or approval of any governmental
or other regulatory authority is required for such execution, delivery, payment or purchase, and that, upon acceptance hereof by
the Company and mailing or delivery of a copy as provided below, this contract will constitute a valid and binding agreement of
the undersigned in accordance with its terms.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 3.2in; text-indent: -0.2in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 11pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">[Name of Purchaser]</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 30%">&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 3.2in; text-indent: -0.2in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt">Accepted:&nbsp;</P>

<TABLE CELLPADDING="2" CELLSPACING="0" STYLE="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD COLSPAN="3">BOSTON SCIENTIFIC CORPORATION</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 30%">&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR></TABLE>


<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 24pt 3.25in 24pt 27.35pt; text-indent: -27.35pt"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: right">EXHIBIT C</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 24pt; text-align: center">[FORM OF OPINION OF SHEARMAN &amp; STERLING
LLP]</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 36; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: right">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: right">EXHIBIT D</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 24pt; text-align: center">[FORM OF OPINION OF VANCE BROWN]</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; text-align: center">D-1</P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>ss173781_ex0402.htm
<DESCRIPTION>FORM OF 1.900% SENIOR NOTE DUE 2025.
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>
<P STYLE="text-align: right; margin: 0"><B>Exhibit 4.2</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"><FONT STYLE="text-transform: uppercase">This Security is
a Registered Security in permanent global form within the meaning of the Indenture hereinafter referred to and is registered in
the name of the Depositary or a nominee of the Depositary. This Security is exchangeable for Securities registered in the name
of a person other than the Depositary or its nominee only in the limited circumstances described in the Indenture. Unless and until
it is exchanged in whole or in part for Securities in definitive registered form, this Security may not be transferred except as
a whole by the Depositary to the nominee of the Depositary or by a nominee of the Depositary to the Depositary or another nominee
of the Depositary or by the Depositary or any such nominee to a successor Depositary or a nominee of such successor Depositary.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"><FONT STYLE="text-transform: uppercase">Unless this Security
is presented by an authorized representative of The Depository Trust Company (55 Water Street, New York, New York) to the issuer
or its agent for registration of transfer, exchange or payment, and any Security issued is registered in the name of Cede &amp;
Co. or such other name as requested by an authorized representative of The Depository Trust Company and any payment hereon is made
to Cede &amp; Co., ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY A PERSON IS WRONGFUL since the registered
owner hereof, Cede &amp; Co., has an interest herein.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"><FONT STYLE="text-transform: uppercase"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 4.25in; text-indent: -4.25in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; width: 69%; padding-right: 5.4pt; padding-left: 5.4pt">No. [&#9679;]</TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; width: 31%; padding-right: 5.4pt; padding-left: 5.4pt">CUSIP No.: 101137 AZ0</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt">ISIN No.: US101137AZ01</TD></TR>
</TABLE>


<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 4.25in; text-indent: -4.25in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt; text-align: center">$[&#9679;]<BR>
1.900% SENIOR NOTE DUE 2025</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">BOSTON SCIENTIFIC CORPORATION promises
to pay<BR>
to Cede &amp; Co. or registered assigns the principal sum of<BR>
[&#9679;] DOLLARS ($[&#9679;]) on<BR>
June 1, 2025.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">Interest Payment Dates: June 1 and December 1 of each year,
commencing December 1, 2020.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">Regular Record Dates: May 15 and November 15.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in">Reference is hereby made to the further
provisions of this Security set forth on the reverse hereof, which further provisions shall for all purposes have the same effect
as if set forth at this place.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>[SIGNATURE PAGE FOLLOWS]</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">2</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt; text-indent: 1in">IN WITNESS WHEREOF, the Company has caused
this instrument to be duly executed.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt">Dated: May 18, 2020</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 12pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">BOSTON SCIENTIFIC CORPORATION</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 30%">&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>[&#9679;]</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>[&#9679;]</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in">[corporate seal]</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 12pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 5%">Attest:</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 30%">&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>[&#9679;]</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>[&#9679;]</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><BR STYLE="clear: both"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">TRUSTEE&rsquo;S CERTIFICATE OF AUTHENTICATION</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">Dated: May 18, 2020</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in">This is one of the Securities of the series
designated therein referred to in the within-mentioned Indenture.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 12pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD COLSPAN="4">U.S. BANK NATIONAL ASSOCIATION, <BR>
as Trustee</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 30%">&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; vertical-align: top">Authorized Signatory</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 3in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 3in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: center"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">[REVERSE OF FORM OF SECURITY]</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0.5in; text-align: center">BOSTON SCIENTIFIC CORPORATION</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">1.900% SENIOR NOTE DUE 2025</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="color: #010000">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Interest</U>.
BOSTON SCIENTIFIC CORPORATION, a Delaware corporation (the &ldquo;Company&rdquo;), which definition shall include any successor
thereto in accordance with the Indenture (as defined below), promises to pay, until the principal hereof is paid or made available
for payment, interest on the principal amount set forth on the reverse side hereof at a rate of 1.900% per annum. Interest on the
Securities will accrue from and including the most recent date to which interest has been paid or, if no interest has been paid,
from May 18, 2020 to but excluding the date on which interest is paid. Interest shall be payable in arrears on June 1 and December
1 of each year (each an &ldquo;Interest Payment Date&rdquo;), commencing December 1, 2020. Interest will be computed on the basis
of a 360-day year of twelve 30-day months.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="color: #010000">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Method
of Payment</U>. The Company will pay interest on the Securities to the Persons who are registered Holders of Securities at the
close of business on the immediately preceding May 15 and November 15 of each year (each, a &ldquo;Regular Record Date&rdquo;).
Holders must surrender Securities to a Paying Agent to collect principal payments. The Company will pay principal, the Redemption
Price (pursuant to paragraph 5 herein), any Change of Control Payment and interest in money of the United States that at the time
of payment is legal tender for payment of public and private debts. At the Company&rsquo;s option, interest may be paid by check
mailed to the registered address of the Holder or by wire transfer to an account designated by the Holder of this Security; provided,
however, that so long as the Securities are registered in the name of The Depository Trust Company (&ldquo;DTC&rdquo;), or its
nominee, all payments of principal, Redemption Price (pursuant to paragraph 5 herein) and interest in respect thereof will be made
by wire transfer in immediately available funds.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="color: #010000">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Paying
Agent and Security Registrar</U>. Initially, U.S. Bank National Association, will act as Paying Agent and Security Registrar. The
Company may change any Paying Agent or Security Registrar without notice.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="color: #010000">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Indenture</U>.
The Company issued the Securities under an Indenture, dated as of May 29, 2013 (the &ldquo;Indenture&rdquo;), between the Company
and U.S. Bank National Association, as Trustee (the &ldquo;Trustee&rdquo;). This Security is one of an issue of Securities of the
Company issued under the Indenture. The terms of the Securities include those stated herein and in the Indenture and those made
part of the Indenture by reference to the Trust Indenture Act of 1939, as amended from time to time (the &ldquo;TIA&rdquo;). The
Securities are subject to all such terms, and Holders of the Securities are referred to the Indenture and the TIA for a statement
of them. Capitalized terms used herein and not otherwise defined have the meanings set forth in the Indenture. The Securities constitute
senior indebtedness of the Company and, as such, shall be general unsecured and unsubordinated obligations of the Company ranking
equally with all of the Company&rsquo;s unsecured and unsubordinated obligations. The Company may, subject to the terms of the
Indenture and applicable law, issue additional Securities under the Indenture. The Securities issued on May 18, 2020 and any additional
Securities subsequently issued shall be treated as a single class for all purposes of the Indenture. The Indenture limits the ability
of the Company to incur certain liens and to merge or consolidate with another entity or transfer all or substantially all of its
property and assets.</P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="color: #010000">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Optional
Redemption</U>. The Securities will be redeemable at any time prior to May 1, 2025, at the option of the Company, in whole or in
part, on at least 15 days, but no more than 60 days prior written notice mailed to the registered holders of the Securities (with
a copy to the Trustee) to be redeemed, on any date prior to maturity at a redemption price equal to the greater of (i) 100% of
the principal amount of the Securities to be redeemed or (ii) as determined by a Quotation Agent, the sum of the present values
of the remaining scheduled payments of principal and interest thereon to the Par Call Date (not including any portion of such payments
of interest accrued to the date of redemption) discounted to the date of redemption (the &ldquo;Redemption Date&rdquo;) on a semi-annual
basis (assuming a 360-day year consisting of twelve 30-day months) at the Adjusted Treasury Rate plus 25 basis points, plus, in
each case, accrued and unpaid interest on the Securities to, but not including, the Redemption Date (subject to the right of holders
as of the close of business on a regular record date to receive interest due on the related Interest Payment Date). At any time
and from time to time on or after May 1, 2025 (the date that is 1 month prior to the maturity date of the Securities) (the &ldquo;Par
Call Date&rdquo;), the Company may redeem the Securities, in whole or in part, at a redemption price equal to 100% of the principal
amount of the Securities being redeemed plus accrued and unpaid interest to the Redemption Date.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in">&ldquo;Adjusted Treasury Rate&rdquo; means,
with respect to any Redemption Date, the rate per year equal to the semi-annual equivalent yield to maturity or interpolated (on
a day count basis) of the Comparable Treasury Issue, assuming a price for the Comparable Treasury Issue (expressed as a percentage
of its principal amount) equal to the Comparable Treasury Price for such Redemption Date.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in">&ldquo;Comparable Treasury Issue&rdquo;
means the United States Treasury security selected by a Quotation Agent as having an actual or interpolated maturity comparable
to the remaining term of the Securities to be redeemed that would be utilized (assuming that the Securities matured on the Par
Call Date), at the time of selection and in accordance with customary financial practice, in pricing new issues of corporate debt
securities of comparable maturity to the remaining term of such Securities.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in">&ldquo;Comparable Treasury Price&rdquo;
means, with respect to any Redemption Date, (1) the average of the Reference Treasury Dealer Quotations for such Redemption Date,
after excluding the highest and lowest such Reference Treasury Dealer Quotations, or (2) if the Trustee obtains fewer than four
such Reference Treasury Dealer Quotations, the average of all such quotations.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in">&ldquo;Quotation Agent&rdquo; means the
Reference Treasury Dealer appointed by the Trustee after consultation with the Company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in">&ldquo;Reference Treasury Dealer&rdquo;
means (1) Barclays Capital Inc., Citigroup Global Markets Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC and
their respective successors; provided, however, that, if any of the foregoing shall cease to be a primary United States Government
securities dealer in the United States (a &ldquo;Primary Treasury Dealer&rdquo;), the Company shall substitute therefor another
Primary Treasury Dealer, and (2) any other Primary Treasury Dealers selected by the Trustee after consultation with the Company.</P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in">&ldquo;Reference Treasury Dealer Quotations&rdquo;
means, with respect to each Reference Treasury Dealer and any Redemption Date, the average, as determined by the Trustee, of the
bid and ask prices for the Comparable Treasury Issue (expressed in each case as a percentage of its principal amount) quoted in
writing to the Trustee by such Reference Treasury Dealer at 5:00 p.m. on the third Business Day preceding such Redemption Date.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in">If the Company redeems only some of the
Securities, the Trustee shall determine by lot the Securities to be redeemed or, in the case of Securities held in global form,
pursuant to applicable Depositary procedures.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="color: #010000">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Repurchase
at the Option of Holders upon Change of Control Repurchase Event</U>. If a Change of Control Repurchase Event occurs, unless the
Company has exercised its option to redeem the Securities as described under paragraph 5 above, each Holder of the Securities will
have the right to require the Company to purchase all or a portion (equal to $2,000 and any integral multiples of $1,000 in excess
thereof) of such Holder&rsquo;s Securities pursuant to the offer described below (a &ldquo;Change of Control Offer&rdquo;) at a
purchase price equal to 101% of the aggregate principal amount of such Holder&rsquo;s Securities that are repurchased, plus accrued
and unpaid interest, if any, to, but not including, the date of repurchase (the &ldquo;Change of Control Payment&rdquo;), subject
to the rights of Holders of Securities on the relevant record date to receive interest due on the relevant Interest Payment Date.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in">The Company will be required to send a
notice to each Holder of the Securities by first class mail, with a copy to the Trustee, within 30 days following the date upon
which any Change of Control Repurchase Event occurred, or at the Company&rsquo;s option, prior to any Change of Control but after
the public announcement of the pending Change of Control. The notice will govern the terms of the Change of Control Offer and will
describe, among other things, the transaction that constitutes or may constitute the Change of Control Repurchase Event and the
purchase date. The purchase date will be at least 30 days but no more than 60 days from the date such notice is mailed, other than
as may be required by law (a &ldquo;Change of Control Payment Date&rdquo;). If the notice is mailed prior to the date of consummation
of the Change of Control, the notice will state that the Change of Control Offer is conditioned on the Change of Control being
consummated on or prior to the Change of Control Payment Date.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in">On the Change of Control Payment Date,
the Company will, to the extent lawful:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>accept for payment all properly tendered Securities or portions of Securities not validly withdrawn;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>deposit with the Paying Agent the required payment for all properly tendered Securities or portions of Securities not validly
withdrawn; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>deliver or cause to be delivered to the Trustee the repurchased Securities, accompanied by an officers&#8217; certificate stating,
among other things, the aggregate principal amount of repurchased Securities.</TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in">The Company will not be required to make
a Change of Control Offer with respect to the Securities upon the occurrence of a Change of Control Repurchase Event if a third
party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for such an offer made
by the Company and the third party purchases all Securities properly tendered and not withdrawn under its offer. In addition, the
Company will not repurchase any Securities if there has occurred and is continuing on the Change of Control Payment Date an Event
of Default under the Indenture.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">The Company will comply with the requirements
of Rule 14e-1 under the Exchange Act, and any other securities laws and regulations thereunder, to the extent those laws and regulations
are applicable, in connection with the repurchase of Securities as a result of a Change of Control Repurchase Event. To the extent
that the provisions of any such securities laws or regulations conflict with the Change of Control Offer provisions of the Securities,
the Company will comply with those securities laws and regulations and will not be deemed to have breached its obligations under
the Change of Control Offer provisions of the Securities by virtue of any such conflict.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in">For purposes of the foregoing discussion,
the following definitions apply:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><I>&ldquo;Capital Stock&rdquo;</I> means
the capital stock of every class whether now or hereafter authorized, regardless of whether such capital stock shall be limited
to a fixed sum or percentage with respect to the rights of the holders thereof to participate in dividends and in the distribution
of assets upon the voluntary or involuntary liquidation, dissolution or winding up of such corporation.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><I>&ldquo;Change of Control&rdquo;</I>
means the occurrence of any of the following:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>the direct or indirect sale, lease, transfer, conveyance or other disposition (other than by way of merger or consolidation),
in one or more series of related transactions, of all or substantially all of the Company&#8217;s assets and the assets of the
Company&#8217;s subsidiaries, taken as a whole, to any &#8220;person&#8221; (as that term is used in Section 13(d)(3) of the Exchange
Act), other than the Company or one of its subsidiaries;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>the consummation of any transaction (including, without limitation, any merger or consolidation) the result of which is that
any &#8220;person&#8221; (as that term is used in Section 13(d)(3) of the Exchange Act), other than the Company or one of its subsidiaries,
becomes the &#8220;beneficial owner&#8221; (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of more than
50% of the Company&#8217;s then outstanding Voting Stock or other Voting Stock into which its Voting Stock is reclassified, consolidated,
exchanged or changed, measured by voting power rather than number of shares; or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>the adoption of a plan relating to the Company&#8217;s liquidation or dissolution.</TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in">Notwithstanding the foregoing, a transaction
will not be considered to be a Change of Control if (a) the Company becomes a direct or indirect wholly-owned subsidiary of a holding
company and (b)(x) immediately following that transaction, the direct or indirect holders of the Voting Stock of the holding company
are substantially the same as the holders of the Company&rsquo;s Voting Stock immediately prior to that transaction or (y) immediately
following that transaction, no person is the beneficial owner, directly or indirectly, of more than 50% of the Voting Stock of
such holding company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><I>&ldquo;Change of Control Repurchase
Event&rdquo;</I> means the occurrence of both a Change of Control and a Rating Event.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><I>&ldquo;Fitch&rdquo;</I> means Fitch
Ratings, Inc. and its successors.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><I>&ldquo;Investment Grade&rdquo;</I> means
a rating of Baa3 or better by Moody&rsquo;s (or its equivalent under any successor rating categories of Moody&rsquo;s), a rating
of BBB- or better by S&amp;P (or its equivalent under any successor rating categories of S&amp;P) and a rating of BBB- or better
by Fitch (or its equivalent under any successor rating categories of Fitch); provided, however, that the Company shall not be required
to maintain a rating by more than two Rating Agencies at any time and if only two Rating Agencies provide a rating with respect
to the Securities, then &ldquo;Investment Grade&rdquo; with respect to the Securities shall mean the applicable rating described
above of such two Rating Agencies with respect to the Securities.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><I>&ldquo;Moody&rsquo;s&rdquo;</I> means
Moody&rsquo;s Investors Service, Inc., a subsidiary of Moody&rsquo;s Corporation, and its successors.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><I>&ldquo;Rating Agencies&rdquo;</I> means
each of Moody&rsquo;s, S&amp;P and Fitch, or if any of Moody&rsquo;s, S&amp;P or Fitch ceases to rate the Securities or fails to
make a rating of the Securities publicly available, any &ldquo;nationally recognized statistical rating organization&rdquo; within
the meaning of Section 3(a)(62) under the Exchange Act that is selected by the Company as a replacement agency for Moody&rsquo;s,
S&amp;P or Fitch, or each of them, as the case may be; provided, however, that the Company shall not be required to maintain a
rating by more than two Rating Agencies at any time.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><I>&ldquo;Rating Event&rdquo;</I> means
the rating of the Securities shall be decreased by each of the Rating Agencies independently by one or more gradations during the
Rating Period (as defined below). If the rating of the Securities by each of the Rating Agencies is Investment Grade, then &ldquo;Rating
Event&rdquo; will mean the rating of the Securities shall be decreased by one or more gradations by each Rating Agency so that
the ratings of the Securities by all of the Rating Agencies fall below Investment Grade, on any date from the date of the public
notice of an arrangement that could result in a Change of Control until the end of the 30-day period following public notice of
the occurrence of the Change of Control (the &ldquo;Rating Period&rdquo;) (which 30-day period shall be extended by no more than
60 days from the date of the occurrence of the Change of Control if the rating of the Securities is under publicly announced consideration
for possible downgrade by any of the Rating Agencies and each other Rating Agency has either downgraded, or publicly announced
that it is considering downgrading, the Securities). A Rating Event otherwise arising by virtue of a particular reduction in rating
will not be deemed to have occurred in respect of a particular Change of Control (and thus will not be deemed a Rating Event for
purposes of the definition of &ldquo;Change of Control Repurchase Event&rdquo;) if each Rating Agency making the reduction in rating
to which this definition would otherwise apply does not announce or publicly confirm or inform the Trustee under the Indenture
in writing at the Company&rsquo;s request that the reduction was the result, in whole or in part, of any event or circumstance
comprised of or arising as a result of, or in respect of, the applicable Change of Control (whether or not the applicable Change
of Control has occurred at the time of the Rating Event).</P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><I>&ldquo;S&amp;P&rdquo;</I> means S&amp;P
Global Ratings, a division of S&amp;P Global Inc., and its successors.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><I>&ldquo;Voting Stock&rdquo;</I> means,
with respect to any specified person as of any date, the Capital Stock of such person that is at the time entitled to vote generally
in the election of the board of directors of such person.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="color: #010000">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Sinking
Fund</U>. No sinking fund is provided for the Securities.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="color: #010000">8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Denominations,
Transfer, Exchange</U>. The Securities are in registered form without coupons in minimum denominations of $2,000 and integral multiples
of $1,000 in excess thereof. A Holder may transfer or exchange Securities in accordance with the Indenture. No service charge shall
be made for any registration of transfer or exchange of Securities, but the Company may require payment of a sum sufficient to
cover any tax or other governmental charge that may be imposed in connection with any registration of transfer or exchange of Securities,
other than exchanges pursuant to Section 304, 906, 1107 or 1305 of the Indenture not involving any transfer.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="color: #010000">9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Persons
Deemed Owners</U>. The registered Holder of a Security may be treated as the owner of it for all purposes.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="color: #010000">10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Unclaimed
Money</U>. Subject to any applicable abandoned property laws, if money for the payment of principal or interest remains unclaimed
for two years, the Trustee or Paying Agent will pay the money back to the Company at its written request. After that, Holders entitled
to the money must look to the Company for payment as unsecured general creditors unless an &ldquo;abandoned property&rdquo; law
designates another Person.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="color: #010000">11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Amendment,
Supplement, Waiver</U>. The Company and the Trustee may, without the consent of the Holders of any outstanding Securities, amend,
waive or supplement the Indenture or the Securities for certain specified purposes, including, among other things, curing ambiguities,
defects or inconsistencies, or making any other change that does not adversely affect the rights of any Holder in any material
respect. Other amendments and modifications of the Indenture or the Securities may be made by the Company and the Trustee with
the consent of the Holders of not less than a majority of the aggregate principal amount of the outstanding Securities affected,
subject to certain exceptions requiring the consent of the Holders of each Security affected thereby.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="color: #010000">12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Successor
Corporation</U>. When a successor corporation assumes all the obligations of its predecessor under the Securities and the Indenture
and the transaction complies with the terms of Article 8 of the Indenture, the predecessor corporation, subject to certain exceptions,
will be released from those obligations.</P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="color: #010000">13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Defaults
and Remedies</U>. Events of Default are set forth in the Indenture. Subject to certain limitations in the Indenture, if an Event
of Default (other than an Event of Default specified in Section 501(5) or Section 501(6) of the Indenture) occurs and is continuing,
then the Holders of not less than 25% in aggregate principal amount of the Outstanding Securities may, or the Trustee may, declare
the principal of, plus accrued interest, if any, to be due and payable immediately. If an Event of Default specified in Section
501(5) or Section 501(6) of the Indenture occurs and is continuing, the principal of and accrued interest on all of the Securities
shall ipso facto become and be immediately due and payable without any declaration or other act on the part of the Trustee or any
Holder. Holders of the Securities may not enforce the Indenture or the Securities except as provided in the Indenture. The Trustee
may require reasonable security or indemnity reasonably satisfactory to it before it enforces the Indenture or the Securities.
Subject to certain limitations, Holders of a majority in principal amount of the then Outstanding Securities may direct the Trustee
in its exercise of any trust or power. The Company must furnish an annual compliance certificate to the Trustee.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="color: #010000">14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>No
Recourse Against Others</U>. A director, officer, employee, or stockholder, as such, of the Company or any of its Affiliates shall
not have any liability for any obligations of the Company under the Securities or the Indenture or for any claim based on, in respect
of or by reason of, such obligations or their creation. Each Holder of the Securities by accepting a Security waives and releases
all such liability. The waiver and release are part of the consideration for the issue of the Securities.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="color: #010000">15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Defeasance</U>.
The Indenture contains provisions (which provisions apply to this Security) for defeasance at any time of (a) the entire indebtedness
of the Company in respect of this Security and (b) certain restrictive covenants and Defaults and Events of Default, in each case
upon compliance by the Company with certain conditions set forth therein.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="color: #010000">16.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Authentication</U>.
This Security shall not be valid until the Trustee signs the certificate of authentication to this Security.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="color: #010000">17.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>GOVERNING
LAW</U>. THE INDENTURE AND THIS SECURITY SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in">The Company will furnish to any Holder
of Securities upon written request and without charge a copy of the Indenture. Requests may be made to:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 1in 12pt">BOSTON SCIENTIFIC CORPORATION<BR>
300 Boston Scientific Way<BR>
Marlborough, Massachusetts 01752<BR>
Telephone: (508) 683-4000<BR>
Telecopy: (508) 683-4350<BR>
Attention: General Counsel</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 1in 12pt"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 1in 12pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">ASSIGNMENT FORM</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">If you the holder want to assign this Security, fill in
the form below and have your signature guaranteed:&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in">I or we assign and transfer this
Security to <U>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<BR>
&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<BR> </U>(Insert
assignee&rsquo;s social security or tax ID number) <U>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<BR>
&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<BR> </U>(Print or type assignee&rsquo;s name, address and zip
code) and irrevocably appoint <U>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<BR> </U>agent
to transfer this Security on the books of the Company. The agent may substitute another to act for him.<BR> <U>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 261pt; text-indent: -261pt">Date:&#9;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Your
signature:&#9;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&#9;<BR> </U>(Sign exactly as your name appears on the
other side<BR> of this Security)</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">Signature Guarantee: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</U></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in">Signatures must be guaranteed by an &ldquo;eligible
guarantor institution&rdquo; meeting the requirements of the Security Registrar, which requirements include membership or participation
in the Securities Transfer Agents Medallion Program (&ldquo;STAMP&rdquo;) or such other &ldquo;signature guarantee program&rdquo;
as may be determined by the Security Registrar in addition to, or in substitution for, STAMP, all in accordance with the Securities
Exchange Act of 1934, as amended.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"></P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>4
<FILENAME>ss173781_ex0403.htm
<DESCRIPTION>FORM OF 2.650% SENIOR NOTE DUE 2030.
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>
<P STYLE="text-align: right; margin: 0"><B>Exhibit 4.3</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"><FONT STYLE="text-transform: uppercase">This Security is
a Registered Security in permanent global form within the meaning of the Indenture hereinafter referred to and is registered in
the name of the Depositary or a nominee of the Depositary. This Security is exchangeable for Securities registered in the name
of a person other than the Depositary or its nominee only in the limited circumstances described in the Indenture. Unless and until
it is exchanged in whole or in part for Securities in definitive registered form, this Security may not be transferred except as
a whole by the Depositary to the nominee of the Depositary or by a nominee of the Depositary to the Depositary or another nominee
of the Depositary or by the Depositary or any such nominee to a successor Depositary or a nominee of such successor Depositary.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"><FONT STYLE="text-transform: uppercase">Unless this Security
is presented by an authorized representative of The Depository Trust Company (55 Water Street, New York, New York) to the issuer
or its agent for registration of transfer, exchange or payment, and any Security issued is registered in the name of Cede &amp;
Co. or such other name as requested by an authorized representative of The Depository Trust Company and any payment hereon is made
to Cede &amp; Co., ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY A PERSON IS WRONGFUL since the registered
owner hereof, Cede &amp; Co., has an interest herein.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"><FONT STYLE="text-transform: uppercase"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 4.25in; text-indent: -4.25in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; width: 69%; padding-right: 5.4pt; padding-left: 5.4pt">No. [&#9679;]</TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; width: 31%; padding-right: 5.4pt; padding-left: 5.4pt">CUSIP No.: 101137 BA4</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt">ISIN No.: US101137BA41</TD></TR>
</TABLE>


<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt 4.25in; text-indent: -4.25in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt; text-align: center">$[&#9679;]<BR>
2.650% SENIOR NOTE DUE 2030</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">BOSTON SCIENTIFIC CORPORATION promises
to pay<BR>
to Cede &amp; Co. or registered assigns the principal sum of<BR>
[&#9679;] DOLLARS ($[&#9679;]) on<BR>
June 1, 2030.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">Interest Payment Dates: June 1 and December 1 of each year,
commencing December 1, 2020.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">Regular Record Dates: May 15 and November 15.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in">Reference is hereby made to the further
provisions of this Security set forth on the reverse hereof, which further provisions shall for all purposes have the same effect
as if set forth at this place.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>[SIGNATURE PAGE FOLLOWS]</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">2</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt; text-indent: 1in">IN WITNESS WHEREOF, the Company has caused
this instrument to be duly executed.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt">Dated: May 18, 2020</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 12pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">BOSTON SCIENTIFIC CORPORATION</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 30%">&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>[&#9679;]</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>[&#9679;]</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in">[corporate seal]</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 12pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 5%">Attest:</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 30%">&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>[&#9679;]</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>[&#9679;]</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><BR STYLE="clear: both"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">TRUSTEE&rsquo;S CERTIFICATE OF AUTHENTICATION</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">Dated: May 18, 2020</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in">This is one of the Securities of the series
designated therein referred to in the within-mentioned Indenture.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 12pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD COLSPAN="4">U.S. BANK NATIONAL ASSOCIATION, <BR>
as Trustee</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 30%">&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; vertical-align: top">Authorized Signatory</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 3in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 3in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: center"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">[REVERSE OF FORM OF SECURITY]</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0.5in; text-align: center">BOSTON SCIENTIFIC CORPORATION</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">2.650% SENIOR NOTE DUE 2030</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="color: #010000">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Interest</U>.
BOSTON SCIENTIFIC CORPORATION, a Delaware corporation (the &ldquo;Company&rdquo;), which definition shall include any successor
thereto in accordance with the Indenture (as defined below), promises to pay, until the principal hereof is paid or made available
for payment, interest on the principal amount set forth on the reverse side hereof at a rate of 2.650% per annum. Interest on the
Securities will accrue from and including the most recent date to which interest has been paid or, if no interest has been paid,
from May 18, 2020 to but excluding the date on which interest is paid. Interest shall be payable in arrears on June 1 and December
1 of each year (each an &ldquo;Interest Payment Date&rdquo;), commencing December 1, 2020. Interest will be computed on the basis
of a 360-day year of twelve 30-day months.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="color: #010000">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Method
of Payment</U>. The Company will pay interest on the Securities to the Persons who are registered Holders of Securities at the
close of business on the immediately preceding May 15 and November 15 of each year (each, a &ldquo;Regular Record Date&rdquo;).
Holders must surrender Securities to a Paying Agent to collect principal payments. The Company will pay principal, the Redemption
Price (pursuant to paragraph 5 herein), any Change of Control Payment and interest in money of the United States that at the time
of payment is legal tender for payment of public and private debts. At the Company&rsquo;s option, interest may be paid by check
mailed to the registered address of the Holder or by wire transfer to an account designated by the Holder of this Security; provided,
however, that so long as the Securities are registered in the name of The Depository Trust Company (&ldquo;DTC&rdquo;), or its
nominee, all payments of principal, Redemption Price (pursuant to paragraph 5 herein) and interest in respect thereof will be made
by wire transfer in immediately available funds.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="color: #010000">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Paying
Agent and Security Registrar</U>. Initially, U.S. Bank National Association, will act as Paying Agent and Security Registrar. The
Company may change any Paying Agent or Security Registrar without notice.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="color: #010000">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Indenture</U>.
The Company issued the Securities under an Indenture, dated as of May 29, 2013 (the &ldquo;Indenture&rdquo;), between the Company
and U.S. Bank National Association, as Trustee (the &ldquo;Trustee&rdquo;). This Security is one of an issue of Securities of the
Company issued under the Indenture. The terms of the Securities include those stated herein and in the Indenture and those made
part of the Indenture by reference to the Trust Indenture Act of 1939, as amended from time to time (the &ldquo;TIA&rdquo;). The
Securities are subject to all such terms, and Holders of the Securities are referred to the Indenture and the TIA for a statement
of them. Capitalized terms used herein and not otherwise defined have the meanings set forth in the Indenture. The Securities constitute
senior indebtedness of the Company and, as such, shall be general unsecured and unsubordinated obligations of the Company ranking
equally with all of the Company&rsquo;s unsecured and unsubordinated obligations. The Company may, subject to the terms of the
Indenture and applicable law, issue additional Securities under the Indenture. The Securities issued on May 18, 2020 and any additional
Securities subsequently issued shall be treated as a single class for all purposes of the Indenture. The Indenture limits the ability
of the Company to incur certain liens and to merge or consolidate with another entity or transfer all or substantially all of its
property and assets.</P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="color: #010000">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Optional
Redemption</U>. The Securities will be redeemable at any time prior to March 1, 2030, at the option of the Company, in whole
or in part, on at least 15 days, but no more than 60 days prior written notice mailed to the registered holders of the
Securities (with a copy to the Trustee) to be redeemed, on any date prior to maturity at a redemption price equal to the
greater of (i) 100% of the principal amount of the Securities to be redeemed or (ii) as determined by a Quotation Agent, the
sum of the present values of the remaining scheduled payments of principal and interest thereon to the Par Call Date (not
including any portion of such payments of interest accrued to the date of redemption) discounted to the date of redemption
(the &ldquo;Redemption Date&rdquo;) on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at
the Adjusted Treasury Rate plus 35 basis points, plus, in each case, accrued and unpaid interest on the Securities to, but
not including, the Redemption Date (subject to the right of holders as of the close of business on a regular record date to
receive interest due on the related Interest Payment Date). At any time and from time to time on or after March 1, 2030 (the
date that is 3 months prior to the maturity date of the Securities) (the &ldquo;Par Call Date&rdquo;), the Company may redeem
the Securities, in whole or in part, at a redemption price equal to 100% of the principal amount of the Securities being
redeemed plus accrued and unpaid interest to the Redemption Date.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in">&ldquo;Adjusted Treasury Rate&rdquo; means,
with respect to any Redemption Date, the rate per year equal to the semi-annual equivalent yield to maturity or interpolated (on
a day count basis) of the Comparable Treasury Issue, assuming a price for the Comparable Treasury Issue (expressed as a percentage
of its principal amount) equal to the Comparable Treasury Price for such Redemption Date.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in">&ldquo;Comparable Treasury Issue&rdquo;
means the United States Treasury security selected by a Quotation Agent as having an actual or interpolated maturity comparable
to the remaining term of the Securities to be redeemed that would be utilized (assuming that the Securities matured on the Par
Call Date), at the time of selection and in accordance with customary financial practice, in pricing new issues of corporate debt
securities of comparable maturity to the remaining term of such Securities.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in">&ldquo;Comparable Treasury Price&rdquo;
means, with respect to any Redemption Date, (1) the average of the Reference Treasury Dealer Quotations for such Redemption Date,
after excluding the highest and lowest such Reference Treasury Dealer Quotations, or (2) if the Trustee obtains fewer than four
such Reference Treasury Dealer Quotations, the average of all such quotations.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in">&ldquo;Quotation Agent&rdquo; means the
Reference Treasury Dealer appointed by the Trustee after consultation with the Company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in">&ldquo;Reference Treasury Dealer&rdquo;
means (1) Barclays Capital Inc., Citigroup Global Markets Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC and
their respective successors; provided, however, that, if any of the foregoing shall cease to be a primary United States Government
securities dealer in the United States (a &ldquo;Primary Treasury Dealer&rdquo;), the Company shall substitute therefor another
Primary Treasury Dealer, and (2) any other Primary Treasury Dealers selected by the Trustee after consultation with the Company.</P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in">&ldquo;Reference Treasury Dealer Quotations&rdquo;
means, with respect to each Reference Treasury Dealer and any Redemption Date, the average, as determined by the Trustee, of the
bid and ask prices for the Comparable Treasury Issue (expressed in each case as a percentage of its principal amount) quoted in
writing to the Trustee by such Reference Treasury Dealer at 5:00 p.m. on the third Business Day preceding such Redemption Date.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in">If the Company redeems only some of the
Securities, the Trustee shall determine by lot the Securities to be redeemed or, in the case of Securities held in global form,
pursuant to applicable Depositary procedures.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="color: #010000">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Repurchase
at the Option of Holders upon Change of Control Repurchase Event</U>. If a Change of Control Repurchase Event occurs, unless the
Company has exercised its option to redeem the Securities as described under paragraph 5 above, each Holder of the Securities will
have the right to require the Company to purchase all or a portion (equal to $2,000 and any integral multiples of $1,000 in excess
thereof) of such Holder&rsquo;s Securities pursuant to the offer described below (a &ldquo;Change of Control Offer&rdquo;) at a
purchase price equal to 101% of the aggregate principal amount of such Holder&rsquo;s Securities that are repurchased, plus accrued
and unpaid interest, if any, to, but not including, the date of repurchase (the &ldquo;Change of Control Payment&rdquo;), subject
to the rights of Holders of Securities on the relevant record date to receive interest due on the relevant Interest Payment Date.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in">The Company will be required to send a
notice to each Holder of the Securities by first class mail, with a copy to the Trustee, within 30 days following the date upon
which any Change of Control Repurchase Event occurred, or at the Company&rsquo;s option, prior to any Change of Control but after
the public announcement of the pending Change of Control. The notice will govern the terms of the Change of Control Offer and will
describe, among other things, the transaction that constitutes or may constitute the Change of Control Repurchase Event and the
purchase date. The purchase date will be at least 30 days but no more than 60 days from the date such notice is mailed, other than
as may be required by law (a &ldquo;Change of Control Payment Date&rdquo;). If the notice is mailed prior to the date of consummation
of the Change of Control, the notice will state that the Change of Control Offer is conditioned on the Change of Control being
consummated on or prior to the Change of Control Payment Date.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in">On the Change of Control Payment Date,
the Company will, to the extent lawful:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>accept for payment all properly tendered Securities or portions of Securities not validly withdrawn;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>deposit with the Paying Agent the required payment for all properly tendered Securities or portions of Securities not validly
withdrawn; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>deliver or cause to be delivered to the Trustee the repurchased Securities, accompanied by an officers&#8217; certificate stating,
among other things, the aggregate principal amount of repurchased Securities.</TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in">The Company will not be required to make
a Change of Control Offer with respect to the Securities upon the occurrence of a Change of Control Repurchase Event if a third
party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for such an offer made
by the Company and the third party purchases all Securities properly tendered and not withdrawn under its offer. In addition, the
Company will not repurchase any Securities if there has occurred and is continuing on the Change of Control Payment Date an Event
of Default under the Indenture.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">The Company will comply with the requirements
of Rule 14e-1 under the Exchange Act, and any other securities laws and regulations thereunder, to the extent those laws and regulations
are applicable, in connection with the repurchase of Securities as a result of a Change of Control Repurchase Event. To the extent
that the provisions of any such securities laws or regulations conflict with the Change of Control Offer provisions of the Securities,
the Company will comply with those securities laws and regulations and will not be deemed to have breached its obligations under
the Change of Control Offer provisions of the Securities by virtue of any such conflict.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in">For purposes of the foregoing discussion,
the following definitions apply:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><I>&ldquo;Capital Stock&rdquo;</I> means
the capital stock of every class whether now or hereafter authorized, regardless of whether such capital stock shall be limited
to a fixed sum or percentage with respect to the rights of the holders thereof to participate in dividends and in the distribution
of assets upon the voluntary or involuntary liquidation, dissolution or winding up of such corporation.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><I>&ldquo;Change of Control&rdquo;</I>
means the occurrence of any of the following:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>the direct or indirect sale, lease, transfer, conveyance or other disposition (other than by way of merger or consolidation),
in one or more series of related transactions, of all or substantially all of the Company&#8217;s assets and the assets of the
Company&#8217;s subsidiaries, taken as a whole, to any &#8220;person&#8221; (as that term is used in Section 13(d)(3) of the Exchange
Act), other than the Company or one of its subsidiaries;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>the consummation of any transaction (including, without limitation, any merger or consolidation) the result of which is that
any &#8220;person&#8221; (as that term is used in Section 13(d)(3) of the Exchange Act), other than the Company or one of its subsidiaries,
becomes the &#8220;beneficial owner&#8221; (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of more than
50% of the Company&#8217;s then outstanding Voting Stock or other Voting Stock into which its Voting Stock is reclassified, consolidated,
exchanged or changed, measured by voting power rather than number of shares; or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>the adoption of a plan relating to the Company&#8217;s liquidation or dissolution.</TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in">Notwithstanding the foregoing, a transaction
will not be considered to be a Change of Control if (a) the Company becomes a direct or indirect wholly-owned subsidiary of a holding
company and (b)(x) immediately following that transaction, the direct or indirect holders of the Voting Stock of the holding company
are substantially the same as the holders of the Company&rsquo;s Voting Stock immediately prior to that transaction or (y) immediately
following that transaction, no person is the beneficial owner, directly or indirectly, of more than 50% of the Voting Stock of
such holding company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><I>&ldquo;Change of Control Repurchase
Event&rdquo;</I> means the occurrence of both a Change of Control and a Rating Event.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><I>&ldquo;Fitch&rdquo;</I> means Fitch
Ratings, Inc. and its successors.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><I>&ldquo;Investment Grade&rdquo;</I> means
a rating of Baa3 or better by Moody&rsquo;s (or its equivalent under any successor rating categories of Moody&rsquo;s), a rating
of BBB- or better by S&amp;P (or its equivalent under any successor rating categories of S&amp;P) and a rating of BBB- or better
by Fitch (or its equivalent under any successor rating categories of Fitch); provided, however, that the Company shall not be required
to maintain a rating by more than two Rating Agencies at any time and if only two Rating Agencies provide a rating with respect
to the Securities, then &ldquo;Investment Grade&rdquo; with respect to the Securities shall mean the applicable rating described
above of such two Rating Agencies with respect to the Securities.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><I>&ldquo;Moody&rsquo;s&rdquo;</I> means
Moody&rsquo;s Investors Service, Inc., a subsidiary of Moody&rsquo;s Corporation, and its successors.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><I>&ldquo;Rating Agencies&rdquo;</I> means
each of Moody&rsquo;s, S&amp;P and Fitch, or if any of Moody&rsquo;s, S&amp;P or Fitch ceases to rate the Securities or fails to
make a rating of the Securities publicly available, any &ldquo;nationally recognized statistical rating organization&rdquo; within
the meaning of Section 3(a)(62) under the Exchange Act that is selected by the Company as a replacement agency for Moody&rsquo;s,
S&amp;P or Fitch, or each of them, as the case may be; provided, however, that the Company shall not be required to maintain a
rating by more than two Rating Agencies at any time.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><I>&ldquo;Rating Event&rdquo;</I> means
the rating of the Securities shall be decreased by each of the Rating Agencies independently by one or more gradations during the
Rating Period (as defined below). If the rating of the Securities by each of the Rating Agencies is Investment Grade, then &ldquo;Rating
Event&rdquo; will mean the rating of the Securities shall be decreased by one or more gradations by each Rating Agency so that
the ratings of the Securities by all of the Rating Agencies fall below Investment Grade, on any date from the date of the public
notice of an arrangement that could result in a Change of Control until the end of the 30-day period following public notice of
the occurrence of the Change of Control (the &ldquo;Rating Period&rdquo;) (which 30-day period shall be extended by no more than
60 days from the date of the occurrence of the Change of Control if the rating of the Securities is under publicly announced consideration
for possible downgrade by any of the Rating Agencies and each other Rating Agency has either downgraded, or publicly announced
that it is considering downgrading, the Securities). A Rating Event otherwise arising by virtue of a particular reduction in rating
will not be deemed to have occurred in respect of a particular Change of Control (and thus will not be deemed a Rating Event for
purposes of the definition of &ldquo;Change of Control Repurchase Event&rdquo;) if each Rating Agency making the reduction in rating
to which this definition would otherwise apply does not announce or publicly confirm or inform the Trustee under the Indenture
in writing at the Company&rsquo;s request that the reduction was the result, in whole or in part, of any event or circumstance
comprised of or arising as a result of, or in respect of, the applicable Change of Control (whether or not the applicable Change
of Control has occurred at the time of the Rating Event).</P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><I>&ldquo;S&amp;P&rdquo;</I> means S&amp;P
Global Ratings, a division of S&amp;P Global Inc., and its successors.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><I>&ldquo;Voting Stock&rdquo;</I> means,
with respect to any specified person as of any date, the Capital Stock of such person that is at the time entitled to vote generally
in the election of the board of directors of such person.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="color: #010000">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Sinking
Fund</U>. No sinking fund is provided for the Securities.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="color: #010000">8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Denominations,
Transfer, Exchange</U>. The Securities are in registered form without coupons in minimum denominations of $2,000 and integral multiples
of $1,000 in excess thereof. A Holder may transfer or exchange Securities in accordance with the Indenture. No service charge shall
be made for any registration of transfer or exchange of Securities, but the Company may require payment of a sum sufficient to
cover any tax or other governmental charge that may be imposed in connection with any registration of transfer or exchange of Securities,
other than exchanges pursuant to Section 304, 906, 1107 or 1305 of the Indenture not involving any transfer.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="color: #010000">9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Persons
Deemed Owners</U>. The registered Holder of a Security may be treated as the owner of it for all purposes.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="color: #010000">10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Unclaimed
Money</U>. Subject to any applicable abandoned property laws, if money for the payment of principal or interest remains unclaimed
for two years, the Trustee or Paying Agent will pay the money back to the Company at its written request. After that, Holders entitled
to the money must look to the Company for payment as unsecured general creditors unless an &ldquo;abandoned property&rdquo; law
designates another Person.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="color: #010000">11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Amendment,
Supplement, Waiver</U>. The Company and the Trustee may, without the consent of the Holders of any outstanding Securities, amend,
waive or supplement the Indenture or the Securities for certain specified purposes, including, among other things, curing ambiguities,
defects or inconsistencies, or making any other change that does not adversely affect the rights of any Holder in any material
respect. Other amendments and modifications of the Indenture or the Securities may be made by the Company and the Trustee with
the consent of the Holders of not less than a majority of the aggregate principal amount of the outstanding Securities affected,
subject to certain exceptions requiring the consent of the Holders of each Security affected thereby.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="color: #010000">12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Successor
Corporation</U>. When a successor corporation assumes all the obligations of its predecessor under the Securities and the Indenture
and the transaction complies with the terms of Article 8 of the Indenture, the predecessor corporation, subject to certain exceptions,
will be released from those obligations.</P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="color: #010000">13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Defaults
and Remedies</U>. Events of Default are set forth in the Indenture. Subject to certain limitations in the Indenture, if an Event
of Default (other than an Event of Default specified in Section 501(5) or Section 501(6) of the Indenture) occurs and is continuing,
then the Holders of not less than 25% in aggregate principal amount of the Outstanding Securities may, or the Trustee may, declare
the principal of, plus accrued interest, if any, to be due and payable immediately. If an Event of Default specified in Section
501(5) or Section 501(6) of the Indenture occurs and is continuing, the principal of and accrued interest on all of the Securities
shall ipso facto become and be immediately due and payable without any declaration or other act on the part of the Trustee or any
Holder. Holders of the Securities may not enforce the Indenture or the Securities except as provided in the Indenture. The Trustee
may require reasonable security or indemnity reasonably satisfactory to it before it enforces the Indenture or the Securities.
Subject to certain limitations, Holders of a majority in principal amount of the then Outstanding Securities may direct the Trustee
in its exercise of any trust or power. The Company must furnish an annual compliance certificate to the Trustee.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="color: #010000">14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>No
Recourse Against Others</U>. A director, officer, employee, or stockholder, as such, of the Company or any of its Affiliates shall
not have any liability for any obligations of the Company under the Securities or the Indenture or for any claim based on, in respect
of or by reason of, such obligations or their creation. Each Holder of the Securities by accepting a Security waives and releases
all such liability. The waiver and release are part of the consideration for the issue of the Securities.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="color: #010000">15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Defeasance</U>.
The Indenture contains provisions (which provisions apply to this Security) for defeasance at any time of (a) the entire indebtedness
of the Company in respect of this Security and (b) certain restrictive covenants and Defaults and Events of Default, in each case
upon compliance by the Company with certain conditions set forth therein.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="color: #010000">16.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Authentication</U>.
This Security shall not be valid until the Trustee signs the certificate of authentication to this Security.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in"><FONT STYLE="color: #010000">17.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>GOVERNING
LAW</U>. THE INDENTURE AND THIS SECURITY SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in">The Company will furnish to any Holder
of Securities upon written request and without charge a copy of the Indenture. Requests may be made to:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 1in 12pt">BOSTON SCIENTIFIC CORPORATION<BR>
300 Boston Scientific Way<BR>
Marlborough, Massachusetts 01752<BR>
Telephone: (508) 683-4000<BR>
Telecopy: (508) 683-4350<BR>
Attention: General Counsel</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 1in 12pt"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 1in 12pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">ASSIGNMENT FORM</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">If you the holder want to assign this Security, fill in
the form below and have your signature guaranteed:&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in">I or we assign and transfer this
Security to <U>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<BR>
&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<BR> </U>(Insert
assignee&rsquo;s social security or tax ID number) <U>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<BR>
&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<BR> </U>(Print or type assignee&rsquo;s name, address and zip
code) and irrevocably appoint <U>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<BR> </U>agent
to transfer this Security on the books of the Company. The agent may substitute another to act for him.<BR> <U>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 261pt; text-indent: -261pt">Date:&#9;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Your
signature:&#9;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&#9;<BR> </U>(Sign exactly as your name appears on the
other side<BR> of this Security)</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">Signature Guarantee: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</U></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 1in">Signatures must be guaranteed by an &ldquo;eligible
guarantor institution&rdquo; meeting the requirements of the Security Registrar, which requirements include membership or participation
in the Securities Transfer Agents Medallion Program (&ldquo;STAMP&rdquo;) or such other &ldquo;signature guarantee program&rdquo;
as may be determined by the Security Registrar in addition to, or in substitution for, STAMP, all in accordance with the Securities
Exchange Act of 1934, as amended.</P>





<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"></P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>5
<FILENAME>ss173781_ex0501.htm
<DESCRIPTION>OPINION OF SHEARMAN & STERLING
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">
<P STYLE="text-align: right; margin: 0"><B>Exhibit 5.1</B></P>

<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&nbsp;</P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 8pt"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 11px; width: 247px"></FONT></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 8pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&nbsp;</P>
        <P STYLE="font: 8pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">599 Lexington Avenue<BR>
        <BR>
        </P>
        <P STYLE="font: 8pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">New York, NY 10022-6069</P>
        <P STYLE="font: 8pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&nbsp;</P>
        <P STYLE="font: 8pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">+1.212.848.4000</P></TD></TR>
</TABLE>


<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>


<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 24pt">May 18, 2020</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; padding-right: 5.75pt; padding-bottom: 0.15in">Boston Scientific Corporation<BR>
300 Boston Scientific Way<BR>
Marlborough, Massachusetts 01752-1234</TD></TR>
</TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 12pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">We have acted as counsel to Boston Scientific Corporation,
a Delaware corporation (the &ldquo;Company&rdquo;), in connection with the issuance and sale of (i) $500,000,000 aggregate principal
amount of 1.900% Senior Notes due 2025 (the &ldquo;2025 Notes&rdquo;) and (ii) $1,200,000,000 aggregate principal amount of 2.650%
Senior Notes due 2030 (the &ldquo;2030 Notes,&rdquo; and together with the 2025 Notes, the &ldquo;Notes&rdquo;) subject to the
terms and conditions set forth in the Underwriting Agreement &mdash; Basic Provisions dated May 14, 2020, as supplemented by the
Terms Agreement dated May 14, 2020 (as so supplemented, the &ldquo;Underwriting Agreement&rdquo;), among the Company and each of
the underwriters named therein. The Notes are to be issued under an Indenture dated as of May 29, 2013 (the &ldquo;Indenture&rdquo;)
between the Company and U.S. Bank National Association, as trustee (the &ldquo;Trustee&rdquo;).</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">In that connection, we have reviewed originals or copies identified
to our satisfaction of the following documents:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD>The Indenture.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD>The certificates representing the Notes.</TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">The documents described in the foregoing clauses (a) and (b)
are collectively referred to herein as the &ldquo;Opinion Documents&rdquo;.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">We have also reviewed the following:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD>The registration statement on Form S-3 (Registration No. 333-223095) filed by the Company under the Securities Act of 1933,
as amended (the &ldquo;Securities Act&rdquo;), with the Securities and Exchange Commission (the &ldquo;Commission&rdquo;) on February
20, 2018 (such registration statement, including the information deemed to be part thereof at the time of effectiveness pursuant
to Rule 430B under the Securities Act and the documents incorporated by reference therein, being hereinafter collectively referred
to as the &ldquo;Registration Statement&rdquo;).</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD>The prospectus dated February 20, 2018, forming a part of the Registration Statement with respect to the offering from time
to time of the Company&rsquo;s securities (the &ldquo;Base Prospectus&rdquo;), as supplemented by the final prospectus supplement
dated May 14, 2020, relating to the Notes (the &ldquo;Final Prospectus Supplement&rdquo;) (the Base Prospectus, as supplemented
by the Final Prospectus Supplement, in the forms filed with the Commission pursuant to Rule 424(b) of the rules and regulations
of the Commission under the Securities Act, including the documents incorporated by reference therein, being hereinafter collectively
referred to as the &ldquo;Final Prospectus&rdquo;).</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; padding-right: 5.4pt; padding-left: 5.4pt; font: bold 9.5pt Arial Narrow, Helvetica, Sans-Serif"><FONT STYLE="font-size: 9pt">SHEARMAN.COM</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font: 6pt/8pt Arial, Helvetica, Sans-Serif; padding-right: 5.4pt; padding-left: 5.4pt">Shearman &amp; Sterling LLP is a limited liability partnership organized in the United States under the laws of the state of Delaware, which laws limit the personal liability of partners.</TD></TR>
</TABLE>


<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Arial, Helvetica, Sans-Serif; padding-right: 5.4pt; padding-left: 5.4pt">May 18, 2020</TD></TR>
</TABLE>


<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD>The Underwriting Agreement.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD>Copies of the certificate of incorporation and by-laws of the Company, each as amended through the date hereof.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD>Originals or copies of such other corporate records of the Company, certificates of public officials and of officers of the
Company and agreements and other documents as we have deemed necessary as a basis for the opinions expressed below.</TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">In our review of the Opinion Documents and other documents,
we have assumed:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD>The genuineness of all signatures.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD>The authenticity of the originals of the documents submitted to us.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD>The conformity to authentic originals of any documents submitted to us as copies.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD>As to matters of fact, the truthfulness of the representations made in the Underwriting Agreement, and in certificates of public
officials and officers of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">We have not independently established the validity of the
foregoing assumptions.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">&ldquo;Generally Applicable Law&rdquo; means the federal law
of the United States of America, and the law of the State of New York (including the rules and regulations promulgated thereunder
or pursuant thereto), that a New York lawyer exercising customary professional diligence would reasonably be expected to recognize
as being applicable to the Company, the Opinion Documents or the transactions governed by the Opinion Documents and, for purposes
of our opinion in paragraph (1) below, the General Corporation Law of the State of Delaware. Without limiting the generality of
the foregoing definition of Generally Applicable Law, the term &ldquo;Generally Applicable Law&rdquo; does not include any law,
rule or regulation that is applicable to the Company, the Opinion Documents or such transactions solely because such law, rule
or regulation is part of a regulatory regime applicable to the specific assets or business of any party to any of the Opinion Documents
or any of its affiliates.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">Based upon the foregoing and upon such other investigation
as we have deemed necessary and subject to the qualifications set forth below, we are of the opinion that:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(1)</TD><TD>The Company (a) is validly existing, (b) has the corporate power to execute, deliver and perform the Notes and (c) has taken
all action necessary to authorize the execution, delivery and performance of the Notes.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(2)</TD><TD>the Notes have been duly executed and delivered by the Company, and, when authenticated by the Trustee in accordance with the
Indenture and delivered and paid for as provided in the Underwriting Agreement, the Notes will be legal, valid and binding obligations
of the Company enforceable against the Company in accordance with their terms and entitled to the benefits of the Indenture.</TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> of 3&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Arial, Helvetica, Sans-Serif; padding-right: 5.4pt; padding-left: 5.4pt">May 18, 2020</TD></TR>
</TABLE>


<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">Our opinions expressed above are subject to the following
qualifications:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD>Our opinion (2) above is subject to the effect of any applicable bankruptcy, insolvency, reorganization, moratorium or similar
laws affecting creditors&rsquo; rights generally (including without limitation all laws relating to fraudulent transfers).</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD>Our opinion (2) above is also subject to the effect of general principles of equity, including without limitation concepts
of materiality, reasonableness, good faith and fair dealing (regardless of whether considered in a proceeding in equity or at law).</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD>Our opinions are limited to Generally Applicable Law, and we do not express any opinion herein concerning any other law.</TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">This opinion letter is rendered to you in connection with
the offering of the Notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">This opinion letter speaks only as of the date hereof. We
expressly disclaim any responsibility to advise you of any development or circumstance of any kind, including any change of law
or fact, that may occur after the date of this opinion letter that might affect the opinions expressed therein.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">We hereby consent to the filing of this opinion letter as
an exhibit to the Current Report on Form 8-K, dated the date hereof, filed by the Company and incorporated by reference into the
Registration Statement and to the use of our name under the heading &ldquo;Legal Matters&rdquo; in the Final Prospectus. In giving
this consent, we do not hereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities
Act or the rules and regulations of the Commission promulgated thereunder.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 60pt">Very truly yours,<BR>
<BR>
/s/ Shearman &amp; Sterling LLP<BR>
<B>&nbsp;</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">RA/AK/JS</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">KT</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> of 3&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>6
<FILENAME>ss173781_ex9901.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">
<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 12pt/120% Times New Roman, Times, Serif; margin: 0"><IMG SRC="image_002.jpg" ALT="letterheadlogoa35.jpg" STYLE="height: 98px; width: 624px"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt/120% Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 13pt/120% Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Boston Scientific Completes $1.7 Billion
Offering of Senior Notes </B></P>

<P STYLE="font: 12pt/120% Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: justify">MARLBOROUGH, Mass. (May 18, 2020) - Boston
Scientific Corporation (NYSE: BSX) completed a public offering of $1.7 billion aggregate principal amount of its senior notes.
The public offering consists of $500.0 million of 1.900% notes due 2025 and $1.2 billion of 2.650% notes due 2030.</P>

<P STYLE="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: justify">The company intends to use the net proceeds
from this offering towards (i) refinancing $450.0 million of borrowings under its revolving credit facility and a portion of its
pre-payable bank debt, including $750.0 million under its $1.0 billion term loan credit facility maturing in February 2021 and
$500.0 million under its $1.25 billion term loan credit facility maturing in April 2021 and (ii) paying related fees, expenses
and premiums.</P>

<P STYLE="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>About Boston Scientific</B></P>

<P STYLE="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: justify">Boston Scientific transforms lives through
innovative medical solutions that improve the health of patients around the world.&nbsp; As a global medical technology leader
for 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs
and reduce the cost of healthcare.</P>

<P STYLE="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Cautionary Statement Regarding Forward-Looking
Statements</B></P>

<P STYLE="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: justify">This press release contains forward-looking
statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E, of the Securities Exchange
Act of 1934, as amended. Forward-looking statements may be identified by words like &ldquo;anticipate,&rdquo; &ldquo;expect,&rdquo;
&ldquo;project,&rdquo; &ldquo;believe,&rdquo; &ldquo;plan,&rdquo; &ldquo;estimate,&rdquo; &ldquo;intend,&rdquo; &ldquo;aiming&rdquo;
and similar words. These forward-looking statements are based on our beliefs, assumptions and estimates using information available
to us at the time and are not intended to be guarantees of future events or performance. These forward-looking statements include,
among other things, statements regarding our proposed offering and intended use of proceeds. If our underlying assumptions turn
out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations
and projections expressed or implied by our forward-looking statements. These factors, in some cases, have affected and in the
future (together with other factors) could affect our ability to implement our business strategy and may cause actual results to
differ materially from those contemplated by the statements expressed in this press release. As a result, readers are cautioned
not to place undue reliance on any of our forward-looking statements.</P>

<P STYLE="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/120% Times New Roman, Times, Serif; margin: 0; text-align: justify">Factors that may cause such differences
include, among other things: future economic, political, competitive, reimbursement and regulatory conditions; new product introductions;
expected pricing environment; demographic trends; intellectual property; litigation; financial market conditions; and future business
decisions made by us and our competitors.&nbsp;New risks and uncertainties may arise from time to time and are difficult to predict,
including those that have emerged or have increased in significance or likelihood as a result of the COVID-19 pandemic. All of
these factors are difficult or impossible to predict accurately and many of them are beyond our control.&nbsp;For a further list
and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A
-&nbsp;Risk Factors&nbsp;in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which
we may update in Part II, Item 1A -&nbsp;Risk Factors&nbsp;in Quarterly Reports on Form 10-Q we have filed or will file hereafter.&nbsp;We
disclaim any intention or obligation to publicly update or revise any forward-looking statements to reflect any change in our expectations
or in events, conditions, or circumstances on which those expectations may be based, or that may affect the likelihood that actual
results will differ from those contained in the forward-looking statements.&nbsp;This cautionary statement is applicable to all
forward-looking statements contained in this press release.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD COLSPAN="5">&nbsp;</TD></TR>
<TR>
    <TD STYLE="width: 16%">&nbsp;</TD>
    <TD STYLE="width: 32%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 16%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding: 1.5pt"><FONT STYLE="font-size: 10pt">CONTACT:</FONT></TD>
    <TD STYLE="padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding: 1.5pt; text-align: right"><FONT STYLE="font-size: 10pt">Media:</FONT></TD>
    <TD STYLE="padding: 1.5pt"><FONT STYLE="font-size: 10pt">Kate Haranis</FONT></TD>
    <TD STYLE="padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt; text-align: right"><FONT STYLE="font-size: 10pt">Investors:</FONT></TD>
    <TD STYLE="padding: 1.5pt"><FONT STYLE="font-size: 10pt">Susie Lisa, CFA</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt; text-align: justify"><FONT STYLE="font-size: 10pt">508-683-6585 (office)</FONT></TD>
    <TD STYLE="padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt; text-align: justify"><FONT STYLE="font-size: 10pt">508-683-5565 (office)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt"><FONT STYLE="font-size: 10pt">Media Relations</FONT></TD>
    <TD STYLE="padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt"><FONT STYLE="font-size: 10pt">Investor Relations</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt"><FONT STYLE="font-size: 10pt">Boston Scientific Corporation</FONT></TD>
    <TD STYLE="padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt"><FONT STYLE="font-size: 10pt">Boston Scientific Corporation</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt"><FONT STYLE="font-size: 10pt; color: blue"><U>kate.haranis@bsci.com</U></FONT></TD>
    <TD STYLE="padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt"><FONT STYLE="font-size: 10pt; color: blue"><U>BSXInvestorRelations@bsci.com</U></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/120% Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>



<P STYLE="margin: 0"></P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  1 7,# 2(  A$! Q$!_\0
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M "2C3O\ KK/_ .C&H YZ:"[^*OQ*UW3+S4[NT\-:"1"UO:R;//ER02Q^JM]
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L[W_@'_H HHH [3X>?\BLW_7=_P"0H^'?_(OS_P#7V_\ ):** .NHHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" "3 Z@# 2(  A$! Q$!_\0
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MHH ****!!1110 E)GFEI,4 %)2T8H 2DIV*0T )1BEI* #%)2TE "&BEI,4
M)12XHQ0 VDIV*,4 -I,4^DH ;BC%+1B@!N!12XI,4 )24[%)B@!*0BG[:-M
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M['IMU@>8)&CS[$9_I7E0.*] ^*^O1:CJ5OIUJX=+/+2L.F\]OP%:7A#0-/\
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M4,*4.?8U8#N.^?K1N5OO1@^XH$0>8/2G;E/>GE(6_O+1]F!^ZX/UH 9CTH*
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MQ_\ ?K_Z]=AI.B#0_!\VES7:7($<OSXV\$'C&:\(\U_^>C_]]&E\R3D>8_\
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M<#):%AVXIFRMW[ P_A!_$4&P8_\ +/-*X&'LHV5LMIQ/_+(C\*B?3)/X8V_
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M/:QZM>ZMX,\9K$^HW!AG1=J^8QC91Z9Z4ED_@OP<SWEK="XN2I"X?S'QZ#'
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M16PZ,OU%/*;1@"DV*Q!MAQADP?:FFV#_ .K<?2K BSVIZV^>U*XFRG]DE0Y
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M42VQ9[:Y_P!3GJ#_ '?UHA6C.5I*S"=&4(WB[HQ_[0NF( ED)/0 GFDGGNT
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MM/,A]J3?ZU1(TT4[<3T(HH ^F:***\(]T**** "BBB@ HHHH **** "BBB@
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M*O\ #Z_0U52^*$F(;?<G)KT%'2Z9YZF[V:.GF#D@8S^-594B_P"6HR?8?UK
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %(:6B@#.UC1++6[4PWL6['W7'#)]#7F'B/P?J.@H\L2M=6@_P"6J#E?
M]X?UKU^@C(P:VI5Y4]MC&K0C4WW/G$SY[TGG5[)K_P /-(UK=+&AL[D_\M(1
MP3[KT->?ZM\-=>TXLUM&E]$.\)PW_?)KOAB83\CSYX:</,Y]+GR^C5(-0;O5
M&Y@N;.0I=02PN.HD0J?UJ'S/>NA.YA9HUUO0>].-UGO6.)*7SCV- &M]K(Z&
MFFY)_BK,\\T>=[T :!N#W"FF&=#U!%4O.]Z3S<T 6RZGHWYTTGW!JKYE'F4
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MZ;_&C_A ?#7_ $"8O^^F_P :**.>7<.2/8/^$!\-?] F+_OIO\:/^$!\-?\
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AQHHHYY=PY(]@_P"$!\-?] F+_OIO\:***.>7<.2/8__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>bsx-20200514.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +qs5w7xRiXgOn8uGaH9cOaiPuaPtzJJ9GZkhsmd6bZlanyEobwepWyjZ9GVWYTwL -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:BSX="http://BSX/20200514" elementFormDefault="qualified" targetNamespace="http://BSX/20200514">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://BSX/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="bsx-20200514_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="bsx-20200514_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="bsx-20200514_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd" />
    <element id="BSX_CommonStock0.01ParValuePerShareMember" name="CommonStock0.01ParValuePerShareMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BSX_Sec0.625SeniorNotesDue2027Member" name="Sec0.625SeniorNotesDue2027Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>bsx-20200514_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://BSX/role/Cover" xlink:href="bsx-20200514.xsd#Cover" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://BSX/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCapitalizationEquityLineItems" xlink:label="loc_us-gaapScheduleOfCapitalizationEquityLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="bsx-20200514.xsd#BSX_CommonStock0.01ParValuePerShareMember" xlink:label="loc_BSXCommonStock0.01ParValuePerShareMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_BSXCommonStock0.01ParValuePerShareMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="bsx-20200514.xsd#BSX_Sec0.625SeniorNotesDue2027Member" xlink:label="loc_BSXSec0.625SeniorNotesDue2027Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_BSXSec0.625SeniorNotesDue2027Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentType_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiAmendmentFlag_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiAmendmentDescription_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentRegistrationStatement_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentAnnualReport_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentQuarterlyReport_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentTransitionReport_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentShellCompanyReport_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentPeriodStartDate_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentPeriodEndDate_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityFileNumber_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityRegistrantName_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityCentralIndexKey_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityPrimarySicNumber_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityAddressAddressLine1_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityAddressAddressLine2_40" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityAddressAddressLine3_40" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityAddressCityOrTown_40" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_40" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityAddressCountry_40" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_40" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiCountryRegion_40" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiCityAreaCode_40" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiLocalPhoneNumber_40" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Extension" xlink:label="loc_deiExtension_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiExtension_40" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiWrittenCommunications_40" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiSolicitingMaterial_40" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiPreCommencementTenderOffer_40" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_40" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiSecurity12bTitle_40" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiNoTradingSymbolFlag_40" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiTradingSymbol_40" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiSecurityExchangeName_40" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiSecurity12gTitle_40" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiSecurityReportingObligation_40" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiAnnualInformationForm_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityVoluntaryFilers_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_40" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_40" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityFilerCategory_40" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntitySmallBusiness_40" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_40" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityExTransitionPeriod_40" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentAccountingStandard_40" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_40" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityShellCompany_40" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityPublicFloat_40" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_40" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>bsx-20200514_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="bsx-20200514.xsd#BSX_CommonStock0.01ParValuePerShareMember" xlink:label="BSX_CommonStock0.01ParValuePerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BSX_CommonStock0.01ParValuePerShareMember" xlink:to="BSX_CommonStock0.01ParValuePerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BSX_CommonStock0.01ParValuePerShareMember_lbl" xml:lang="en-US">Common Stock, $0.01 par value per share</link:label>
      <link:loc xlink:type="locator" xlink:href="bsx-20200514.xsd#BSX_Sec0.625SeniorNotesDue2027Member" xlink:label="BSX_Sec0.625SeniorNotesDue2027Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BSX_Sec0.625SeniorNotesDue2027Member" xlink:to="BSX_Sec0.625SeniorNotesDue2027Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BSX_Sec0.625SeniorNotesDue2027Member_lbl" xml:lang="en-US">0.625% Senior Notes due 2027</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCapitalizationEquityLineItems" xlink:label="us-gaap_ScheduleOfCapitalizationEquityLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCapitalizationEquityLineItems" xlink:to="us-gaap_ScheduleOfCapitalizationEquityLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCapitalizationEquityLineItems_lbl" xml:lang="en-US">Schedule of Capitalization, Equity [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>bsx-20200514_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://BSX/role/Cover" xlink:href="bsx-20200514.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://BSX/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCapitalizationEquityLineItems" xlink:label="loc_us-gaapScheduleOfCapitalizationEquityLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapScheduleOfCapitalizationEquityLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="bsx-20200514.xsd#BSX_CommonStock0.01ParValuePerShareMember" xlink:label="loc_BSXCommonStock0.01ParValuePerShareMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_BSXCommonStock0.01ParValuePerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bsx-20200514.xsd#BSX_Sec0.625SeniorNotesDue2027Member" xlink:label="loc_BSXSec0.625SeniorNotesDue2027Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_BSXSec0.625SeniorNotesDue2027Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ss173781_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://BSX/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="ss173781_8k.htm">ss173781_8k.htm</File>
    <File>bsx-20200514.xsd</File>
    <File>bsx-20200514_def.xml</File>
    <File>bsx-20200514_lab.xml</File>
    <File>bsx-20200514_pre.xml</File>
    <File>ss173781_ex0101.htm</File>
    <File>ss173781_ex0402.htm</File>
    <File>ss173781_ex0403.htm</File>
    <File>ss173781_ex0501.htm</File>
    <File>ss173781_ex9901.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>14
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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MUQ]^%V$W&+NU_]CX+"A;^'47\@M02P,$%     @ ^(BR4)E<G",0!@  G"<
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M.AQG0GS/]O:1I24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG
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M@U;NK3]=N',]?EZ, ZN&Z=.IN'Z_;?X!4$L#!!0    ( /B(LE!CY21^C (
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MF0$  &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ ^(BR4)E<G",0!@
MG"<  !,              ( !MP(  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"
M% ,4    " #XB+)0F,9\2]X"  #+#0  &               @ 'X"   >&PO
M=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ ^(BR4&/E)'Z, @
M508  !0              ( !# P  'AL+W-H87)E9%-T<FEN9W,N>&UL4$L!
M A0#%     @ ^(BR4+JA.8K7 0  ,@8   T              ( !R@X  'AL
M+W-T>6QE<RYX;6Q02P$"% ,4    " #XB+)0, /WOC<!   B @  #P
M        @ ',$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ ^(BR4/_
M)@B]    A0(  !H              ( !,!(  'AL+U]R96QS+W=O<FMB;V]K
M+GAM;"YR96QS4$L! A0#%     @ ^(BR4 N/V ,A 0  5P0  !,
M     ( !)1,  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      H "@"  @
&=Q0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ss173781_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "contextCount": 3,
   "dts": {
    "definitionLink": {
     "local": [
      "bsx-20200514_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "ss173781_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "bsx-20200514_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bsx-20200514_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "bsx-20200514.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 65,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 2,
   "memberStandard": 0,
   "nsprefix": "BSX",
   "nsuri": "http://BSX/20200514",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "ss173781_8k.htm",
      "contextRef": "From2020-05-14to2020-05-14",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://BSX/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "ss173781_8k.htm",
      "contextRef": "From2020-05-14to2020-05-14",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 2,
   "tag": {
    "BSX_CommonStock0.01ParValuePerShareMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Common Stock, $0.01 par value per share"
       }
      }
     },
     "localname": "CommonStock0.01ParValuePerShareMember",
     "nsuri": "http://BSX/20200514",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "BSX_Sec0.625SeniorNotesDue2027Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "0.625% Senior Notes due 2027"
       }
      }
     },
     "localname": "Sec0.625SeniorNotesDue2027Member",
     "nsuri": "http://BSX/20200514",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The start date of the period covered in the document, in CCYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfCapitalizationEquityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Schedule of Capitalization, Equity [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfCapitalizationEquityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://BSX/role/Cover"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r10": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r11": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r12": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1-"
  },
  "r13": {
   "Name": "Forms 10-K, 20-F, 40-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d-1"
  },
  "r14": {
   "Name": "Forms 20-F, 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220 and 240",
   "Subsection": "f"
  },
  "r15": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-13"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6606798624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>May 14, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationEquityLineItems', window );"><strong>Schedule of Capitalization, Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 14,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-11083<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BOSTON SCIENTIFIC CORPORATION<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000885725<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-2695240<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">300 Boston Scientific
Way<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Marlborough<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">01752-1234<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">508<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">683-4000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=BSX_CommonStock0.01ParValuePerShareMember', window );">Common Stock, $0.01 par value per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationEquityLineItems', window );"><strong>Schedule of Capitalization, Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BSX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=BSX_Sec0.625SeniorNotesDue2027Member', window );">0.625% Senior Notes due 2027</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationEquityLineItems', window );"><strong>Schedule of Capitalization, Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.625% Senior Notes due 2027<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BSX27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCapitalizationEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCapitalizationEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=BSX_CommonStock0.01ParValuePerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=BSX_CommonStock0.01ParValuePerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=BSX_Sec0.625SeniorNotesDue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=BSX_Sec0.625SeniorNotesDue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0000947871-20-000487-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000947871-20-000487-xbrl.zip
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M/$MV&\Y1' @,!OFV!T:6>C,A8R,1/XK("B?$%P<Z%0>:?"\.]%V^^1HO2#A
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M&UIYG&)&4]XE[F;4AV<N'5%FT>I5A3I@K2$.8=;')P!;+?0H>^8%4;$&7!:
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M5,F28?7+<!DHWRII/S-3-=4_/ &LB0S/FS4&E6ES1>$$*: M:-)<?7."S<R
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MH- <[(?F (XFP'R_4H2@T!SNA^80CB; G+]2!/]H.OKCK7C@,\M3%U9C*)8
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MV)9[;^I9SKP4/H$'LS3&]1H9M,),:Z";CPW[.%]FQXWK."R?XD(<0]-SN$&
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M?),Q$_MR4I:E0N;/4L4M57YJJ=IT6 ^R>"IONVS="A==[8OIZ[ER9FWKMH"
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MY501;'5L$BE'H@SE#WCY6+1Q<8$52L@*?BGUZ20HJ7PNGH2,-$,"/(B2@!0
MKZR>B!4%XL0&$V*GM&*:_,D^]"Q%;I\9DZNW7%;<,*V NV#\$&8K";&CN/9C
MI<!]9)(*Q)#%W$=0AO;"I>4A"]5-" 1YBH ZHRD%L$P@^9XZ",-1B9#'-&SL
MSK"0ET[Z@:XU#LA=X()%5,-R86P.^]G G-SC<? >L.AZ<AATW+=-G?'(('K\
MA3L<Y(_/?Z9(>TX\L7*?Z0ZA73QG"LP"(OKTCN\R8?@%PLN/"S@<^7>H>1/0
M!BKO<<X$S\24-1C+@CD!,K_#<^@\N(A.O0OA'O' K'-5PI]80^Q/0KT1P<%Q
M>UYE8%6B;.JR8'9L:#/39:O.!]P&Q%!SXVZ#B>^A-T;KA#$1504_PP!("UFP
M>#*!80-<!=SF*PEV@@4K D1T?%A)YKJ+DP;OUYDB;X52WX,C)#J>69D.[C!/
MP.\F^ ZLF'!ME,LC.CBEB%Y8SI .\^X9,^<4X!SOK!V \) &EU00KY+K6B!G
M^(F[&,\!:AB;LB;U<,C0(' QV-P8/X^HJG7'(&8%G?'ZU -]!;.@JUZL[:!@
M#'4/!(5[%Q5@+G2!>^C,#K0;9KRE?R08I?,KDS ,CXG09H8R(ZY1BG>P81WQ
M5F4\FFT8^-GU.Q@Q>Z!+Z*3P89>_#P"/CL.8@C/4=<%-;_/?MW08$PRR[Q #
M4(P0>I=%YD9ARM#O-7A';C_T ;Y5 ]=H0CWOZM:'-0ZMB;LMTFZNZNB=B8\>
M<U$HUX2I'+X$,;Y0A(EF\M=YX,*#%+ N]0TO14J:L&FPJAZ'0N&Q!(S9!5H0
MTL7)9QYV"8P/R.!J!U6X^X6Y.K!V-II)1#\63'?<T1I5:X$BO**^82C2LW"2
M8F'L*0L?]4R;&S.H([)2P@9&V>L/8/2Q6X(G@2B,UUT70NLPD, .>K;@W:UC
M9FO!ZT[0RZ&MYK<J"/4\6%*A]M5A7^^@*,LI>9MDQ3\*'S&;R@C@I -$]6$M
M03:#=\.$7KF0_+J-"FHCQKMCQDA(?Z APCW@B),;R?@R#5 V!A.(4ORN3>TD
M7BO@D8Y%P=II^ZC:)-4+B,1:[ST4P]SN?EE EHE2\U.-\.136G_7U#\22!;"
M0#+JNWBJE''YX\X_F&JHI0T1,: ZFV#6P&2J$ &X 0!9U #$O>OA*T69YJL<
M>OI1'*KI+D^Y!@ (R!P(#1AW%H*B;>&N^66D(:\%CN8O>3M?4$ ;@Z #S'-\
MM+0] V\P9^Q&T\AS4UK"!&AWSU/#Z#8=%N2/H=)?V5PT H(V';#P_+J2&\![
M-"1 GV7<80,5(G$=7 15N9,6IH&@ >'AR]B'LJ1-1SPEAJ 4F-GQ(C?!R%\[
M4^-.1H)H2!H'ANBNB&$!NID=%KCI\UF"S:FQCN.C\P,!D05<G GLIKJ'N.9I
M_9<@##-XYQ,8 )/#4H<9'&LA(-X>+WP 61TVT/W!$K>X+AUY)54L@;[9XVMM
M-K_["@Q@&$G; J5Q=Q@$YH%R1F[)Q8LF>"*(#X")03)!Y_D,]$@35R9F6"RF
MQ!)$70]Y6<_SMBQ?)6NMQ&>ME^\>K)I=_9/5_I_.:B^R!..(PA@M3 F&VAZ<
M!V#1;-+8K;GAG5H*"]N#",6RP8I@A@4^.2+(@/IW0('& [EI1ST/>DD.;,0,
MPMW<F(>XOPDX+0(X32U$I[5ZH]0HUTO'XD6]N%_0@G"$OSOWJ'Y0;[=2[Q^T
M;FE3;T@(@Y=W=<LC<HP+2G!O^W,BL^ VUOR1KW"HW(?E1\/">JM5*V1C#--K
MW$E9?!2M&%Q^"'6Q8:7>\.+&XW16)J$]67P/XZTN^#WO,N"S3AP^>KJ0$O'M
M,ZXK[V1V"O(5&THRF*:^!PR04_*G--W_SYN?G0S[6$[N\JDNVD^:3:I.MC97
MW7:<VG$,V_)=Q*6;H[^XKTA>=%LQ-5YSNI9S[2L+8LPWC)0<M8]TIID&V"$-
M[*9I\64C:4F"Y<_N9/-%.2-)^5RNF*:*(N<R1>6!#9/9JT TLD*2WX\@OR4S
M)GG,&=D7,PMW%;;'VPJ/BK%H^)3=!A$9S@:"V1#CS6\>-*-;CJW9+4?1'/<=
M1<>6.3^?E2),/'Q*7\I?/,,69R4EE&#EJ;;X:4YG^?#+2:\%>PGS6^;C'?,E
M!N5M^)H)^9IY8;[^ G$A7^?/ 8R/ ;PS><V%SCCW=.SPXGP=$W<:!*,1SQWD
MH04%P/)6GU$'PHLPA,D4]L#L\'?N]<"1GKU7OBN9]\SXLF6Z3)QW>8S!9$MD
ME<4&VI2; -E:9J=?W"U'IE8LAE/#).;[0,O/Q/V3J9SQ%' S2 $'QQ+ 2R['
M ?/*] 9K! #H=^!_V8)&/.,+B!Z$GO(M65(!-"?>E[R%EZ T+<B>CT\.X!L_
M"7Z9]'BW^&-JW0Q>![[]9?;%A,"+;V2]4+I+SCWMHA%?V?^0\&M+PNT/\-A=
MWS%UMQ^S%[(T7;GJZ'F\8);:$=;YI;][9H6=B\R?G8L_.Q>OLG,1_;*I^F&C
MU#YO+O]RJW>1&9\]ZNS@5\4[T^=8%]RBY)LN>(V2A]-TP"^<B;V7YO0E-<TW
M1D2E/MXKBVZ^PI@=1EQ@GXB3<?>\P_K4Z(8)+IX'"BI@B.SC^7S>'?6]ON6
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M0'!2ZTQI>K+F#6)&$JVSK.<T2S?\:\K,LBJO];_W80^GU70TL.O93^72\A'
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MNH2S#FOH&GC-6$6!E38C@3PIC>K)DKL:Q6<:8,]X?"N41/')VA5#$UX-S6$
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M)1X;V'!HY-1'U8+66N5554RX@N%M\.[K>R7A,=04XB^NLUL,,/&_]1TNL]*
MP$QA.8?D2"A_S,(\=AJQ?,=A%::%2@<_S ',%/AN;2TCWS\B\MW:6H:^%R7T
M/4F^?W@0;-6.KM^0$B"\\H612MK)GM  .0,04TV^6P-G*Y!Z,<:F53A%1W?;
M?<S_JN0=!WG]K9ALJ7*&'UNR.0C&D6XU:)>:J0JRK_.!*M_9Z,?I%0V)&PS
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MPO=4N4F4K?VL( &NP@B<HNQ'R8""] /@2[&FM=ES"Y*YR!!RC@H>E$A>,SI
MS4Y&ZUWJ]VW/&VY,GL9CW7VJ=82],/TZ8QCS.I33+C%W;2SRH%Y2].Q'BTO-
M$) ]U95OT0"W>R4^KL)+K?3JZ!XO(@EF9]7>P]J*>5@5%F(DK%WCLNS'=G"1
M'D)I$/WF]3#X9Y8(YBT/LZ+R JO[0%; QSE@]$=I'U2]LS[ -OOL*TCZ0(&L
M%_&<50J=S\ $!"8F9P)F/2[*)*)UHH+MD75*6Y.U$' K%-;>M&E0*@6/M5?
MP"+UF2- S_B*D.@F-8I@F6JG-)%9E<!HB(DH2R.W_^PI&O6$3NH8Q;+5D%(J
M4[9+1J@U147M3O].-[B4JC^]TNA2B5^*QRR?IB4X,UUFGP?TUNW5O--Y($O:
MBW7.([+&0-[=H9\R:Z(^!"RT_ </LFJ6>XXRN/-)P@D\S%$&SDG.T=.D ) ?
MH*EIGF')=I25833;,8F1OMM-1W@NJM3P>TFQ4-02!"-2^3T]7'\399.13&.1
M2THL65*)CP[C</KPP(VSSDX_<CX&SR=?7:KV4Z='HA#62KD=>:F*9*"+AVXA
MST@7-"0[2ULK1U7$;9,.H-&GX _UE#:QS0706-GHZMJ?F0 "P2\*FD69!](K
MB.M]BXU][1BO&K%'4689E\:I28KJG.F<B'C^%=>!:[C.J; &EWI 8EA$J&:(
MEMIX#8'I\IK05LCJ*L>J@Y[GL!A?GW6Z<K\UJQL+#C6G0?U M]+V7'VA_(5O
MC3Z.L$/ IKL>B1E*D6/)%@;]8B83UN*]T$'DYH;7+*]&Z4-!<C,!.$; J,*(
M7F>V1R_ET\T*VT(+EY#S! M:0_)KQ%+5%_\(UK//8%I=J5I,3VLU<VVPQVP.
MGL9JQ@/PF\W!PUO-7A-929I!\&-,9++#] '\*!-9$,,FF&1/9")+Q/M>AM5]
M360SPN#!3&1M2SSLH3RNG=Q89+VTD^]L)U.Q(6FG.:Q;"6S?V;P-'L"ZQ9Z*
M^YJWP7VL6U=7>\Q;VDAE8+VW?[;99#R9:-G*,=S3M TF6K9*=8C$K:X0Y^;<
MU:JM+N@^ANVDK,?+9=;CAV0]7BZS'O_.R!5G,D$#3'8!_^59<#R^2+EFF'?F
MPCTI21JU"W%1UO;7R2@Y #.22FA $)F)KZ34G/E?,HVOPU:[2"7]EM45?@WY
M9NQ=B=%=MUNIB( 4,K<Y6B/#M$M),&W.P@G'3*T^5",(.2N"'P1"R(/ I1N8
MM4F1EGYG@4&.TD;>\VU7+76M+=,S5!H> 4 S]7:+TF-"=K6(0)H^%_0D4#/4
M,^$3Q E7B)(_:XE9Y4J^7 =%E+)]H!5TU%&;:N>\']D\%P#4CC^4@C9>.-5/
MI3YB3R!%V'1 2N<@[!2X78SDA']*L,'86&?21VV;,FKO,0Y%0M956E\8T9D7
M;[_>\+69)&.NP0V=!7X^0EE4H%LH3Z13J#*OHA&-RRI&,DV%7%<5Z,)>?IX2
MS!4'EFM<[0MIN!J;P6E6XC/02M1E#KB^JXPL0?_^,JZ\Q2.SXA[D7Y$!BO7M
M@V$_&W-=J08;ODW56@G7RHFBLF59^HJHM.6DX2-4L;"8.LJ45)^;N&+&O[0J
MN.@)M%PE5#PO,[4:$9=5_0^[-^J^HK&7QL9PJG"DS(BRRZ9T48<Z4_5B)<X<
M[#S_(RN%XKR+N#L#1S K5@DEQ:X,X'8-&D/OR+](%8^JCY)FSC>RNRJW*7ZI
M=IHYR-;3C]!I_]([!.)*IY*R@7.%M:Z67S@3ZFE( G/G0!F@.48#>]0X).(Q
M<^9MTIVGJ93VJ'LZ>KNZR']<:WH^%WM6US1V=OJY.C>+@Y63#L5Q.:;=X/50
MWT6-#4)3+,7*K]]&??O:&+A3)62^?="( 620*]WC8"E[$9\4Z"3,H=2516&#
M/G FOTE.1HUFG1!E$^)P<[WT%:'3B2)*1#Q/JX OSYHJ$D'!DQ]N!8]WE%I,
MB6^Y!JL0)6WC9O1,++Z5#2,E/,I!X3-X=ZX@!5R03FLNJCL$@(Z^056C4J=Z
MO1'%T[4HE+^RN^S:-M7/BHEC8)K;XR:=A]T'9BRGM3%=:RL]B60QC%)=&$G=
M0GU"QVQ4!0VME$VBD@R'IB>Q^835)MI\PIU3]%32?;D$;21:R[!$>G7VD%JN
MSN7]6<"<M%$^%A/=B$A,J\!DUYK6VXM&_3(,.J/^T*K7C+2IB.8$FS6^U%MM
MCPN/GX08V4XCDL_/</2%JD'W"Q=*3M@5IO6GT7#NJE2D0*ANS' 8QGJZ/;XD
M*8TDG2C%<!5I1$7V3L=<V\P[?KEVN+ZZ(C;A) FG90HX0VN.PK7>"9>=O'RR
M<$J[B75WCSM7:^X= WHU&^_&YI4#L,V;)FKYNKQ=;U#/M^#W6WN(L!,Y L=K
M9ZO2;%O=+4?3G U7\&TGKT]K:<TW78$,]XC1>@TZ@_(*T)G30*<:R"L+GBW"
M]6H9X?HA$:Y7RPC7HD2X_(KFU;T&CN@AQK7>S!,J5Y-DC9B.)- [UK?(!W32
M,HD]$Z!J0SGM(U9+Z\O !*V4SF#[!95 7Z661JEQ4G2DQR>C>?9\6HRPP"&1
M+E&W=B+2$LS(M%(;<Q0H2*<Z-)H4!AG\Z@H'VL O5"*ZDGMV,M.UJ$"#:J2F
M95<$VQ0E6\DJ4&"RZ'H!&7<5<5,F5VC8?;1-;5Q6#0#E_C'&XLG]AY6895*!
MVG=*#+"GL #AAZ4'&!]AQ0LL@2U[RJV2 6= CPH1$8=B&A7QT&-K;KP!>1J[
MK*M5<.6#Q%E<P8)95R(7&0NE!^_T.B.//.H76<7NL=_E--[(H^VBF$J)WH22
MF-65.]7$3*STF5;>(VU!4E)4A=)==\ID['(/!U]+(@ID>OEZNR2N(7Y%J+N>
MJ$,HUZ/A<0AX-,1?YDG$URZ/>WT50."!5>2BI7$/[<2F4U9]I\XB&+S+;DWT
M=%+F&&!0 8I^/S.Q;[2<G.EG%F1 /[KE#'XM8D[H85JNT4A!1C-K#+UP: &-
M-/Q-U91L@ UX:?4Y5TG+E T:"$M#URE#;E$8\?8TB?5(1,ERT,WN%YE[)N3*
M^;#7:N?0T"WFH-N9$H5"6(ZI9G7,S22"K5(@*I>YC;'8B1L]-*!P?(-PTECH
MP!!*"AN.FQ4I17QOYO-,SFQKJ!]"KW0/S&[41:^^C#30B8^3UU*><Z?1B_"7
MW:3H<%F7(+5HDN(1L@UF26=%J/7JSMPYW-KMQP7,^+XJJ5PY:\"$^N-*.4?D
M](6J83K<!*E@!&\(6L,$?ZO%-3SP<3JC>IM2Y=C,2*,J6A.VJ(,&16DBRH0Q
M"Q6"(%.)BD%F[JC0HS?L AYN<6@LR*H7[O0)F(FJ3$UA!%47^7MI:YM7C"QF
MD<;0TJ2DF2\@SBW$340B*VIO900D9.\1%5F4F89^)6N"0KCB.OJ*8IR9G096
MP%TMC0-3P0J>R2)AUW^."H$#T7<\Z;GV@CL#SDH>ON+2(^?XJ54:._TC6T>L
MQ81)[>$B>H*>^JKA)A,)S["\9KPGRBBK83_$0 /@HXRXT[P+6Z 2PIB2R!OB
M'BE$#L7(30*M+M+]B36WU]PE"H?ATXQO*=^2:CF,L9BRG.XXKL(.'+'A21?^
M>\<"C_4*E<H061)+A3/DD%J,NSI2:R]%F_[S[]3< A1B]!6:,@QW/T1-+19?
M<#5*^AQ!ZN71J#OJ$VY14K@H6,':E)KHUEIOO6H"KAOMH3+$?(,,_X*$5"Z3
MK >-/Q7C-VN3 <K-"]P,/N"-9&;T'7QC%R6E(U0;94,7Y0.5@5?SN*0_*>54
M4 3<N=FJ ,Q:D572/K$==&;#W6P"3/C9#7<IU_<AAL]=IJ^WI"9B9;5'-E.M
MRDYJK((]4..? M3MU%J"\463O!7D!(9)Q8>PN8:G=PO^50,+4Q5$Z*U&&)9N
M:<WDLIJD)%5I9RNDK(4%K8IM5K-)NMZF%@<1]\6IM8E2&]3+9"A578TT8]2R
MP71/J;[&]PK..YGJ D?/ZZ(9:Q^U/+-5,\/YN3NMP$1@#&Q'H///XXGE-J^<
M(GXQGZW'^.PLFQ?B2<I82T)IL,&#M"QGU@Q);MF4@@ZF2Y4L&!*G,V>V2/7K
M9:3ZAT2J7R\CU8N*0/%Z[ACUNZ_OSUUP4#"E_C1#)/!>[IOA"W"I$9X+/8XC
M ?RJ!;3W"6S'?::#-JHJO-7SK>$.%C!O?5Z%V*HT3MZ"$!05H1M'K!$EC%/?
M$),#12H1)"WD%- 9B3;TK@81ME(PT/U-K,K[>Z,^P?0( J 44_" ];Z%ONH9
M/3P!67/-Q@Q*' 0BCOPU@!1+1>*Z[C%S0M*L*J=WS(;*UNJ;V*EN)M?&!Y4^
MD-POA TL^$/^\Y !*9$^'+&>C(?X!-A?;^Z>N;DT)^@#U42TR?JT*XTI=N<3
M#X/93AQN"9A?70PD@IE&'2A>R-7PCIBK)M7/OK0U5B(,/ ,SO)-W,WNH5 VM
MFB',:Z.E@NF3I29 '7!O\Z.,G/*.O5!6[J.-G*I/NU!S,!0FSL2Q%TZ_GG.4
M9B X&IBCDE0MQ6H+,$:TZ+K.0*"80"[;V_B! 1<*@<>)Z^%B+TWGJS@EP[";
M#5 @=3@P#YOD&P5_B8$*8%AWP-G(\/$=/@1S(M98GSBAMXKWAZL8E4A![>Y]
M3:E-F/PP=II$,AL&$P>4RZ"H,RXI]03<?XZZ5W;M3 UE,AD,<Z1_1X528)G=
MFZ309:'BZ)A(NHH*AX*UEE?A8ITF4K><%<\ICU3!74625CA,W4HL(*&10+%G
MJK;2#QYP2FEZI"7#ZC;@APV*]5 O5?XM+C5JH2Q)SK8_5M'?_0'LM!/!$B[*
M#*SI8XU[B7_5X^7=/TY_KYECHW=&2P$)FPQ&5* YB+[3CW!U.EA013V[LDQ[
M-OQW]57Y?(XKX$0X?Y5#@(8ZYLNJ]S)$J@HCHKS#/*VB8<'Q0I7--R=4(3]?
MGBO<;XKLAB+*(&XRE:.@':7?< ,#5 #P-UBOID0W!N]84J^RF ]QEZX:7D5-
M:_58PUPWGLG;E8'J?''N,T]= V^[3#KO0/7@'O/4&7SXG@/537'C_//4I;_Y
M7@/5@VGSU)_ =FIMS0=J=Q134J=>Y8*S&J>DIID=L>!4]6<T#K?,#)!E)6VL
MVY!4? 0K:272H-IYU%<-!,(D(PW_+M,Z9'>H9/0;973'NBEEJ2'(FGO&YA)%
M^D*ER;9W0;V.<NG*IEA;J-43N4U7XAWUR(:O$3'-THTNKPPIY&;T'*%C3U0)
M75I0-;E&W&#4DRCE7\M[?+O7.6 %6Q'I$@.!S-%]T;H/GHLO%527;F/>#$[
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M224.\/%_CACWU8ASN^I6B@4,5BHWCF#D*O-(9HK2V]4&;I,L;^PI^&2>P;C
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MQV*!J%SBP8)%@)M-&V'?Z]J'MTWJU!WW>!N#/(^H%1XNSVH^IY+F<SM)*0)
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M'DR>._$&&*R6%D*C!G OF<Z,H]I6*F-=3$5HUCKBLW0G<<L/P"W'D&PV&+M
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M&&S'9LZDX&-: M]IQ$URIFJ]J<G6J)W:R:?E8FS;&<!M$[ERWKH#Q*><O:S
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MH]\Z.&Z+P_;Q\5GKZ*AS\OZ?S[:>T=^]L]:A_EM-J48;)E'D3S)8FO[7:U!
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MR@!=ID=\D97_0!HLI>#!_Y/8Y'U9.6KJDPS&PT!)(#'X@8O$CS%)Q<D/5%E
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M^CEB9Z>T^ -0/SP^FG9"SXQ7O-DP05?VF=&,?Q:4V>+&R\Q^5*#+-^[/-6/
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M0%HD8I$<;4A'K/9]$&S"IX+Q(!,AXP:$FB=&1""U&K:4N-?8WN+L3$1\QK6
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M:Q?I/DC3@\D.-TA$((S!(R-*F@VY@>0+PIH]^EE\S#!QBU"@P3."B-3LK\0
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M94R,Q5Y75'[7Y85G[G JC:"=^KJ%F(I(I;8O'8Q%ZB"/3>;/VSCDD\1S8F'
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MK;L2,Q%S5\#9K:[G(6\N+P;++EJA;<>8[!\/]@^V>=GA9B7713YDT%^P]LG
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M#P  $               @ $     8G-X+3(P,C P-3$T+GAS9%!+ 0(4 Q0
M   ( /B(LE!WP3<8& D  +AN   4              "  1 $  !B<W@M,C R
M,# U,31?9&5F+GAM;%!+ 0(4 Q0    ( /B(LE G\]\G' P  *"1   4
M          "  5H-  !B<W@M,C R,# U,31?;&%B+GAM;%!+ 0(4 Q0    (
M /B(LE#Z(X9'7P@  %-I   4              "  :@9  !B<W@M,C R,# U
M,31?<')E+GAM;%!+ 0(4 Q0    ( /B(LE!?_:_"0QH  !N/   /
M      "  3DB  !S<S$W,S<X,5\X:RYH=&U02P$"% ,4    " #XB+)00F2\
MCH.!  #\,@, $P              @ &I/   <W,Q-S,W.#%?97@P,3 Q+FAT
M;5!+ 0(4 Q0    ( /B(LE V"1XJS2@  $WB   3              "  5V^
M  !S<S$W,S<X,5]E># T,#(N:'1M4$L! A0#%     @ ^(BR4$:IZNS3*
M=N$  !,              ( !6^<  '-S,3<S-S@Q7V5X,#0P,RYH=&U02P$"
M% ,4    " #XB+)0</4A&#8/  #=2   $P              @ %?$ $ <W,Q
M-S,W.#%?97@P-3 Q+FAT;5!+ 0(4 Q0    ( /B(LE#5M=KX\0H  ! I   3
M              "  <8? 0!S<S$W,S<X,5]E>#DY,#$N:'1M4$L%!@     *
-  H A@(  .@J 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>ss173781_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:BSX="http://BSX/20200514"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="bsx-20200514.xsd" xlink:type="simple"/>
    <context id="From2020-05-14to2020-05-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2020-05-14</startDate>
            <endDate>2020-05-14</endDate>
        </period>
    </context>
    <context id="From2020-05-142020-05-14_custom_CommonStock0.01ParValuePerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BSX:CommonStock0.01ParValuePerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-14</startDate>
            <endDate>2020-05-14</endDate>
        </period>
    </context>
    <context id="From2020-05-142020-05-14_custom_Sec0.625SeniorNotesDue2027Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BSX:Sec0.625SeniorNotesDue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-14</startDate>
            <endDate>2020-05-14</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2020-05-14to2020-05-14">0000885725</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2020-05-14to2020-05-14">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2020-05-14to2020-05-14">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2020-05-14to2020-05-14">2020-05-14</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2020-05-14to2020-05-14">BOSTON SCIENTIFIC CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2020-05-14to2020-05-14">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2020-05-14to2020-05-14">1-11083</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2020-05-14to2020-05-14">04-2695240</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2020-05-14to2020-05-14">300 Boston Scientific Way</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2020-05-14to2020-05-14">Marlborough</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2020-05-14to2020-05-14">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2020-05-14to2020-05-14">01752-1234</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2020-05-14to2020-05-14">508</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2020-05-14to2020-05-14">683-4000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2020-05-14to2020-05-14">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2020-05-14to2020-05-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2020-05-14to2020-05-14">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2020-05-14to2020-05-14">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2020-05-142020-05-14_custom_CommonStock0.01ParValuePerShareMember">Common Stock, $0.01 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2020-05-142020-05-14_custom_CommonStock0.01ParValuePerShareMember">BSX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2020-05-142020-05-14_custom_CommonStock0.01ParValuePerShareMember">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2020-05-142020-05-14_custom_Sec0.625SeniorNotesDue2027Member">0.625% Senior Notes due 2027</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2020-05-142020-05-14_custom_Sec0.625SeniorNotesDue2027Member">BSX27</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2020-05-142020-05-14_custom_Sec0.625SeniorNotesDue2027Member">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2020-05-14to2020-05-14">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
